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Abstract 
 
The amphidinolides are marine macrolides extracted from dinoflagellates of the 
genus Amphidinium. To date, 37 amphidinolides have been isolated and identified, 
most of them possessing cytotoxicity against human cancer cell lines. Among 
these, amphidinolides C, F, C2 and C3 represent synthetic targets of interest 
owing to their scarcity, structural complexity and promising biological activities. 
 
 
 
 
 
 
 
This thesis describes the work realised towards the total synthesis of 
amphidinolides C and F, with a focus on the different strategies investigated and 
the key fragments synthesised. 
In the first approach, the C18−C29 fragment of amphidinolide F was prepared 
using an intramolecular etherification of an epoxide under acidic catalysis to 
produce the 2,5-trans-disubstituted tetrahydrofuran ring featured in the natural 
product. Unfortunately, dithiane alkylation with the C1−C17 iodide counterpart 
generated the desired coupling product in low yield. A second approach proposing 
to build the C17−C18 bond by a silicon-tethered RCM proved unsuccessful, 
because the requisite diene could not be obtained. It was then envisioned to form 
the C18−C19 bond by displacement of a triflate with an alkyne and install the 
ketone at C18 by a protoborylation/oxidation sequence. To this end, the C19−C29 
triflate precursor was synthesised. Displeasingly, the C1−C18 alkyne counterpart 
(work by Dr Filippo Romiti) could not be prepared and coupling of the two 
fragments was not attempted. In the latest approach, the C10−C29 fragment of 
amphidinolide F was obtained employing a boron-mediated aldol condensation 
and a dithiane alkylation to form the C13−C14 and C18−C19 bonds. Several end-
game strategies were examined including the successful Yamaguchi esterification 
of the C13-epi C10−C29 fragment and the C1−C9 acid. A challenging Stille cross-
coupling was then effected to close the macrocycle but only yielded the desired 
macrolactone in trace amounts after global desilylation. 
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1. Introduction 
 
1.1. Drug Discovery from the Marine World 
 
Natural products can be defined as substances produced by living organisms 
found in nature and are characterised by a high structural diversity and complexity. 
The latter feature means that natural products cover a wide area of biologically 
relevant chemical space.1 In fact, the elaborate geometry of these molecules 
enables an efficient interaction with their biological targets by complementing 
precisely their spatial environment. In this regard, nature represents a unique 
source and an inspiration for drug discovery. To this day, many of the world's best 
selling pharmaceutical products are derived from natural products or have been 
inspired by them.  
 
Even though most of the currently available treatments derived from nature are 
based of terrestrial natural products, the marine world has proven to be an 
incredibly rich source of chemical and biological diversity. 2  In this mostly 
unexplored environment, which represents 70% of the planet's surface and 90% of 
the biosphere, marine organisms produce a fascinating range of structurally 
elaborate and diverse secondary metabolites as protection against aggressive 
conditions such as elevated pressures, extreme temperatures and the absence of 
light, or for defense against predators (Figure 1). These secondary metabolites, 
which are not essential to the survival of the organism but provide it with an 
evolutionary advantage, often possess interesting biological activities and can 
involve unprecedented mechanisms of action.3  
 
 
 
 
 
 
 
 
 
Figure 1. Examples of Marine Secondary Metabolites 
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The structural diversity and novelty of marine natural products make them 
excellent candidates for the investigation of new bioactive molecules with a high 
pharmacological potential. 
Nevertheless, the transition from drug discovery to a pharmaceutical product is 
paved with challenges. The determination of full bioactivity, elucidation of the 
mechanism of action, and the undertaking of preclinical and clinical studies are 
generally unfeasible because low yields of natural products are usually obtained 
from natural sources and access to the marine environment is technically difficult. 
This supply problem has stimulated tremendous interest in the synthesis of such 
compounds. To this end, a viable total synthetic approach is often necessary, to 
provide reasonable amounts of the bioactive molecule, as well as allowing further 
structure-activity relationship (SAR) studies to be conducted to identify simpler 
potent analogues which are easier to access by means of synthesis.3  
A striking example is halichondrin B (1), a marine macrolide isolated from the sea 
sponge Halichondria okadai in Japan, which displays potent cytotoxicity (Figure 
2)4. This complex product, bearing 32 stereocentres, was first synthesised by Kishi 
and co-workers in 1992.5 Further to the understanding of its mechanism of action, 
which involves the inhibition of tubulin, SAR studies led to the more potent, more 
stable and structurally simpler analogue eribulin (2). Its mesylate form was 
approved by the FDA in 2010 for metastatic breast cancer under the name 
Halaven. 
 
 
 
 
 
 
 
 
 
Figure 2. From Halichondrin B to Eribulin 
 
Consequently, total synthesis is one of the key activities required to provide 
answers to the challenges of drug discovery and to pave the way from marine 
natural products to pharmaceutical products used in the clinic. 
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1.2. The Amphidinolide Family of Natural Products 
 
The amphidinolides are structurally complex marine macrolides extracted from 
dinoflagellates of the genus Amphidinium, endosymbionts naturally found in the 
inner wall cells of Okinawan acoel flatworms from the Amphiscolops species.6 
These microorganisms are a rich source of secondary metabolites and are also 
amenable to laboratory culture, which make them readily available for further 
studies. To date, 37 amphidinolides have been isolated and identified by 
Kobayashi and co-workers; most of them possess cytotoxicity against human 
cancer cell lines (Figure 3).7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Various Examples of Amphidinolides 
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This family of natural products is characterised by the wide structural diversity of 
the compounds in it, with a particular prevalence of the macrolactone compounds 
with ring size varying from 12 (e.g. amphidinolides Q, 6) to 29 (e.g. amphidinolide 
M). However, common general features such as exo-methylene groups, 1,3-diene 
units, multiple sites of unsaturation and the inclusion of oxacycles (epoxides, 
tetrahydrofurans and tetrahydropyrans) within the macrocycle are evident across 
the entire series.  
 
Almost all amphidinolides display encouraging levels of cytotoxic activity against 
two cancer cell lines: KB human epidermoid carcinoma cells and L1210 murine 
lymphoma cells.8 Among those macrolides, amphidinolides B (3), C (4) and N (5) 
exhibit truly remarkable potencies (Table 1). 
 
Amphidinolide Macrolactone Size 
Cytotoxicity (IC50, ng/mL) 
L1210 KB 
B (3) 26 0.14 4.2 
C (4) 25 5.8 4.6 
N (5) 26 0.05 0.06 
 
Table 1. Cytotoxicity of Amphidinolides B, C and N 
 
The unprecedented and unique molecular architecture of this set of molecules, 
their scarcity and their biological properties make them attractive targets for total 
synthesis,9 because this is the most viable method of providing sufficient material 
to allow the determination of the full bioactivity and mechanism of action and to 
pave the way for further SAR development. To this end, the Clark group has a 
particular interest in those amphidinolides that bear one or more tetrahydrofuran 
units, with the intention of applying its expertise in the synthesis of such 
heterocycles and their incorporation in complex structures.10 
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1.3. Amphidinolides C and F: Structure, Isolation and Bioactivity 
 
Amphidinolides C (4), F (7), C2 (8) and C3 (9) are 25-membered lactones 
possessing a common macrocyclic core and feature eleven or twelve stereogenic 
centres, two 2,5-trans substituted tetrahydrofurans, a 1,4-diketone and two 1,3-
diene units, one of which contains an exocyclic alkene (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Structures of Amphidinolides C, F, C2 and C3 
 
Amphidinolide C (4) was isolated in 1988 by Kobayashi and co-workers. It was the 
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structure of amphidinolide C was elucidated by extensive 2D NMR studies. Further 
NMR experiments combined with Mosher ester analyses of amphidinolide 
derivatives,12 as well as comparison between synthetic fragments and degradation 
products,13 allowed a full determination of the absolute configuration for the 12 
stereocentres featured in the natural product.14 Later, closely related macrocycles 
were isolated by the Kobayashi group: amphidinolide F 15  (7) in 1991, 
amphidinolide C216 (8) in 2004 and amphidinolide C317 (9) in 2010. Even though 
the structures of amphidinolides C2 and C3 were established at the time, the low 
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isolated yield of amphidinolide F prevented the structure of this natural product to 
be determined with a high degree of certainty. It was only after the first total 
synthesis of amphidinolide F by Carter and co-workers18 in 2012 that the structure 
elucidation and stereochemical assignment of this macrolactone was confirmed. 
 
Among the subgroup, amphidinolide C displays the highest potency with a 
remarkable IC50 = 4.6 ng/mL against KB human epidermoid carcinoma cells and 
an IC50 = 5.8 ng/mL against L1210 murine lymphoma cells (Table 2). Interestingly, 
amphidinolides C2, C3 and F, whose only structural difference is located at the 
C29 position of the side chain, exhibit lower biological activity towards the 
previously mentioned cancer cells than amphidinolide C. This observation 
underlines the likely importance of this area in terms of establishing a SAR. 
 
Amphidinolide Isolation Yield Cytotoxicity (IC50, µg/mL) 
 (%) L1210 KB 
C (4) 0.0015 0.0058 0.0046 
F (7) 0.00001 1.5 3.2 
C2 (8) 0.00015 0.8 3.0 
C3 (9) 0.00006 7.6 10.0 
 
Table 2. Bioactivity and Isolation Yields of Amphidinolides C, C2, C3 and F 
 
 
1.4. Previous Syntheses of Amphidinolides C and F 
 
The rarity of amphidinolides C, F, C2 and C3, their structural complexity and 
promising biological activities predestined these molecules for synthetic 
investigations. Fragment syntheses have been reported by the research groups of 
Roush,19 Armstrong,20 Spilling,21 Mohapatra,22 Pagenkopf,23 Figadère,24 Forsyth25 
and Clark26. The first total synthesis of amphidinolide F was completed by the 
Carter group,18 which later employed a similar strategy to produce amphidinolide 
C. 27 Finally, Fürstner and co-workers reported concise and efficient syntheses of 
amphidinolides C and F.28 This work will be discussed in detail in this section. 
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1.4.1. Roush: Diastereoselective [3+2]-Annulation Reaction 
 
In 2004, Roush and co-workers reported the synthesis of the C11−C29 fragment 
of amphidinolide F, followed by the C1−C9 fragment of amphidinolides C and F 
four years later.19 Their approach relied on a diastereoselective [3+2]-annulation 
reaction between a functionalised allylsilane and ethyl glyoxylate to prepare the 
key trans-tetrahydrofurans, a methodology developed within the group.29 
The retrosynthetic analysis proposed the assembly of amphidinolide F (7) through 
two major fragments 10 and 11 via a late-stage cross coupling and 
macrolactonisation sequence (Scheme 1). Fragments 10 and 11 were to be 
derived from tetrahydrofurans 12 and 13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Roush's Retrosynthetic Analysis 
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arrangement 17 features a syn-synclinal arrangement of the π reacting system, 
where the alkene lies syn to the carbonyl oxygen, providing the lowest energy 
pathway due to favourable HOMO-LUMO interactions.31  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. trans-Tetrahydrofuran 12 Elaboration 
 
Reduction of the ethyl ester followed by conversion of alcohol 18 to alkyl iodide 19 
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Scheme 3. Aldehyde 22 Synthesis 
 
After formation of the dicyclohexylboron enolate of methyl ketone 23 and its 
addition to aldehyde 22, β-hydroxy ketone 24 was obtained in 93% yield as a 
single diastereomer (dr > 20:1), as a consequence of 1,4-stereoinduction 
(Scheme 4). The high diastereoselectivity observed in this Cy2BCl-mediated aldol 
reaction is to be linked to the relative steric and electronic properties of the three 
substituents at the α stereocentre of the boron enolate intermediate. 32  It is 
postulated that the 1,4-syn aldol addition proceeds via the favoured boat-shaped 
transition state 25, which involves a stabilising formyl hydrogen bond with the PMB 
ether oxygen. The diastereomeric differentiation originates from A(1,3) allylic strain 
within the enolate. In the preferred transition state 25, this strain is minimised due 
to a gauche interaction between a hydrogen and the enolate double bond, and si-
face attack of the aldehyde is observed. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Cy2BCl-Mediated Aldol Reaction and Transition States 
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Further Evans-Tishchenko reduction of β-hydroxy ketone 24 afforded anti-1,3-
benzoate 27 as the major product in a 11:1 dr (Scheme 5). The stereochemical 
outcome of this reaction can be rationalised by consideration of the chelated 
transition state 26. The C11−C29 fragment 30 was completed through a two-step 
stannylation/iododestannylation to give vinyl iodide 28 followed by a Stille cross-
coupling with vinylstannane 29. Vinyl iodide 28 was completed in 18 steps and 
with an overall yield of 10%. The authors envisioned using vinyl iodide 28 as the 
key handle to install a range of multiple side chains in order to prepare analogues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5. Completion of Fragment C11−C29 
 
Following the successful synthesis of the C11−C29 fragment, the preparation of 
the C1−C9 fragment was reported, including two different approaches to the 
synthesis of the tetrahydrofuran ring.19b First, allylsilane 32 was synthesised in two 
steps from methyl ester 31 using an enantioselective insertion of a rhodium 
carbenoid, generated from the corresponding diazoester intermediate, into the 
Si−H bond of phenyldimethylsilane (Scheme 6).33 Conversion of the methyl ester 
into a silyl ether gave allylsilane 33 in good yield. The key trans-tetrahydrofuran 13 
was obtained as a single diastereomer in 82% yield using a SnCl4-promoted [3+2]-
annulation reaction and was further converted into aldehyde 34 in six steps. 
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Scheme 6. Aldehyde 34 Formation 
 
Using γ-borylallylborane 35, anti-diol 36 was obtained from aldehyde 34 in 47% 
yield and with a 6:1 dr (Scheme 7). The final C1−C9 fragment 37 was obtained in 
five steps, including conversion of the dithiane moiety into the corresponding 
methyl ester and ozonolysis of the alkene to produce its aldehyde counterpart. The 
total sequence involved 17 steps and was accomplished with a 4% overall yield.    
 
 
 
 
 
 
 
Scheme 7. C1−C9 Fragment Completion 
 
To improve the step-count of this synthetic sequence, an alternative method to 
provide the trans-tetrahydrofuran was implemented (Scheme 8). Using the Still-
Gennari modification of the Horner-Wadsworth-Emmons (HWE) olefination, 
glyceraldehyde isopentylidene acetal 38 was converted into Z-enoate 39 in 
excellent yield and high selectivity (20:1, Z:E). Subsequent acid-catalysed 
deprotection of the ketal triggered an in situ lactonisation of the γ-hydroxy ester. 
Hydrogenation of the butenolide installed the C4 stereocentre in a 
diastereoselective fashion. Further protection of the alcohol gave lactone 40 in 
78% yield over three steps and with an excellent dr. Reduction and olefination 
using a stabilised phosphonium ylide provided alkene 41. 
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Scheme 8. Second Generation Elaboration of the trans-Tetrahydrofuran 
 
Finally, tetrahydrofuran 42 was formed by treatment of enoate 41 with TBAF in 
THF via an intramolecular Michael cyclisation reaction. The diastereoselectivity of 
this kinetically controlled process can be explained by a reduction of the A(1,3) 
strain as can be seen in transition state 43a, which is favoured over the more 
sterically demanding transition state 43b (Scheme 9). 
 
 
 
 
 
 
 
Scheme 9. Rationalisation of the Observed Diastereoselectivity 
 
The target fragment was completed using similar transformations as the ones 
outlined in the first-generation route, leading to aldehyde 44 in 12 steps and with 
21% overall yield (Scheme 10). 
 
 
 
 
 
Scheme 10. Second Generation C1−C9 Fragment Completion 
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1.4.2. Armstrong: Sharpless Dihydroxylation / Iodocyclisation 
 
Armstrong and co-workers reported the synthesis of the C18−C29 fragment of 
amphidinolide F, relying on a Sharpless asymmetric dihydroxylation reaction 
followed by iodo-etherification to build the desired 2,5-trans-disubstituted 
tetrahydrofuran.20 The proposed retrosynthesis disconnected the macrolactone at 
the C17−C18 bond, the C9−C10 diene bond, and the ester bond, revealing 
dithiane 45 as the targeted fragment of their work (Scheme 11). Diester 46 was 
obtained by a desymmetrisation of dienoate 47 using a mono-Sharpless 
dihydroxylation/iodocyclisation sequence. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 11. Armstrong's Retrosynthesis 
 
Sharpless asymmetric dihydroxylation of dienoate 47, using AD-mix-β 
(K2OsO42H2O, (DHQD)2PHAL, K3Fe(CN)6) and methanesulfonamide, delivered 
diol 48 in 85% yield and a moderate 73% ee. (Scheme 12). Further iodocyclisation 
generated trans-tetrahydrofuran 49 with an improved 93% ee, upon 
recrystallisation. A standard deiodination protocol followed by a selective reduction 
of the α-hydroxy ester led to diol 50. Aldehyde 51 was obtained by a simple 
protection/deprotection sequence and subsequent oxidation of the primary alcohol. 
The aldehyde was readily subjected to an E-selective olefination to provide the 
corresponding alkene in a 87:13 E:Z ratio. Finally, the dithiane moiety was 
installed by reduction of the ethyl ester and subsequent treatment of the aldehyde 
with 1,3-propanedithiol in the presence of a mild Lewis acid. Formation of the 
C18−C29 fragment 45 was completed in a total of 12 steps and 4% overall yield. 
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Scheme 12. Fragment C18−C29 Synthesis 
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1.4.3. Spilling: Nickel-catalysed Homoallylation 
 
The Spilling group reported their efforts towards the synthesis and elaboration of a 
variety of tetrahydrofuran-containing fragments that are potentially useful for the 
synthesis of amphidinolide C or F.21  
First, their attention focused on preparing trisubstituted tetrahydrofuran rings with 
the correct 3,6-trans and 3,4-syn relationships, as featured in the amphidinolide C 
series (Scheme 13).21a Their strategy relied on a nickel-catalysed homoallylation 
methodology developed by Tamaru and co-workers to access 1,3-anti unsaturated 
alcohols (52) with high diastereoselectivity.34 
 
 
 
 
 
Scheme 13. General Retrosynthetic Outline 
 
The Tamaru reaction was first illustrated in an example for which mechanistic 
considerations accounting for the regioselectivity and stereoselectivity have been 
proposed (Scheme 14). The regioselectivity of the reaction is likely to be 
determined by the electronic densities of the diene extremities, the terminal with 
the highest electron density reacting with the aldehyde. First, oxidative cyclisation 
of a Ni0 species across isoprene and the aldehyde is believed to lead from 
transition state 54 to two diastereomeric intermediates 55a and 55b. In this 
transition, the diene acts as a nucleophile towards the aldehyde and as an 
electrophile towards the Ni0 species, with electron donation from the Ni0. The 
oxidative cyclisation reaction is accelerated by coordination of Et3B to the 
aldehyde. Intermediate 55b suffers from a 1,3-diaxial repulsion between the 
methyl of the isoprene and the substituent of the aldehyde and so the reaction 
proceeds through the more favourable intermediate 55a. Ethyl transfer from the 
boron to the nickel follows, concomitant to an ionic Ni−O bond cleavage, to form 
intermediate 56, which readily undergoes β-H elimination. Finally, reductive 
elimination provides the anti homoallylation product 53.  
 
 
4
3
O
6
R1 HH
CO2R
R1
OH
52
R1 H
O
+
Ni-catalysed Homoallylation
Introduction | 16 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 14. Ni-catalysed Homoallylation Example and Rationalisation 
 
Hemiacetal 58, derived from silyl protected erythronolactone 57, was identified as 
a suitable substituted aldehyde partner for the aforementioned strategy, as it 
possesses the 1,2-anti relationship found at the C7 and C8 positions of the 
targeted amphidinolides (Scheme 15). Unfortunately, the nickel-catalysed 
homoallylation reaction yielded the desired 1,3-anti product 59 with an 
unsatisfactory 1:6 dr. Even though the authors did not propose a rationalisation for 
this result, consideration of the Felkin-Ahn model can help explain this outcome, 
where the transition state corresponding to the Newman projection 60 is favoured 
due to reduced steric interactions. 
 
 
 
 
 
 
 
 
 
Scheme 15. Ni-catalysed Homoallylation of Hemiacetal 58 
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After separation, minor diastereomer 59 was subjected to a cross-metathesis 
reaction with methyl acrylate using Grubbs second-generation ruthenium catalyst, 
yielding α,β-unsaturated ester 61 in decent yield. Oxa-Michael cyclisation using 
DBU provided a mixture of tetrahydrofurans 62 and 63, as a result of partial silyl 
migration (Scheme 16). 
 
 
 
 
 
Scheme 16. C1−C9 Fragment Completion Attempt 
 
A moderate improvement of the stereochemical outcome was obtained when 
using phenylglycidal 64 as a partner for the homoallylation reaction. In this case, 
alcohol 65 was obtained as the major diastereomer with low selectivity (2.5:1 dr) 
(Scheme 17). Tetrahydrofuran 42 was completed in four additional steps. 
  
 
 
 
 
 
 
 
 
Scheme 17. C1−C7 Fragment Synthesis 
 
Further to these results, elaboration of a C18−C29 fragment of amphidinolide F 
was also reported.21b First, (S)-epoxide 66 was treated with allylmagnesium 
chloride and copper iodide to furnish alcohol 67 in good yield (Scheme 18). 
Subsequent cross-metathesis with (S)-carbonate 68 gave phosphonoallylic 
carbonate 69 in 78% yield as an inseparable 9:1 mixture of E and Z isomers. Tsuji-
Trost palladium-catalysed allylation led to tetrahydrofuran 70 in excellent yield. 
Vinylphosphonate 70 was then converted into β-ketophosphonate 71 using a 
three-step sequence that included hydroboration and oxidation.  
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Scheme 18. Synthesis of β-Ketophosphonate 71 
 
The mechanism of the Tsuji-Trost allylation reaction is outlined below (Scheme 
19). The catalytic cycle begins with the coordination of the Pd0 species to alkene 
72. Oxidative addition then proceeds with inversion of configuration leading to PdII 
species 73 and the leaving group is expelled. The nucleophile adds to the π-
allylpalladium complex with inversion of configuration. In the case of an 
unsymmetrical π-allylpalladium complex, this addition is also regioselective, as it 
favours the least substituted allyl terminus, regardless of the initial position of the 
leaving group. Finally, reductive elimination provides alkene product 74. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 19. Tsuji-Trost Allylation Reaction 
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Synthesis of the C18−C29 fragment was completed by HWE olefination and 
subsequent reduction of the dienone under Felkin-Ahn control, to afford alcohol 75 
as a single diastereomer in excellent yield (Scheme 20). Two related fragments - 
76 and 77 - were prepared in a similar fashion. 
 
 
 
 
 
 
 
 
Scheme 20. C18−C29 Fragment Completion 
 
 
1.4.4. Mohapatra: Ring-Closing Metathesis / Nozaki-Hiyama-Kishi Coupling 
 
In 2007, Mohapatra and co-workers reported the synthesis of the C19−C34 
fragment of amphidinolide C.22 First, the retrosynthetic analysis proposed to install 
the C29 stereocentre through a Nozaki-Hiyama-Kishi (NHK) coupling between 
aldehyde 78 and vinyl iodide 79 (Scheme 21). The C25−C26 alkene could be 
obtained by an olefination reaction. Further formation of the tetrahydrofuran ring 
was to be completed by a ring-closing metathesis (RCM) reaction to form the 
C21−C22 bond. Finally, regioselective opening of epoxide 81 with alcohol 82 
would provide diene 80, bearing three out of the four required stereocentres with 
the appropriate configuration. 
 
 
 
 
 
 
 
 
Scheme 21. Retrosynthetic Proposal 
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The synthesis started by the treatment of alcohol 82 and epoxide 81 with a 
catalytic amount of Cu(OTf)2 to yield diene 80 in 67% yield (Scheme 22).35 RCM 
using Grubbs second-generation catalyst delivered the corresponding 
dihydrofuran derivative 83 in good yield. Submission of the alkene to 
hydrogenation conditions and PMB cleavage led to key tetrahydrofuran 84. 
Oxidation of the primary alcohol and subsequent HWE olefination using 
phosphonate 85 gave ethyl ester 86 bearing the required diene moiety. 
Unsurprisingly, attempts to perform NHK coupling between the corresponding C29 
aldehyde and vinyl iodide 87 produced alcohol 88 as a 1:1 mixture of separable 
diastereomers. The required C19−C34 fragment was obtained in 14 steps and 
with 2% overall yield.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 22. Elaboration of the C19−C34 Fragment 
 
The mechanism involved in the NiII-catalysed NHK reaction is outlined below 
(Scheme 23).36 The first step is the reduction of NiII to Ni0, which then undergoes 
an oxidative addition and inserts into the C−halogen bond. Because CrII is a one-
electron donor, two equivalents are required for the reduction process. Further 
transmetallation of the organonickel species 89 with CrIII forms the 
organochromium nucleophile 90. Finally, this species reacts with the carbonyl 
partner 91. In this reaction, aldehydes react noticeably faster than ketones and 
high chemoselectivity can be achieved when both functionalities are present. A 
significant drawback of this transformation is the toxicity of the nickel and 
chromium salts used. 
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Scheme 23. NHK Reaction Mechanism 
 
 
1.4.5. Ferrié: Mukaiyama Aldol Reaction / C-Glycosylation 
 
Ferrié and co-workers developed a synthetic approach towards the C1−C9 
fragment of amphidinolides C and F.24 Their strategy relied on disconnection of the 
macrolactone in three main fragments: vinyl iodide 92, lactol derivative 93 and 
stannane 94 (Scheme 24). Completion of the fragment 94 included a key 
stereoselective vinylogous Mukaiyama aldol reaction with silyloxyfuran 95 and a 
C-glycosylation to install the methyl ester with the required trans configuration.  
 
 
 
 
 
 
 
 
 
 
 
Scheme 24. General Retrosynthetic Analysis 
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The synthesis began by the vinylogous addition of furan 95 on aldehyde 96 in the 
presence of TMS triflate (Scheme 25) to give a 3:1 mixture of the TMS ethers 97 
and 98 in 80% yield. The exclusive C7−C8 anti relationship can be rationalised by 
a Felkin-Ahn control favouring an attack on the si-face of the aldehyde, as shown 
with Newman projection 99. On the other hand, the sterically less demanding open 
transition state 100, with anti-periplanar attack of the aldehyde, can account for the 
preferential formation of the C6−C7 syn adduct. 
 
 
 
 
 
• C7−C8 anti relationship: Felkin-Ahn control 
 
 
 
 
 
 
• C6−C7 syn relationship: open transition state 
 
 
 
 
 
 
Scheme 25. Vinylogous Mukaiyama Aldol Reaction 
 
Further hydrogenation of the double bond in lactone 97 under acidic conditions in 
MeOH proceeded only on the less hindered face of the lactone to deliver the 
corresponding triol as a single diastereomer (Scheme 26). This triol was readily 
converted into tris-TBS ether 101 in excellent yield. Subsequent partial reduction 
of the lactone and acetylation of the lactol produced the acetate derivative 102 in 
96% yield. The C-glycosylation product was obtained by treatment of the acetate 
with the titanium enolate generated from the achiral acetyloxazolidinethione 103,37 
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followed by methanolysis. This reaction proceeded with excellent control of the 
diastereoselectivity to deliver the 2,5-trans-tetrahydrofuran 104. Selective 
cleavage of the primary TBS ether, oxidation with TEMPO and trichloroisocyanuric 
acid as co-oxidant,38 followed by Seyferth-Gilbert homologation using the Ohira-
Bestmann reagent 105 furnished terminal alkyne 106. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 26. C4 Methyl Installation and C-Glycosylation 
 
The final step towards the completion of the C1−C9 fragment was regioselective 
hydrostannylation of hindered terminal alkyne 106 (Scheme 27). Using a protocol 
developed by Kazmaier,39 which involved the use of an excess of n-Bu3SnH and a 
catalytic amount of molybdenum complex Mo(CO)3(CNt-Bu)3,40 1,1-disubstituted 
olefin 107 was obtained as the major product alongside E-substituted olefin 108, 
as a minor component, in a 4:1 ratio. The two regioisomers were separated by 
silica gel chromatography to afford pure C1−C9 fragment 107 in 70% yield. In 
conclusion, a short and elegant synthesis of highly functionalised fragment 107 
was completed in nine steps and with 16% overall yield. 
 
 
 
 
Scheme 27. Metal Catalysed Hydrostannylation of Alkyne 106 
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The regioselectivity observed in the molybdenum-catalysed hydrostannylation 
reaction can be rationalised by steric considerations (Scheme 28).39 After 
oxidative addition into the tin hydride bond and coordination of alkyne 109 to give 
the intermediate 110, insertion of the alkyne into the molybdenum tin bond occurs 
so that the sterically more demanding molybdenum fragment is added to the less 
hindered terminus of the alkyne, leading to intermediate 111. Finally, reductive 
elimination completes the catalytic cycle to form 112. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 28. Mechanistic Rationale for the Mo-catalysed Hydrostannylation 
 
 
1.4.6. Pagenkopf: Cobalt Catalysed Mukaiyama Oxidative Cyclisation 
 
The general approach of the Pagenkopf group to the synthesis of this series of 
macrolactones featured general disconnections that are similar to those 
highlighted previously, revealing the tetrahydrofuran-containing fragments 11323a 
and 11423b as the focus of their work  (Scheme 29). 
 
 
 
 
 
 
 
Scheme 29. General Disconnections of the Macrocycle 
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The strategy that was adopted by Pagenkopf and co-workers to access the 
C18−C34 fragment 113 of amphidinolide C relied on the Mukaiyama oxidative 
cyclisation of alkenol 117 using a cobalt catalyst developed within their group 
(Scheme 30). The diene side chain was to be installed by the diastereoselective 
alkynylation of aldehyde 115 by enyne 116. 
 
 
 
 
 
 
 
 
Scheme 30. Approach Towards the C18−C34 Fragment 
 
The tetrahydrofuran segment was assembled from chiral non-racemic epoxide 118 
in only four steps (Scheme 31). γ,δ-Unsatured alcohol 117 was converted into 
trans-tetrahydrofuran 120 by means of an oxidative Mukaiyama cyclisation 
reaction, a transformation in which molecular oxygen acts as the stoichiometric 
oxidant. Cobalt catalyst 119 had been developed by the Pagenkopf group to 
promote this reaction.41 Subsequent Swern oxidation provided aldehyde 115. 
 
 
 
 
 
 
 
 
Scheme 31. Elaboration of the trans-Tetrahydrofuran Segment 
 
In order to explain the 5-exo-ring closure and the preferred formation of the 2,5-
trans-tetrahydrofuran, Hartung and co-workers have proposed a mechanistic 
interpretation of the outcome (Scheme 32).42 First, oxygen activation would occur 
by binding to CoII leading to adduct 121. Intermediate 122 would furnish radical 
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cation 123, followed by 5-exo attack of the hydroxyl oxygen atom. A 
stereochemical model where the alkenol chain in 122 and 123 would adopt a 
chair-like conformation to direct substituents in the equatorial positions is thought 
to account for the 2,5-trans relationship observed. Finally, in the presence of a 
suitable hydrogen donor, alcohol 124 and HOCoIII would be obtained. CoII 
regeneration would occur via a hydride shift from coordinated isopropanol.  
 
• Oxygen activation:  
 
• Oxidative ring closure: 
 
 
 
 
 
 
 
 
 
• CoII regeneration: 
 
 
 
 
 
Scheme 32. Mechanistic Interpretation of the Oxidative Cyclisation Reaction 
 
The required enyne counterpart was then prepared (Scheme 33). Starting from 
known 2-methylenehexanal (125), acetylide addition and manganese mediated 
oxidation delivered ketone 126. Subsequent enantioselective Corey-Bakshi-
Shibata (CBS) reduction using (S)-methyl-oxazaborolidine 127 yielded alcohol 128 
with 90% ee and in 81% yield over three steps. Further protecting group 
manipulation and installation of the required methyl group via Michael addition on 
a propargylic ester intermediate furnished enoate 129. Finally the ester 
functionality was converted into alkyne 116 by the use of a four-step protocol. 
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Scheme 33. Enyne Side Chain 116 Formation 
 
The CBS reduction of ketones is thought to proceed as follows (Sceme 34).43 
First, complexation of the borane to the nitrogen atom of oxazaborolidine 127 
occurs. Ketone 130 then coordinates to the endocyclic boron and then hydrogen 
transfer from the NBH3- unit to the carbonyl takes place via a six-membered 
transition state, as shown in intermediate 131. Finally, the catalytic species is 
regenerated. As proposed by Liotta, 44  the enantioselective outcome can be 
explained by a chair arrangement in 131, in which the 1,3-diaxial interaction 
between the oxazaborolidine methyl group and the large or small substituents of 
the ketone dictates the face of the aldehyde that will undergo the hydride transfer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 34. CBS Reduction Mechanism 
125
O 1) Me3SiCCH     n-BuLi
2) MnO2, CH2Cl2
126
O
TMS
128
OH
TMS
127, BH3•THF
81% (3 steps)
90% ee
N B
O
Me
Ph PhH
4 steps
         70%
129
OTBS
i-PrO2C
116
OTBS1) i-Bu2AlH2) MnO2
3) CBr4, PPh3
4) n-BuLi
 76% (4 steps) (S)-Me-CBS127
N B
O
Me
Ph PhH
127
N B
O
Me
Ph PhH
H3B
N
B O
HB
RS
H
Me
RL
H
O
H
PhPh
131
BH3•THF
RL
O
RS
RL >> RS
130
N
B O
HB
RS
H
Me
RL
H
O
H
PhPh
RL
OH
RS RL
OBH2
RS
work-up
Introduction | 28 
Finally, treatment of the lithium acetylide of alkyne 116 with aldehyde 115 in 
methyl t-butyl ether at −90 °C furnished propargylic alcohol 132 with a C23−C24 
anti relationship with high diastereoselectivity (20:1 dr) under Felkin-Ahn control 
(Scheme 35). Further inversion of configuration at the C23 alcohol under 
Mitsunobu conditions followed by reduction with Red-Al provided the C18−C34 
fragment 113 in a total of 17 steps and in 26% overall yield. 
 
 
 
 
 
 
 
 
 
Scheme 35. Completion of C18−C34 Fragment 113 
 
Following completion of the synthesis of the C18−C34 fragment, efforts were 
directed towards the preparation of its C1−C9 counterpart (Scheme 36).23b 
Starting from chiral non-racemic epoxide 133, the alkenol cyclisation precursor 
134 was prepared in nine steps. The sequence included homologation via 
formation of an enol ether by Schlosser modification of the Wittig olefination and 
subsequent hydrolysis. The key cobalt-catalysed oxidative cyclisation reaction 
furnished 2,5-trans-tetrahydrofuran 135 in excellent yield and with high dr. 
Aldehyde 136 was obtained using a standard Parrikh-Doering oxidation reaction. 
 
 
 
 
 
 
 
 
 
Scheme 36. C3−C6 Tetrahydrofuran Preparation 
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Aldehyde 136 was converted into α,β-unsaturated ester 138 by a Still-Gennari 
olefination with phosphonate 137 to provide the desired alkene as a mixture of 
isomers (14:1, Z:E) (Scheme 37). Installation of the appropriate stereocentres at 
the C7 and C8 positions was effected by a Sharpless asymmetric dihydroxylation. 
The resulting diol was obtained as a 5:1 mixture of inseparable diastereomers 
which were readily protected to acetonide 139. Further transformations installed 
the methyl ester functionality as well as the terminal alkyne featured in adduct 140. 
Finally, hydrostannylation under the conditions used by Ferrié and Figadère in 
their synthesis of a similar fragment24 provided 1,1-disubstituted vinyl stannane 
114, and the lengthy 23-step sequence was completed in 10% overall yield. 
 
 
 
 
 
 
 
 
 
 
Scheme 37. Elaboration of C1−C9 Fragment 114 
 
 
1.4.7. Forsyth: Alkenyllithium Addition / Peterson Olefination 
 
In 2013, the Forsyth group reported the syntheses of both the C1−C14 (142) and 
C15−C25 (141) fragments of amphidinolides C and F (Scheme 38).25 The 
retrosynthetic approach that was adopted involved the usual macrolactone 
disconnection at the C1 ester bond and the use of a sulfone alkylation reaction, 
similar to the one employed by Carter and co-workers,18,27 to form the C14−C15 
bond. Finally, the C9−C10 bond was to be constructed by addition of an 
alkenyllithium species, generated from vinyl iodide 144, to aldehyde 143. The 
originality of this strategy relied on a potential late-stage installation of the 
C26−C34 polyene side chain after elaboration of the macrocycle, in order to 
facilitate the generation of analogues, a goal that has not been accomplished yet. 
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Scheme 38. Main Retrosynthetic Disconnections 
 
The synthesis of thioether 141 started with reduction of lactone 145 and Wittig 
olefination of the lactol intermediate to provide α,β-unsaturated ester 146 in 
excellent yield (Scheme 39). Further Mukaiyama aerobic alkenol cyclisation using 
cobalt complex 147 developed by Hartung45 yielded trans-tetrahydrofuran 148 as 
a single diastereomer in which the C20, C23 and C24 stereocentres were 
introduced with the appropriate configuration. In four additional steps, the 
acetonide segment was converted into the corresponding PMB ether 149.     
 
 
 
 
 
 
 
 
 
 
 
Scheme 39. C20−C23 Tetrahydrofuran 149 Preparation 
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The ester segment of tetrahdyrofuran 149 was converted into phosphonium iodide 
151 via iodide 150 (Scheme 40). Coupling of the anion of phosphonium 151 with 
aldehyde 152 under Wittig conditions furnished alkene 153 (15:1, Z:E) in 73% 
yield. Finally, ketone 141 was prepared in moderate yield by a sulfur-directed 
regioselective Wacker oxidation, under conditions initially proposed by Raghavan 
for the oxidation of internal alkenes.46 In this case, the sulfide moiety directs 
palladium to the proximal terminus of the tethered olefin and water attacks the 
distal carbon preferentially affording regioselectively the keto-sulfide product after 
reductive elimination. The C15−C25 thioether 141 was obtained in 12 steps from 
known lactone 145 in 13% overall yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 40. Regiocontrolled Wacker Oxidation to Thioether 141 
 
Elaboration of the C1−C9 fragment started from known aldehyde 154 as the 
source of the C7−C8 stereochemistry (Scheme 41). The general synthetic 
approach was derived from Roush's precedent.19b Ando olefination using 
phosphonate 155 furnished Z-olefin 156 in excellent yield. Further formation of a 
butenolide and diastereoselective hydrogenation to install the C4 stereocentre 
provided lactone 157. After reduction to the lactol and incorporation of the α,β-
unsaturated ester segment, enoate 158 was cyclised by treatment with TBAF to 
provide trans-tetrahydrofuran 159, which was readily converted into alcohol 160 in 
three additional steps. 
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Scheme 41. Preparation of C1−C9 Alcohol 160 
  
Installation of the C10−C14 side chain was effected by lithium-halogen exchange 
of Carter's iodide 14447 and subsequent addition to aldehyde 143, to give alcohol 
161 as a 1:1 diastereomeric mixture (Scheme 42). Finally, oxidation and Peterson 
olefination of the resulting ketone formed the C9 exocyclic methylene. The 
synthesis of fragment 142 was completed in a total of 17 steps from aldehyde 154 
and with 11% overall yield. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 42. Completion of C1−C14 Fragment 142 
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1.4.8. Carter: First Total Synthesis by Use of Hidden Symmetry 
 
In 2012, Carter and co-workers reported the preparation of amphidinolide F. This 
work was the first total synthesis of a member of the amphidinolide C series 
(Scheme 43).18 The Carter group approach relied on the identification of hidden 
symmetry within the two trans-tetrahydrofuran rings present in macrolactone 7, 
with the C1−C8 and C18−C25 segments bearing similar stereochemistry, 
oxidation states and functionalisation. The retrosynthetic analysis proposed 
disconnections of the ester bond of the macrolactone and the C14−C15 bond 
through an umpolung strategy, revealing two main fragments: sulfone 162 and 
alkyl iodide 163, which could be accessed from the common intermediate 164.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 43. Retrosynthesis and Hidden Symmetry 
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silver-catalysed cyclisation of diol 169 furnished dihydrofuran 173 in excellent yield 
and with complete diastereoselectivity. It was hypothesised that the benzoate 
oxygen undergoes nucleophilic addition to the activated alkyne 170 leading to 
chiral allene 172 via stabilised carbocation 171. A second silver-mediated 
activation of the allene species promotes nucleophilic attack by the nearby alcohol 
to deliver dihydrofuran 173 after protodemetalation. Finally, silyl protection and 
removal of the enol benzoate produced dihydrofuranone 164. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 44. Ag-catalysed Cyclisation Towards Dihydrofuranone 164  
 
To account for the formation of furan 175 as a minor byproduct during the silver-
catalysed cyclisation of diol 169, it was proposed that competitive nucleophilic 
attack onto the activated alkyne 170 by the nearby alcohol produces vinyl silver 
intermediate 174, followed by protodemetalation and acid-catalysed aromatisation 
to give furan 175 (Scheme 45). 
 
 
 
 
Scheme 45. Competitive Formation of Furan 175 
O O
Ph
OH
165
BzO PivO
166
BzO PivO
168
OTBS
4 steps
     41%
AD-mix-β
t-BuOH/H2O
87%
 > 20:1 dr
167
PdCl2(PPh3)2
CuI, Et3N
THF, 78%
ITBSO
167
BzO PivO
169
TBSO
OH
OH
TBSO
R
OH
OH
O
Ph
O BzO
OH
HO
OTBS
H
RAg
Ag
170 172
AgBF4
benzene, 80 °C
TBSO
O
TBSO
H H
OPiv
164
O
TBSO
O
HO
H H
OPiv
173
BzO
1) TBSOTf
    2,6-lutidine, 85%
2) MeLi•LiBr
    Et2O, 81%
TBSO
OH
OH
OO
Ph
Ag
R
171
70%
 > 20:1 dr
169
TBSO
R
HO
OH
O
Ph
O
Ag
170 174
AgBF4
benzene, 80 °C
O
TBSO
H
HO
H
R
OBz
Ag
175
O
TBSO OBz
OPiv
15%
Introduction | 35 
First diversification of common dihydrofuranone 164 was achieved with the 
installation of the C4 methyl group by trapping the enolate intermediate using 
Eschenmoser's salt to give enone 176 (Scheme 46). Subsequent hydrogenation 
of the double bond using Wilkinson's catalyst then produced ketone 177. The 
stereocontrol observed during the hydrogenation reaction was linked to the 
stereochemistry at the C6 position because this was the dominant element in the 
direct alkylation process. This observation was made during previous attempts to 
perform direct enolate alkylation, which gave the undesired C4 stereochemistry.  
 
 
 
 
 
 
 
 
 
Scheme 46. Synthesis of the C1−C8 Aldehyde 
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Scheme 47. Preparation of Vinyl Iodide 183 
TBSO
O
TBSO
H H
OPiv
164
O
TBSO
6
4
O
TBSO
H H
OPiv
176
O
TBSO
6
4
O
TBSO
H H
OPiv
O
LDA, THF
then DMPU
[Me2NCH2]I
71%
177
RhCl(PPh3)3
H2
toluene, 89%
10:1 dr
TBSO
O
TBSO
H H
OPiv
1) NaBH4, 92%
2) Im2C=S, toluene
    100 °C, 91%
3) Bu3SnH, AIBN
    toluene, 96%
8
O
O
TBSO
H H
1
OPiv
2 steps
     81%
I
OH
178
12
I
13
OTBS
179
1) (+)-DET, Ti(Oi-Pr)4
    t-BuOOH, CH2Cl2 
    87%, 95% ee
2) TBSCl, imid., DMAP
     DMF, 99%
I
OTBS
O OAl
Me
Me
Me 12
I
13
OTBS
180
OH
10
I
14 OTBS
181
OTBS
TBSOTf
2,6-lutidine
CH2Cl2, 98%
AlMe3
CH2Cl2
98%, 10:1 dr
OTBS
182
OTBS
9
14 OTBS
183
OTBS
I
1) Me3SiCCH
    Pd(PPh3)4,CuI
    Et3N, THF, 98%
2) K2CO3, MeOH, 95%
1) PdCl2(PPh3)2
    Bu3SnH, THF, 78%
2) I2, CH2Cl2, 94%
Introduction | 36 
Further Sonogashira coupling of vinyl iodide 181 with TMS-acetylene provided 
enyne 182 in excellent yield. Finally, regioselective hydrostannylation of the alkyne 
and subsequent iodination furnished 2-iodo-1,3-diene 183.   
 
To complete the targeted alkyl iodide fragment 163, metal-halogen exchange was 
performed by treatment of vinyl iodide 183 with n-butyllithium, and addition of 
aldehyde 184 to the resulting vinyl lithium species produced allylic alcohol 185 in 
reasonable yield and with modest diastereoselectivity (Scheme 48). The required 
iodide fragment 163 was obtained after three additional steps. 
 
 
 
 
 
 
Scheme 48. Completion of the C1−C14 Fragment 
 
Diversification of dihydrofuranone 164 en route to sulfone 162 began with 
deoxygenation at C22 and formation of aldehyde 186 (Scheme 49).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 49. Elaboration of Final Sulfone 162 
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Addition of the organolithium species obtained from known iodide 187 generated a 
1.5:1 mixture of inseparable diastereomeric secondary alcohols 188 in 72% yield. 
Even though it would have been possible for both diastereomers to have been 
used to complete the synthesis, a two-step oxidation/reduction sequence was 
applied to convert the mixture into the single isomer 189 bearing the C18-(S) 
configuration. Cleavage of the benzyl protecting group and installation of the key 
sulfone moiety gave adduct 190 in excellent yield over three steps. Finally, 
oxidation of primary alcohol 191 and subsequent olefination using the Vedejs-type 
phosphonium salt 19248 formed the C25−C26 E-alkene in excellent yield and with 
high selectivity. Protecting group manipulation completed the synthesis of sulfone 
162. 
 
The endgame of the synthesis was initiated by deprotonation of sulfone 162 using 
LiHMDS in the presence of HMPA and subsequent addition of the anion to iodide 
163, forming the C14−C15 bond in 74% yield (Scheme 50). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 50. Total Synthesis of Amphidinolide F 
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Oxidative desulfurisation of sulfone 193 upon treatment with Davis' oxaziridine 
(194) yielded a 1.8:1 mixture of the desired ketone 195 alongside the pivalate-
deprotected hydroxy ketone 196. Both ketones were converted into acid 197 in 
good yield using standard reactions. Formation of the seco acid and Yamaguchi 
macrolactonisation using acyl chloride 198 provided macrolactone 199 in 65% 
yield over two steps. Finally, selective removal of the EE protecting group under 
aqueous acidic conditions, oxidation of the resulting alcohol and global desilylation 
afforded amphidinolide F. The synthesis was completed in a total of 34 steps and 
with an overall yield of 0.3%. 
 
In 2013, Carter used the same strategy to synthesise amphidinolide C.27 In order 
to install the appropriate side chain, phosphonium salt 201 was prepared (Scheme 
51). The key feature of this seven-step sequence was the use of a Trost 
asymmetric alkynylation with ligand 200 to install the C29 stereocentre.49  
 
 
 
 
 
 
 
 
 
Scheme 51. Synthesis of Phosphonium Salt 201 
 
The side chain was installed by olefination of aldehyde 202 under Vedejs 
conditions using phosphonium salt 201, which provided E-alkene 203 selectively 
(Scheme 52). Sulfone 203 was employed in the same synthetic sequence as 
described previously to yield amphidinolide C, in 33 steps and 0.2% overall yield. 
 
 
 
 
 
Scheme 52. Completion of C15−C34 Sulfone 203 
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1.4.9. Fürstner: Ring-Closing Alkyne Metathesis / Alkyne Hydration 
 
In 2013, the Fürstner group reported the second total synthesis of amphidinolide 
F.28a Their original and concise approach relied on the use of a ring-closing alkyne 
metathesis (RCAM) to close the macrocycle followed by a directed transannular 
alkyne hydration reaction to access the 1,4-diketone functionality (Scheme 53). 
Further disconnections revealed three main fragments of comparable size and 
complexity: vinyl iodide 205, allylic alcohol 206 and vinyl stannane 207, which 
could be coupled by Yamaguchi esterification and Stille cross-coupling to give 
diyne 204. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 53. Retrosynthetic Analysis and Main Fragments 
 
The synthesis of vinyl iodide 205 exploited the latent symmetry of this building 
block. Starting from 1,3-propanediol, an anti-propargylation methodology 
developed by Marshall50 was implemented to set the C13 and C15 stereocentres 
(Scheme 54). First, zinc-mediated palladium catalysed propargylation of aldehyde 
208 with chiral mesylate 209 gave alcohol 211 in excellent yield and with a 9:1 dr, 
through the less sterically demanding orientation (210) of the complexed aldehyde 
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indium(I) iodide variant of Marshall protocol with alkyne 212 completed this two-
directional approach and delivered alcohol 213 with high diastereoselectivity. 
Regioselective silylcupration of the terminal alkyne followed by a methyl iodide 
quench provided vinyl silane 214 in 90% yield. Methylation of the remaining alkyne 
and iodine-silicon exchange completed the elaboration of vinyl iodide 205. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 54. anti Propargylation Methodology Towards Iodide 205 
 
A possible catalytic cycle for the zincation of propargylic mesylates (215) was 
proposed (Scheme 55).50 First, a SN2' palladium insertion gives PdII species 216. 
Reaction with diethylzinc then leads to alkylpalladium 217. Further exchange of 
ligands with remaining EtZnOMs provides allenylzinc mesylate 218 and a PdII 
species. The latter decomposes rapidly to form ethylene and ethane, thereby 
regenerating the active Pd0 catalyst. 
 
 
 
 
 
 
  
 
Scheme 55. Proposed Catalytic Cycle to Allenylzinc Reagent 218 
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Preparation of the tetrahydrofuran building block 206 from chiral epoxide 219 was 
achieved in just four steps (Scheme 56). After nucleophilic opening of the epoxide 
with lithiated propyne, Mukaiyama cyclisation of alkenol 220 using the cobalt 
catalyst developed by Pagenkopf41 afforded trans-tetrahydrofuran 221 as a single 
diastereomer. Finally, a reagent-controlled N-methylephedrine-assisted reaction of 
an organozinc reagent,51 generated from vinyl bromide 223, with aldehyde 222 
furnished allylic alcohol 206 in excellent yield and with high diastereoselectivity, 
and completed the installation of the diene side chain. 
 
 
 
 
 
 
 
 
 
Scheme 56. Elaboration of trans-Tetrahydrofuran 206 
 
Vinyl stannane fragment 207 was assembled from commercially available 
furanone 224 (Scheme 57). The lactone was converted into the enoate 225 in four 
steps. The unsaturated ester underwent oxa-Michael addition upon treatment with 
TBAF to obtain the corresponding trans-tetrahydrofuran in excellent yield and as a 
single diastereomer. Removal of the trityl group and subsequent oxidation of the 
resulting alcohol delivered aldehyde 226. The key proline-catalysed aldol reaction 
between aldehyde 226 and hydroxyacetone derivative 227 yielded alcohol 229 in 
decent yield and installed the required C7−C8 anti relationship. In transition state 
228, accounting for the C−C bond formation, proline is employed as a bifunctional 
entity, with the enamine catalytic role and the carboxylic acid cocatalyst used to 
protonate the acceptor carbonyl group. 52  Finally, the ketone segment was 
converted into the vinyl stannane and the ester was saponified to complete 
carboxylic acid 207. 
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Scheme 57. Proline-catalysed Aldol Reaction Towards Stannane 207 
 
With the three key fragments in hand, Fürstner and co-workers commenced the 
fragment coupling sequence by using a Yamaguchi esterification to join alcohol 
206 and carboxylic acid 207 (Scheme 58). Stille coupling of the resulting vinyl 
stannane 230 and vinyl iodide 205 under mild conditions 53  produced the 
corresponding diene unit in 56% yield. Selective silyl deprotection at C15 then 
provided diyne 204 required for the key macrolactonisation reaction and 
subsequent ring-closing diyne metathesis of this substrate, mediated by the 
molybdenum complex 231, afforded macrolactone 232 in 70% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 58. Endgame RCAM Towards Macroclycle 232 
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Platinum-catalysed transannular alkyne hydration provided enol ether 233 in 97% 
yield (Scheme 59). Hydration of the cyclic enol ether delivered hydroxy ketone 
234, in equilibrium with the corresponding hemiketal. Finally, oxidation and global 
deprotection furnished amphidinolide F, in a total of 21 steps and 2.2% overall 
yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 59. Transannular Alkyne Hydration Towards amphidinolide F 
 
The Fürstner group applied an identical strategy to the synthesis of amphidinolide 
C,28b for which the extended side chain 239 was prepared (Scheme 60). The side 
chain synthesis featured asymmetric addition of bis-alkenylzinc 236 to aldehyde 
235 in the presence of (−)-3-exo-morpholinoisoborneol (MIB, 237) as the chiral 
ligand.54 This reaction delivered the required alcohol in excellent yield and with 
85% ee, and the compound was then silylated to give the fragment 238.  
 
 
 
 
 
 
 
 
Scheme 60. Synthesis of the Extended 1-Bromo-1,3-diene 239 
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In the final step in the synthetic sequence, asymmetric addition of the organozinc 
species generated from 1-bromo-1,3-diene 239 to aldehyde 222 produced alcohol 
240, bearing the extended side chain, in decent yield and with reasonable 
diastereoselectivity (Scheme 61). 
 
 
 
 
 
Scheme 61. Analogous Building Block 240 Completion 
 
 
1.4.10. Conclusion on Fragment / Total Syntheses of Amphidinolides C and F 
 
The syntheses of fragments and the total syntheses discussed in this review 
showcase a wide range of innovative synthetic strategies and transformations, but 
also highlight the problems and challenges that need to be faced when attempting 
to complete such natural products.  
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stereocentre in a diastereoselective fashion (Schemes 31, 35, 56). On the other 
hand, an oxa-Michael addition on an α,β-unsaturated ester proves to be a reliable 
and highly diastereoselective method to assemble the C4−C6 trisubstituted 
tetrahydrofuran (Schemes 16, 17, 41, 57).  
 
To date, two total syntheses of amphidinolides C and F have been reported. 
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strategy with the elaboration of three major fragments of high complexity. 
Fragment coupling was performed at a late stage using sequential Yamaguchi 
esterification, a challenging Stille coupling and a RCAM to complete syntheses of 
both macrolide natural products in just 21 steps. 
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2. Results and Discussion 
 
2.1. Previous Work in the Clark Group 
 
The Clark group approach for the synthesis of the amphidinolide C series of 
macrolides initially relied on the hidden symmetry within the two trans-
tetrahydrofuran rings.26 Since the project was commenced in our group, the 
recognition of hidden symmetry has proven valuable with regard to the strategy 
employed in the first total synthesis of amphidinolide F reported by Carter and co-
workers.18 Disconnection of the macrocycle at the C17−C18 bond, implying a 
dithiane alkylation reaction in the forward direction, and at the ester bond, implying 
a macrolactonisation reaction in the forward direction, revealed two building 
blocks: alkyl iodide 241 and dithiane 242 (Scheme 62). Both these fragments 
were to be prepared from a common intermediate, dihydrofuranone 243, which 
could be readily accessed using the Clark group oxonium ylide rearrangement 
methodology.55 This common precursor was to be employed twice and further 
functionalised before reaction with enyne 244 to form the C8−C9 bond and 
coupling with vinyl iodide 245 to install the side chain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 62. Clark Group Initial Retrosynthesis 
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The common dihydrofuranone building block 243 was prepared in six steps from 
dimethyl D-malate (246) (Scheme 63). Selective reduction of the α-hydroxy ester 
and subsequent silyl protection of the primary alcohol afforded TBS ether 247. 
Further acid-catalysed allylation of the remaining alcohol delivered allyl ether 248 
in excellent yield. The methyl ester functionality was saponified and the resulting 
carboxylic acid 249 was converted into α-diazoketone 250. Finally, ketone 243 
was produced as a single diastereomer in 95% yield upon treatment with 
Cu(acac)2.55 
 
 
 
 
 
 
 
 
 
 
 
Scheme 63. Synthesis of Common Dihydrofuranone 243 
 
According to the proposed reaction mechanism, the electrophilic metal carbenoid 
251 is formed by treatment of diazoketone 250 with a transition metal catalyst 
(Scheme 64).   
 
 
 
 
 
 
 
 
 
 
Scheme 64. Proposed Mechanism 
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One of the two diastereotopic lone pairs of the ether oxygen then attacks the metal 
carbenoid to give metal-bound ylide 252 possessing an anti relationship between 
the allyl group and the R substituent. Finally, the metal-bound intermediate either 
undergoes direct rearrangement to yield dihydrofuranone 243, or dissociates to 
deliver the highly reactive free oxonium ylide 253, which then undergoes [2,3]-
sigmatropic rearrangement with efficient transfer of chirality. 
 
Dihydrofuranone 243 was then used to prepare the C18−C29 fragment of 
amphidinolide F (Scheme 65). A three-step deoxygenation protocol afforded 
disubstituted tetrahydrofuran 254. The alkene segment was converted into alcohol 
255 in good yield.  Protecting group manipulation and oxidation afforded aldehyde 
256 in three steps. Stereoselective nucleophilic addition to aldehyde 256 was then 
attempted using a range of alkyne nucleophiles and reaction conditions and 
relying on either reagent control or substrate control to dictate the stereochemical 
outcome of the reaction. Unfortunately, low levels of diastereocontrol were 
observed and propargylic alcohol 257 was obtained along with its C24 
diastereomer (1.5:1 dr) in 71% yield from the addition of magnesium 
(trimethylsilyl)acetylide. The mixture of isomers was separated and a copper-free 
Sonogashira coupling reaction with 1-bromo-2-methylpropene (258) followed by 
reduction provided E-allyl alcohol 259.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 65. Construction of the C18−C29 Fragment 
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In order to access the more complex side chain of amphidinolide C, vinyl iodide 
245 was prepared (Scheme 66). Alkyne 261 was obtained in five steps from 
hexanal (260), using a similar sequence as the one employed by Pagenkopf.23a 
The terminal alkyne was submitted to modified Negishi carboalumination and 
iodination conditions56 to provide E-vinyl iodide 245.  
 
 
 
 
Scheme 66. Elaboration of Coupling Partner 245 
 
Side chain 245 was then introduced by means of a Sonogashira coupling with 
alkyne 257mix, which was used as a diastereomeric mixture. Subsequent 
stereoselective reduction of the alkyne moiety to give the corresponding E-olefin 
262 was performed using Red-Al (Scheme 67). Finally, sequential oxidation of the 
C24 alcohol and ketone reduction under Luche conditions completed the assembly 
of the C18−C34 fragment 263 as a single diastereomer and in excellent yield. 
 
 
 
 
 
 
 
 
 
Scheme 67. Completion of the C18−C34 Fragment of Amphidinolide C 
 
Unfortunately, efforts to convert both fragments 259 and 263 into the 
corresponding dithianes 264 and 242 were unsuccessful (Scheme 68). 
Consequently, a new approach had to be adopted. 
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Dihydrofuranone 243 was also employed for construction of the C1−C17 fragment 
of amphidinolides C and F. Methylenation of the ketone functionality and 
conversion of the monosubstituted olefin into the corresponding primary alcohol 
was accomplished in three steps and afforded alkene 265 (Scheme 69). Further 
directed hydrogenation of this alkene using Crabtree's catalyst57 installed the C4 
methyl substituent with the desired stereochemistry. Weinreb amide 266 was then 
produced in good yield using a three-step sequence. Addition of vinylmagnesium 
bromide to Weinreb amide 266 and subsequent diastereoselective reduction of the 
enone intermediate under Luche conditions furnished alkene 267 in 70% yield 
over three steps and with a 9:1 dr. Finally, aldehyde 268 was obtained by 
sequential dihydroxylation of the alkene and cleavage of the 1,2-diol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 69. Construction of the C1−C8 Aldehyde 268 
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prepared (Scheme 70). A Paterson aldol reaction between aldehyde 270 and the 
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of the ketone functionality yielded the corresponding anti-1,3-diol with a high level 
of diastereocontrol; alcohol 272 was obtained after protecting group manipulation. 
Further oxidation to the corresponding methyl ketone and HWE olefination using 
phosphonate 273 gave enyne 274 in good yield and as a single isomer. Finally, 
palladium-catalysed hydrostannylation provided stannane 275. 
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Scheme 70. Completion of the C9−C17 Vinyl Stannane 275 
 
The C1−C17 alcohol 277 was assembled by reaction of aldehyde 268 with the 
organolithium species generated from vinyl stannane 275 (Scheme 71). Alcohol 
276 was obtained in a modest 31% yield and with the undesired stereochemical 
outcome. Consequently, an oxidation/reduction sequence was required to install 
the C8 stereocentre with the appropriate configuration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 71. Coupling of Aldehyde 268 and Stannane 275 
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Unfortunately, the protecting group strategy adopted during elaboration of this 
fragment was judged to be unsuitable for the completion of the natural product 
because differentiation between the C13 and C15 hydroxyl groups was not 
possible and removal of the PMB protecting group proved challenging. Therefore, 
fragment 277 was not elaborated further. 
 
In the light of these results, it is important to note that the entire carbon framework 
required to complete the natural target had been introduced. However, the general 
protecting group strategy did not allow fragments 259/263 and 277 to be 
elaborated further and then coupled. In addition, the number of steps needed to 
convert common dihydrofuranone 243 to each of the tetrahydrofuran-containing 
sub-units highlighted the inefficiency of a synthetic approach based on a common 
precursor, an observation that was apparent in the total synthesis of 
amphidinolides C and F by Carter.27 These considerations invited us to revisit our 
original approach to this series of macrolides. 
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2.2. Evolution of the Strategy Towards Amphidinolides C and F  
 
2.2.1. Retrosynthetic Analysis 
 
In an effort to complete amphidinolides C and F, it was proposed to use a dithiane 
alkylation reaction as a key C−C bond-forming step, which has been known to be 
amenable to the construction of these macrocycles.58 
 
Main disconnections of the macrocycle recognised a dithiane alkylation reaction to 
form the C17−C18 bond and a macrolactonisation reaction to reveal iodide 278 
and dithiane 264 (Scheme 72). Dithiane 264 was further disconnected through the 
C26−C27 bond leading to alkyne 281 and vinyl bromide 258. This disconnection 
implied a Sonogashira coupling and subsequent enyne reduction in the forward 
direction. Additionally, disconnection of alkyl iodide 278 through the C9−C10 bond 
revealed the Stille coupling of vinyl iodide 279 and stannane 280 in the forward 
direction. The tetrahydrofuran-containing stannane 280 and alkyne 281 were to be 
accessed through different synthetic sequences rather than by differentiation of a 
common precursor. The revisions proposed in this synthetic approach were 
expected to allow the concise elaboration of fragments bearing suitable protecting 
groups and lead to the completion of the natural product in a highly convergent 
fashion. The work discussed in this section will focus on the synthesis of C18−C29 
dithiane 264 and coupling attempts to unite the main fragments. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 72. Revised Retrosynthetic Approach 
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2.2.2. Synthesis of the C18−C26 Alkyne 
 
It was expected that trans-tetrahydrofuran 281 could be prepared by acid-
catalysed intramolecular nucleophilic opening of cis-epoxide 282 (Scheme 73). 
Previous work by Nicolaou 59  and Braddock 60  had shown that intramolecular 
etherification of α-epoxy alkynes led to exclusive formation of the 5-exo-tet 
cyclisation product, which supported our approach. Epoxide 282 was to be 
accessed by Sharpless asymmetric epoxidation of allylic alcohol 283, which would 
be prepared from the opening of chiral epoxide 284 using Grignard reagent 285. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 73. Synthetic Plan for Tetrahydrofuran 281 
 
The synthesis of alkyne 281 started by the bromination of D-aspartic acid (286) 
using sodium nitrite and potassium bromide in an acidic aqueous medium to 
deliver (R)-2-bromosuccinic acid (287) in good yield and with retention of 
configuration (Scheme 74).61 The diacid was then reduced to bromodiol 288 in 
excellent yield. Further treatment of diol 288 with sodium hydride in THF, to effect 
epoxide formation, followed by addition of t-butyldimethylsilyl chloride, after 
complete consumption of the diol, afforded epoxide 284 in 81% yield as a single 
enantiomer. Finally, epoxide ring-opening with propargylmagnesium bromide 
285,62 prepared from propargyl bromide and magnesium turnings in the presence 
of mercury(II) chloride, generated terminal alkyne 289 in decent yield. 
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Scheme 74. Completion of Alkyne 289 by Epoxide Opening  
 
Silyl protection of alcohol 289 to give bis-TBS ether 290 was followed by addition 
of paraformaldehyde to the lithium acetylide generated from the terminal alkyne to 
produce propargylic alcohol 291 in high yield (Scheme 75). Along with the desired 
product 291, formate 292 was obtained initially (ca. 20% yield). However, 
formation of this by-product could be avoided by use of a simple basic work-up 
procedure (addition of a 1 M NaOH aq. solution to the reaction mixture) to convert 
formate 292 into the desired alcohol. Subsequent reduction of the alkyne moiety 
under Lindlar conditions delivered Z-alkene 283 in 95% yield, with no over 
reduction observed. Finally, Sharpless asymmetric epoxidation63 of allylic alcohol 
283 using (−)-diethyl D-tartrate (30 mol %) and titanium isopropoxide (25 mol %) 
yielded cis-epoxide 293 in 91% yield and with a 9:1 dr.  
 
 
 
 
 
 
 
 
 
 
Scheme 75. Formation of Epoxide 293 by Asymmetric Epoxidation  
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The exact structure of the active catalyst involved in the Sharpless epoxidation 
remains uncertain but studies have shown that it is likely to have a dimeric 
structure.64 The ion pair 295 is potentially formed from the binuclear reagent 294 
(Scheme 76). In this assembly, the arrangement of the ligands around the titanium 
centre of the cationic moiety creates a stereogenic centre, the absolute 
configuration of which is dictated by the tartrate ligand. Other arrangements of 
ligands around titanium would create additional steric repulsion with the t-butyl 
group. In addition, the t-butylperoxy group is chelated to the titanium with the 
terminal oxygen cis to the coordinated allylic hydroxyl group. This chirality and the 
fixed hydrogen bond between the hydroxyl group of the allylic alcohol and the 
carbonyl of the tartrate ester favour internal epoxidation at only one face of the 
olefin in which the π-system approaches the peroxy O−O bond with an optimal 
stereoelectronic arrangement. The formation of the epoxy alcohol from ion pair 
295 then allows regeneration of reagent 294 by dissociation of the epoxide from 
the catalytic site. 
 
   
 
 
 
 
 
 
 
 
 
 
 
Scheme 76. Catalyst Structure in the Sharpless Epoxidation 
 
Attempts to improve the diastereoselectivity of the Sharpless epoxidation reaction 
to form epoxide 293 by replacing (−)-diethyl D-tartrate with the more bulky (−)-
diisopropyl D-tartrate failed to provide a better outcome and identical yields and 
levels of diastereoselectivity were obtained.  
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The alcohol segment was then oxidised under Swern conditions and the unstable 
aldehyde product was subjected to Seyferth-Gilbert homologation using Ohira-
Bestmann reagent (105)65 to yield α-epoxy alkyne 296 in 55% yield over two steps 
(Scheme 77). The instability of the aldehyde intermediate over time limited the 
scale of this two-step sequence to ca. 3 g of starting alcohol due to practical 
considerations. Subsequent global silyl deprotection of alkyne 296 using TBAF in 
THF afforded diol 282, the key substrate required for the intramolecular 
etherification reaction envisioned in this approach. After a rapid filtration of diol 282 
through silica gel, it was submitted to Nicolaou's cyclisation conditions59 − a sub-
stoichiometric amount of CSA (10 mol %) in CH2Cl2 − to promote the 
stereospecific ring-opening of the epoxide functionality. Pleasingly, full conversion 
of the epoxide into the tetrahydrofuran product was observed and trans-
tetrahydrofuran 281 was obtained as a single diastereomer.  
 
 
 
 
 
 
 
 
 
Scheme 77. Elaboration of trans-Tetrahydrofuran 281 
 
The reaction proceeded with complete inversion of configuration at C23 and 
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formed and the bond being broken, in agreement with Baldwin's rules for ring 
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to provide silyl ether 257, a compound that had been synthesised within the group 
already, and comparison of NMR data.26b 
 
 
 
 
 
Scheme 78. C18−C26 Fragment Completion and Confirmation of Stereochemistry 
 
 
2.2.3. Side Chain Installation and C18−C29 Fragment Completion 
 
Preparation of the diene side chain found in amphidinolide F started by use of the 
copper-free variant67 of the Sonogashira cross-coupling reaction between alkyne 
281 and commercially available vinyl bromide 258 to provide enyne 299 (Scheme 
79). Standard Sonogashira conditions performed in the presence of copper iodide 
had been shown to be unsuitable for the coupling of similar substrates because 
they resulted in the generation of a significant amount of alkyne homocoupling 
product.26b The alkyne was then reduced stereoselectively to the corresponding E-
alkene 300 using Red-Al by exploiting the anchimeric assistance of the 
neighbouring hydroxyl group. Finally, double silyl protection afforded bis-TES ether 
301 in 61% yield over five steps. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 79. Diene Side Chain Assembly 
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The mechanism of the copper-free Sonogashira reaction remains unclear, but two 
possible reaction mechanisms (A and B) have been proposed, depending on the 
ligand, the amine used as well as the rate of the competition between the amine 
and the alkyne in the substitution of a ligand (Scheme 80).68 In pathway A, 
substitution of a ligand after oxidative addition by the amine is less favored than 
substitution by the alkyne, and so prior coordination of the alkyne is suggested, 
followed by deprotonation of the ligated alkyne by the amine, the ligated alkyne 
being more acidic than the free alkyne. A more basic amine is then more efficient 
in this process as it is more reactive during the deprotonation step. In contrast, 
pathway B operates when the amine is a better ligand than the alkyne for the PdII 
centre. In this case, substitution of a ligand by the amine happens first and is 
followed by substitution of the second ligand by the alkyne. Deprotonation of the 
alkyne by an external amine furnishes the product after reductive elimination. 
Pathways A and B are branched at the PdII species obtained after the initial 
oxidative addition. It has been suggested that altering the relative concentrations 
of the alkyne and the amine might allow switching from one pathway to the other. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 80. Proposed Mechanisms for Copper-free Sonogoshira Coupling 
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With bis-TES ether 301 in hand, formation of the requisite dithiane segment was 
then investigated. In order to access the key aldehyde 302, direct chemoselective 
Swern oxidation was first attempted (Scheme 81). The acidic conditions of the 
Swern oxidation were expected to trigger selective deprotection of the primary 
alcohol, which could then be oxidised in situ to provide aldehyde 302. 69 
Unfortunately, this approach proved to be unsuccessful and not only was the C18 
silyl ether converted to the corresponding aldehyde but the C24 silyl ether was 
also eliminated to form the highly conjugated adduct 303 as a mixture of E and Z 
isomers in 59% yield. 
 
 
 
 
 
Scheme 81. Attempt at Chemoselective Oxidation of Silyl Ether 301 
 
In order to obtain aldehyde 302, attention was focused on achieving selective 
deprotection of the C18 alcohol (Table 3) and subsequent oxidation as two distinct 
transformations. Aqueous acidic conditions, using a 8:8:1 mixture of AcOH, THF 
and water at −20 °C, resulted in full conversion of the bis-TES ether to give a 3:1 
mixture of alcohol 304 and diol 300 (Entry 1). Decreasing the reaction 
temperature resulted in a longer reaction time over which more complete 
deprotection was observed (Entry 2). Desilylation using HFPyr and an excess of 
pyridine in THF at 0 °C resulted in a similar outcome and products 304 and 300 
were formed in a 2:3 ratio (Entry 3). Pleasingly, decreasing the reaction 
temperature to −20 °C prevented formation of diol 300 and adduct 304 was 
obtained in 79% yield (Entry 4). 
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   (a) Ratio observed by 1H NMR analysis of the crude mixture. 
   (b) Isolated yield. 
 
Table 3. Selective Deprotection of the C18 Alcohol in 301 
 
Further treatment of alcohol 304 with Dess-Martin periodinane and pyridine in 
CH2Cl2 afforded key aldehyde 302 in 84% yield (Scheme 82). 
 
 
 
 
Scheme 82. Two-step Formation of Aldehyde 302 
 
Conversion of aldehyde 302 into the final C18−C29 dithiane fragment 264 was 
attempted by treatment with 1,3-propanedithiol and a Lewis acid (Scheme 83). A 
variety of Lewis acids were used for this reaction but unfortunately decomposition 
of the starting material occurred in all cases.  
 
 
 
 
Scheme 83. Attempt at Formation of the Dithiane Segment 
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Although the complex mixtures obtained did not allow characterisation of side 
products, it appeared that the Lewis acid, including MgBr2OEt2, triggered 
cleavage of the silyl protecting group and further decomposition, including opening 
of the tetrahydrofuran ring or loss of the diene side chain, then followed, as 
suggested by analysis of the 1H NMR spectra of the crude mixture. 
 
With these unsatisfying results in mind, it was envisioned that the dithiane 
functionality could be installed at an earlier stage in the synthesis, on an aldehyde 
that would be more tolerant of the reaction conditions required for the formation of 
the dithiane. Starting from the C18−C26 tetrahydrofuran 298, enyne 305 was 
obtained in 82% yield by Sonogashira cross-coupling with vinyl bromide 258 under 
the conditions described previously (Scheme 84). The propargylic alcohol was 
protected and silyl ether 306 was obtained in excellent yield. Cleavage of the 
pivalate ester using lithium aluminium hydride in Et2O at −20 °C delivered the C18 
primary alcohol 307 in high yield. Finally, treatment of the alcohol with Dess-Martin 
periodinane and pyridine in CH2Cl2 produced aldehyde 308 in 89% yield. 
 
 
 
 
 
 
 
 
 
 
Scheme 84. Elaboration of Aldehdye 308 
 
To install the dithiane segment, aldehyde 308 was treated with 1,3-propanedithiol 
and MgBr2OEt2 in Et2O (Scheme 85). Full conversion of the starting material was 
achieved within 1.5 h. No decomposition was observed due to the use of the more 
resistant TBS protecting group. Further deprotection and stereoselective reduction 
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264 was obtained in 46% yield over four steps after chromatographic purification. 
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Scheme 85. Completion of the C18−C29 Dithiane Fragment 264 
 
In conclusion, the C18−C29 fragment 264 was prepared in 18 steps from known 
epoxide 284 and with 6.6% overall yield. Failure to form the dithiane segment 
directly from aldehyde 302 required the implementation of a more robust synthetic 
sequence but added several steps. This drawback would be addressed upon 
success of the coupling strategy. Nevertheless, having dithiane 264 in hand 
allowed for coupling attempts with iodide 278 to be carried out. 
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2.2.4. Coupling Attempts of the C1−C17 and C18−C29 Fragments 
 
According to the revised strategy, coupling was expected to proceed by 
nucleophilic displacement of iodide in fragment 278 by the anion generated from 
deprotonation of dithiane 264 with t-BuLi in the presence of HMPA. In order to 
identify suitable reaction conditions, two simple model compounds were proposed 
that mimic the steric environments within the nucleophilic and electrophilic sites of 
the two building blocks (Scheme 86).  
 
• Fragment coupling envisioned           
 
 
 
 
 
 
 
 
 
• Model system proposed 
 
 
 
 
 
Scheme 86. Model System Proposed for Coupling Conditions 
 
The simplified dithiane 312 was prepared from alcohol 31070 by oxidation, to give 
aldehyde 311, followed by formation of the dithiane ring in high yield (Scheme 87).  
 
 
 
 
 
Scheme 87. Synthesis of Model Dithiane Coupling Partner 312 
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Two iodide substrates were easily synthesised from 2-methyl-1,3-propanediol 
(Scheme 88). Monoprotection using either PivCl or TBSCl afforded alcohols 313 
and 315. Iodides 314 and 316 were then prepared by treatment of alcohols 313 
and 315 with triphenylphosphine and iodine in the presence of imidazole. 
 
 
 
 
 
 
 
Scheme 88. Model Alkyl Iodides 314 and 316 
 
A rapid study concerning the deprotonation of dithiane 312 was carried out first 
(Table 4). Solutions of dithiane in a 4.5:1 mixture of THF and HMPA at −78 °C 
were treated with t-BuLi (1.0 equiv.) and stirred for 5, 10, 20 and 30 min, before 
addition of deuterated methanol. After five minutes, incomplete deprotonation (ca. 
30%) was observed by 1H NMR of the crude reaction mixture (Entry 1), whereas 
full deprotonation was reached after only ten minutes (Entry 2). Longer reaction 
times resulted in partial reprotonation of the substrate, potentially from the THF 
itself (Entry 3 and 4). Therefore, ten minutes appeared to be the optimum time for 
lithiation of the dithiane prior to addition of the iodide.  
 
 
 
 
 
Table 4. Optimised Conditions for Dithiane 312 Deprotonation 
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1 t-BuLi HMPA −78 5 30% 
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Coupling reactions on the model system were then attempted (Table 5). 
Deprotonation of an excess of dithiane 312 (1.8 equiv.) with an equimolar amount 
of t-BuLi (1.8 equiv.) for ten minutes at −78 °C followed by addition of iodide 314 
(1.0 equiv.) and stirring for one hour at −78 °C afforded coupling product 317 in 
54% yield; almost complete recovery of unreacted 312 was possible (Entry 1). In 
the presence of silver triflate, an efficient halide activating reagent,71 both the yield 
and the amount of unreacted 312 recovered decreased significantly, probably as a 
consequence of the ability of silver salts to react with dithianes (Entry 2).72 
Reduced solubility of dithiane 312 was observed in Et2O, resulting in incomplete 
deprotonation and a lower yield (Entry 3). Finally, to assess the compatibility of 
the pivalate ester with the proposed conditions, TBS ether 316 was submitted to 
the coupling reaction (Entry 4). Coupling product 318 was obtained in a 63% yield, 
demonstrating the small deleterious effect that the pivalate ester has on the 
reaction outcome. It is important to note that removal of traces of water present in 
the starting materials by azeotropic distillation with benzene proved to be critical in 
all cases. 
 
 
 
 
 
 
Entry R Solvent Additive 317/318 Recovered 312a 
1 Piv THF − 54% 94% 
2 Piv THF AgOTf b 8% 67% 
3 Piv Et2O − 38% 87% 
4 TBS THF − 63% 87% 
(a) Percentage calculated based on the theoretical amount of 312 remaining. 
(b) 1.0 equiv. used. 
 
Table 5. Model Study: Conditions and Results 
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Following the identification of the optimum experimental procedure, fragment 
coupling was attempted. An excess of dithiane 264 was treated with an equimolar 
amount of t-BuLi in the presence of HMPA and after ten minutes iodide 27873 was 
added (Scheme 89). After one hour, the reaction was quenched and the desired 
1,1-disubstituted dithiane product 319 was obtained in just 13% yield. Unreacted 
iodide 278 and dithiane 264 were recovered in 50% yield and 42% yield 
respectively. Extending the reaction time did not improve the yield of coupling 
product and only resulted in more decomposition of the starting materials.    
 
 
 
 
 
 
 
 
 
 
 
Scheme 89. Coupling Attempt of Iodide 278 and Dithiane 264 
 
Coupling with truncated iodide fragment 32073 was also investigated (Scheme 90). 
Unfortunately, the use of this sterically less demanding fragment did not result in 
any improvement and only a trace amount of coupled product 321 was observed 
along with significant amounts of recovered starting materials. 
 
 
 
 
 
 
 
 
 
Scheme 90. Coupling Attempt of Iodide 320 and Dithiane 264 
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The poor results obtained following an umpolung strategy for the coupling of 
fragments 264 and 278 meant that a different approach was necessary in which 
the original building blocks could be used. Formation of alcohol 322 by generation 
of the organolithium species from iodide 278 using t-BuLi and subsequent addition 
of this lithiated compound to aldehyde 302 was attempted (Scheme 91). 
Unfortunately, significant decomposition of the aldehyde was observed under 
these reaction conditions and the required alcohol product was not formed. 
Addition of t-BuLi to a mixture of iodide 278 and aldehyde 302 in Et2O at −78 °C 
resulted in an identical outcome. 
 
 
 
 
 
 
 
 
 
Scheme 91. Coupling Attempt of Iodide 278 and Aldehyde 302 
 
In conclusion, formation of the C17−C18 bond by coupling of two main fragments 
using either of the two approaches outlined above proved to be unsuccessful. The 
proposed strategy was not investigated further because the synthesis of dithiane 
264 suffered from an unsatisfying step-count and because the stocks of both 
building blocks were depleted. A revision of the synthetic strategy was therefore 
considered in order to access the targeted macrolactone. 
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2.3. Revised Strategy: Silicon-Tethered RCM 
 
2.3.1. Retrosynthetic Analysis 
 
Attention was directed at employing a silicon-tethered RCM74 to assemble the 
C17−C18 bond. Disconnection of the macrolactone at the ester bond and 
formation of the C18 ketone by Fleming-Tamao oxidation in the forward direction 
revealed vinylsilane 323 (Scheme 92). This fragment was to be generated by 
treatment of siloxacycle 324 with phenyllithium. Disconnection across the 
C17−C18 olefin led to diene 325 and suggested a challenging RCM reaction in the 
forward direction. Finally, cleavage of the silicon-oxygen bond revealed alcohol 
326 and chlorosilane 327. In the forward direction, alkyne 328 would be converted 
into chloro(dimethyl)vinylsilane 327 by ruthenium-catalysed hydrosilylation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 92. Silicon-tethered Approach Towards Amphidinolide F 
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2.3.2. Synthesis of the C18−C29 Alkyne 
 
The terminal alkyne of the C18−C29 fragment required for the hydrosilylation 
reaction was prepared in one step from previously synthesised aldehyde 302 
(Scheme 93). A Seyferth-Gilbert homologation reaction using Ohira-Bestmann 
reagent 105 produced a 3:1 mixture of trans-tetrahydrofuran 328 and cis-
tetrahydrofuran 329 in 82% yield. Pure alkyne 328 could be obtained following 
chromatographic isomer separation.  
 
 
 
 
 
 
 
 
 
Scheme 93. Homologation of Aldehyde 302 
 
Basic conditions are used in the homologation reaction and so formation of cis-
tetrahydrofuran 329 can be explained by deprotonotion of aldehyde 302 to 
produce enolate 330 which then undergoes retro oxa-Michael addition to provide 
alcoholate species 331 (Scheme 94). Finally, an oxa-Michael addition on the enal 
segment regenerates the tetrahydrofuran moiety with potential formation of both 
diastereomers.75 
 
 
 
 
 
Scheme 94. Proposed Mechanism for the Formation of Diastereomer 329 
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2.3.3. Coupling Attempts of the C1−C17 and C18−C29 Fragments 
 
The proposed two-step one-pot silylation reaction was first attempted on simple 
homoallylic alcohol 334 (Scheme 95). Using conditions developed by Trost,76 3-
cyclohexyl-1-propyne (332) was treated with 1 mol % of ruthenium complex 
[Cp*Ru(MeCN)3]PF6 in the presence of chlorodimethylsilane. Formation of the 
required 1,1-disubstituted vinylsilane 333 was then directly followed by the addition 
of a solution of alcohol 334 and Et3N in CH2Cl2 to provide diene 335 in 76% yield.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 95. Model System for the Silylation of Alcohol 334 
 
Mechanistic hypotheses have been proposed for this hydrosilylation reaction of 
alkynes (Scheme 96). 77  trans Addition of silane reagents across acetylene 
derivatives in the presence of cationic [Cp*Ru]-based catalysts (336) is thought to 
involve complex 338 that is produced by binding of alkyne 337 to the electrophilic 
metal centre followed by coordination of the silane. Inner-sphere delivery of the 
hydride to the bound alkyne then generates metallacyclopropene 339 without prior 
formation of a discrete metal hydride species. The β-carbon atoms of such η2-vinyl 
complexes are configurationally labile and can swap places by reversible hapticity 
change. Consequently, isomer 340, in which the hydrogen rather than the larger 
substituent R is oriented towards the bulky Cp* ligand, is favored over isomer 339. 
The presence of the Cp* ligand appears to have a decisive steric influence. 
Finally, reductive elimination from intermediate 340, in which the silicon entity is 
anti to the hydrogen, provides E-alkenylsilane product 341.  
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Scheme 96. Possible Mechanism for the trans Hydrosilylation 
 
The key coupling sequence, which was shown to be viable on the simplified 
system, was then applied to homoallylic alcohol 32678 and terminal alkyne 328 
(Scheme 97). Unfortunately, the desired Si−O bond in diene 325 was not formed 
under the reaction conditions and homoallylic alcohol 326 was recovered fully. As 
an alternative, it should have been possible to convert the silyl chloride 
intermediate into the more reactive silyl triflate in situ using silver triflate prior to 
addition of a solution of alcohol and 2,6-lutidine.74b Unfortunately, significant 
difficulties were encountered when attempting to prepare the homoallylic alcohol 
(work by Dr Filippo Romiti) and so a revised synthetic approach for the coupling of 
two major fragments was required. 
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Scheme 97. Silylation Attempt of Alcohol 326 
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2.4. Alkylation and Protoborylation Approach 
 
2.4.1. Retrosynthetic Analysis 
 
In order to access the challenging 1,4-diketone functionality at C15 and C18, an 
alkyne protoborylation to give a vinyl boronic ester and subsequent oxidation, 
unprecedented on such a complex substrate, were envisioned (Scheme 98).79 
Disconnection of the macrolactone and functional group interconversion revealed 
alkyne 342. Further disconnection at the propargylic C18−C19 bond led to the 
terminal alkyne 344 and triflate 343 as the main advanced fragments in this 
approach.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 98.  Alkylation and Alkyne Protoborylation Approach  
 
 
2.4.2. Synthesis of the C19−C29 Triflate Precursor 
 
The synthesis of triflate 343 started from the commercially available glycidyl ether 
345 (Scheme 99). Epoxide opening using allylmagnesium chloride yielded known 
pentenol 346 in excellent yield.80 Tetrahydrofuran 347 was prepared as a single 
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119. Oxidation of the resulting alcohol with Dess-Martin periodinane afforded 
unstable aldehyde 348 and this was treated directly with magnesium 
(trimethylsilyl)acetylide. Finally, cleavage of the silyl group under basic conditions 
gave propargylic alcohol 349 as a 1.3:1 mixture of diastereomers at C24 in 73% 
yield over three steps. 
 
 
 
 
 
 
 
 
 
 
Scheme 99. Mukaiyama Oxidative Cyclisation Towards Alkyne 349 
 
The mixture 349 was submitted to a copper-free Sonogashira cross-coupling with 
vinyl bromide 258 in pyrrolidine to provide enyne 350 in 83% yield (Scheme 100). 
Stereoselective reduction of the diastereomeric mixture using Red-Al yielded E-
alkene 351. Formation of the key C24 stereocentre was achieved by oxidation of 
the allylic alcohol and subsequent reduction of enone 352 under Luche 
conditions,81 providing (R)-alcohol 353 in 75% yield and with an 8:1 dr. Pure 
alcohol 353 was obtained in 60% yield after separation from the minor 
diastereomer by silica gel chromatography. 
 
 
 
 
 
 
 
 
 
Scheme 100. Elaboration of Allylic Alcohol 353 
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Finally, protecting group manipulation, including selective cleavage of the C19 silyl 
group of 355, delivered alcohol 356. The synthesis of the C19−C24 fragment was 
completed in a total of 12 steps and with an overall yield of 10% (Scheme 101). 
 
 
 
 
 
 
 
 
 
Scheme 101. Completion of Triflate Precursor 356 
 
 
2.4.3. Alkylation by Displacement of a Simple Triflate 
 
A model system was chosen in order to perform a rapid investigation of the 
coupling conditions. First, racemic tetrahydrofurfuryl alcohol was converted to the 
corresponding unstable triflate (Scheme 102). Deprotonation of known alkyne 
35782 using LDA and subsequent addition of the lithium acetylide to the triflate 
produced alkyne 358 with creation of a new C−C bond in 68% yield over two 
steps. Cleavage of the pivalate ester afforded alcohol 359 and completed a three-
step sequence that would be potentially suitable to join the main fragments. 
 
 
 
 
 
 
 
 
 
 
Scheme 102. Simple Model System for Coupling Conditions 
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Unfortunately, alkyne 344 required for the coupling strategy outlined above could 
not be obtained, owing to the unexpected difficulty of forming the C17−C18 triple 
bond, either on the full fragment or at an earlier stage in its synthesis (work by Dr 
Filippo Romiti). Therefore, alcohol 356 was not converted into the triflate 343 and 
the coupling reaction developed in the context of the aforementioned model 
system was not applied to the fully functionalised fragments (Scheme 103).  
 
 
 
 
 
 
 
 
Scheme 103. Envisioned Coupling Towards Alkyne 342 
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2.5. Umpolung and Aldol Strategy 
 
2.5.1. Retrosynthetic Analysis 
 
Current efforts focus on implementing an umpolung and aldol approach to the 
synthesis of the amphidinolide C series (Scheme 104). This strategy relies on a 
Stille cross-coupling reaction to unite the two main fragments. Disconnection of the 
macrolactone at the ester bond and the C9−C10 diene then reveals vinyl iodide 
360 and vinyl stannane 280. Iodide 360 could be prepared from alkyl iodide 361, 
dithiane 362 and aldehyde 363. These three fragments were to be joined by a 
boron-mediated aldol reaction to form the C13−C14 bond and a dithiane alkylation 
to construct the C18−C19 bond.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 104. Umpolung and Aldol Strategy 
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2.5.2. Synthesis of the C19−C29 Iodide Precursor 
 
The synthesis of alcohol 365, a stable precursor to alkyl iodide 361, started from 
allylic alcohol 353, previously synthesised in nine steps and with 13% overall yield 
from commercially available glycidyl ether 345 (Scheme 105). Silyl protection and 
selective deprotection of the C19 alcohol of 364 using HFPyr complex, provided 
the desired C19−C29 alcohol in a total of 11 steps and with 11% overall yield. 
 
 
 
 
 
 
 
 
 
Scheme 105. Synthesis of Precursor to Iodide 361 
 
 
2.5.3. Preparation of the C14−C18 Dithiane 
 
The synthesis of the C14−C18 dithiane fragment 362 commenced from the 
commercially available (R)-methyl-3-hydroxybutanoate as a chiral pool starting 
material (Scheme 106). Diastereoselective α-methylation produced (R,R)-ester 
367 in 65% yield and with an excellent 15:1 dr.83  
 
 
 
 
 
 
 
 
 
Scheme 106. Preparation of Dithiane 362 
19
(R)
TBSO
O
O H
TBSO
H
OH
O
24
H19
TBSO
H
OTBS
TBSOTf
2,6-lutidine
CH2Cl2, 94%
345 353
9 steps
     13%
HF•Pyr
THF, 0 °C, 86% O
24
H19
HO
H
OTBS
365
364
OH
OMe
O OH
OMe
O
OEE
OMe 15
OEE
18
S
S
i.  i-Pr2NH, n-BuLi
   THF, 0 °C → −78 °C
ii. MeI, HMPA 
   −78 °C → 0 °C
   65%, 15:1 dr
                      , PPTS
CH2Cl2, RT, 94%
1) PPh3, imid., I2 
    THF, 0 °C → RT
2) 1,3-dithiane, n-BuLi
    THF/HMPA, −20 °C
    71% (3 steps)
367
368 362
366
O O LiAlH4
Et2O, 0 °C
OEE
OH
369
IMe
O
Li
O
Li
Me
H
MeO
Results and Discussion | 80 
The high diastereoselectivity obtained during the Fráter-Seebach alkylation can be 
rationalised by six-membered intermediate 366, in which the reaction with the 
electrophile proceeds on the less hindered face of the chelated adduct.84 Acid-
catalysed protection of the hydroxyl group using ethyl vinyl ether provided methyl 
ester 368 as a 1.1:1 diastereomeric mixture in excellent yield. The choice of an EE 
acetal for the protection of the C15 alcohol resulted from the difficulties 
encountered previously within our group when using various acetal protecting 
groups such as the MOM protecting group,70 and was influenced by the successful 
use of an EE acetal by Carter and co-workers in their synthesis of amphidinolides 
C and F.27 Subsequent reduction of the methyl ester using lithium aluminium 
hydride in Et2O at 0 °C afforded primary alcohol 369. Finally, iodination and 
addition of the anion generated by treatment of 1,3-dithiane with n-BuLi installed 
the dithiane moiety in 71% yield over three steps. Overall, the C14−C18 dithiane 
362 was completed in five steps and with 43% overall yield. 
 
 
2.5.4. Elaboration of the C10−C13 Aldehyde Precursor 
 
The final small C10−C13 fragment required for the elaboration of vinyl iodide 360 
was prepared from commercially available (S)-Roche ester (370) (Scheme 107). 
First, the primary alcohol was protected and silyl ether 371 was obtained in 
excellent yield.85 Reduction of the methyl ester moiety using i-Bu2AlH gave alcohol 
372 and subsequent oxidation afforded aldehyde 373 in good yield. Finally, 
conversion of the aldehyde into terminal alkyne 37586 was achieved in two high-
yielding steps via dibromo olefin 374 using the Corey-Fuchs protocol.87 
 
 
 
 
 
 
 
 
 
Scheme 107. Preparation of Alkyne 375 
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The synthesis of alcohol 377, the stable precursor to aldehyde 363, was 
completed in two additional steps (Scheme 108). First, terminal alkyne 375 was 
subjected to a carboalumination reaction under Negishi's conditions.88 Treatment 
with a solution of AlMe3 (4.0 equiv.) and Cp2ZrCl2 (1.5 equiv.) in 1,2-
dichloroethane at room temperature produced the corresponding alkenylmetal 
species; the desired syn addition product 376 was obtained in excellent yield and 
with high regioselectivity and stereoselectivity following an iodine quench. Finally, 
deprotection of the alcohol using TBAF provided vinyl iodide 377 in 92% yield, 
completing a seven-step synthetic sequence with an overall yield of 59%. 
 
 
 
 
 
Scheme 108. Completion of Aldehyde Precursor 377 
 
The carboalumination of alkynes with a methylalane species and a zirconocene 
derivative represents a convenient tool to access (E)-2-methyl-1-alkenylalanes. 
This transformation is generally catalytic in zirconium. Although the mechanism 
has not been fully elucidated,89 it is likely to involve a zirconium-assisted direct 
Al−C bond syn addition to the triple bond (Scheme 109). The zirconium catalyst is 
thought to activate the aluminium centre towards the alkyne by polarisation 
between these two metals via three-centre two-electron bonding, as can be seen 
in intermediate 378. E-alkenylalane 379 is then obtained alongside the catalytic 
species. The regioselectivity of this process is dictated by the steric requirements 
of the Al−Me system. 
 
 
 
 
 
 
 
 
Scheme 109. Mechanistic Rationale for the Carboalumination Reaction 
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2.5.5. Completion of the C10−C29 Vinyl Iodide Fragment 
 
With alcohol 365, dithiane 362 and vinyl iodide 377 now available, efforts to 
complete fragment 360 were initiated.  
 
First, alcohol 365 was converted cleanly into the unstable alkyl iodide 361 using 
triphenylphosphine, imidazole and iodine in THF (Scheme 110). Displacement of 
iodide from fragment 361 using the anion obtained by deprotonation of dithiane 
362 with t-BuLi in the presence of HMPA forged the C18−C19 bond, yielding a 1:2 
mixture of 1,1-disubstituted dithiane 380 and excess dithiane 362. Finally, 
cleavage of the ethoxyethyl acetal (vide infra) delivered secondary alcohol 381 in a 
satisfying 44% yield over three steps. Practically, this also allowed complete 
separation of the alcohol produced by deprotection of excess acetal 362, which 
could not be separated from dithiane 380 by chromatography.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 110. Construction of the C18−C19 Bond of Alcohol 381 
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derived from 380 using TBSOTf and 2,6-lutidine in CH2Cl2. Treatment of the 
ethoxyethyl acetal 380 with PPTS in a mixture of EtOH and CH2Cl290 (Entry 1) 
provided alcohol 381 in 86% yield after nine hours. Deprotection of the same 
substrate under aqueous acidic conditions (Entry 2) afforded the desired product 
after an extended reaction time and in a lower 75% yield.  
 
 
 
 
 
 
Entry 
 
Conditionsa 
 
T 
(°C) 
Time 
(h) 
381 
 
1 PPTSb in EtOH/CH2Cl2 (3:1) 23 9 86% 
2 THF/AcOH/H2O (4:4:1) 23 17 75% 
     (a) All reactions were performed on a 10 mg scale. 
     (b) 10 mol % used. 
 
Table 6. Ethoxyethyl Acetal Cleavage Conditions 
 
The successful synthesis of alcohol 381 was followed by oxidation under mild 
conditions using the Parikh-Doering protocol.91  This reaction delivered the α-
substituted ketone 382 in 78% yield after 48 h (Scheme 111).  
 
 
 
 
 
 
Scheme 111. Preparation of the C15 Ketone 382 
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Deprotection of the C24 alcohol appeared to be a difficult transformation because 
of the potential for epimerisation of the C16 stereocentre. Attempts to perform an 
acid-mediated cleavage of the silyl protecting group by a slow in situ generation of 
HCl (Table 7, Entry 1) resulted in the complete decomposition of ketone 382 to 
give a complex mixture of products. Treatment of the silyl ether with a solution of 
TBAF in THF buffered with acetic acid provided allylic alcohol 383 as a single 
diastereromer in quantitative yield, but only after an impractically long reaction 
time (Entry 2). Finally, exposure of ketone 382 to a solution of TBAF in THF 
afforded the desired product in quantitative yield and in only five hours; no 
epimerisation was observed under these basic conditions92 (Entry 3). 
 
 
 
 
 
 
Entry 
 
Conditions 
 
T 
(°C) 
Time 
(h) 
dr 
 
383 
 
1 AcCl, EtOH 23 4 − 0%a 
2 TBAF, AcOH, THF 23 92 > 20:1b quant. 
3 TBAF, THF 23 5 > 20:1b quant. 
     (a) Complete decomposition of the material observed. 
     (b) No epimerisation observed by 1H NMR of the crude mixture.  
 
Table 7. C24 Alcohol Deprotection Conditions 
 
Finally, methyl ketone 384 was completed by silyl protection of allylic alcohol 383 
to furnish the corresponding TES ether in 89% yield (Scheme 112). 
 
 
 
 
 
 
Scheme 112. Completion of Ketone Partner 384 
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Successful synthesis of ketone 384 allowed the key boron-mediated aldol reaction 
to be investigated. First, alcohol 377 was converted to unstable aldehyde 363 
using Dess-Martin periodinane buffered with sodium bicarbonate (Scheme 113). 
Purification of the aldehyde product by silica gel chromatography resulted in 
complete decomposition of the material and so crude aldehyde 363 was used in 
the subsequent reaction. Aldol condensation of aldehyde 363 with the boron 
enolate generated by treatment of ketone 384 with Cy2BCl proceeded with full 
conversion to afford a 1:2.2 diastereomeric mixture of (S)-β-hydroxy ketone 385 
and (R)-aldol product 386. Unfortunately, following tedious separation of the two 
diastereomers by silica gel chromatography, the desired fragment 385 was only 
isolated in 10% yield and the undesired (R)-β-hydroxy ketone 386 was obtained in 
55% yield. A third fraction that contained a mixture of both diastereomers and 
boron residues was also isolated. Attempts to remove the boron residues during 
the reaction work-up by treatment with aqueous hydrogen peroxide produced a 
complex mixture of unidentifiable side products.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 113. Key Boron-mediated Aldol Reaction 
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state 38793 in which the aldehyde attacks from the face away from the R2 group, 
with the hydrogen pointing towards the incoming aldehyde and the R2 group 
directed away from it (Scheme 114). Therefore, the low level of diastereocontrol 
could arise from similar steric demands of the R2 and Me groups, as well as other 
more complex competing effects.  
 
 
 
 
 
 
 
 
Scheme 114. Aldol Condensation Transition States 
 
The low diastereoselectivity is also consistent with a Felkin-type addition to the 
aldehyde (Scheme 115). The size discrepancy between the methyl group at the α 
stereogenic centre of the aldehyde and the larger R1 substituent may also be 
insufficient to generate significant facial discrimination on the aldehyde. 
 
 
 
 
 
Scheme 115. Facial Selectivity of the Aldehyde 
 
In order to establish the stereochemistry at C13 conclusively for each 
diastereomer obtained from the aldol condensation reaction, Mosher ester 
analysis was conducted on the predominating β-hydroxy ketone isomer 386 
(Scheme 116).94 This NMR-based method relies on the fact that the protons in 
diastereomeric Mosher esters 390 and 391 display predictable changes in 
chemical shifts in their 1H NMR spectra. To this end, β-hydroxy ketone 386 was 
treated with either (S)-α-methoxy-α-trifluoromethylphenylacetic acid 388 or its (R) 
equivalent 389, DCC and DMAP in CH2Cl2 at room temperature for 24 h to provide 
analytical samples of both Mosher esters 390 and 391. Subsequent analysis of 
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their 1H NMR spectra revealed the C13 stereocentre of fragment 386 to be of (R) 
configuration and therefore the undesired diastereomer. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 116. Advanced Mosher Analysis 
 
In an attempt to convert β-hydroxy ketone 386 into the desired diastereomer 385, 
Mitsunobu conditions were employed (Table 8). Not unexpectedly,95 the system 
proved to be unreactive, most likely due to the sterically hindered environment of 
the hydroxyl group. Treatment of adduct 386 with 4-nitrobenzoic acid (4 equiv.), 
DEAD (4 equiv.) and triphenylphosphine (4 equiv.) in benzene at room 
temperature resulted in partial recovery of the starting material and decomposition 
products after an extended reaction time and the ester 392 was not observed 
(Entry 1). Increasing the reaction temperature and the amount of reagents did not 
bring any improvement and even more decomposition was observed (Entry 2 and 
Entry 3).  
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Entry 
 
Acida 
(equiv.) 
DEAD 
(equiv.) 
PPh3 
(equiv.) 
T 
(°C) 
Time 
(h) 
392 
 
386 
 
1 4 4 4 23 44 0% 48% 
2 6 6 6 40 20 0% − 
3 6 6 6 70 20 0% − 
     (a) 4-nitrobenzoic acid used. 
 
Table 8. Mitsunobu Inversion of β-Hydroxy Ketone 386 
 
Instead, both (S)-β-hydroxy ketone 385 and (R)-β-hydroxy ketone 386 were 
converted to silyl ethers 360 and 393 in excellent yield (Scheme 117). The 
required vinyl iodide 360 was therefore synthesised in 19 steps and with 0.31% 
overall yield. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 117. C10−C29 Vinyl Iodide Fragment Completion 
O
OTES
OH
H
S
S
(S)
O
I
392
O
NO2
O
OTES
OH
H
S
S
(R)
OH
I
386
conditions
O
OTES
OH
H
S
S
(S)
OH
I
O
OTES
OH
H
S
S
(R)
OH
I
385
386
O
OTES
24OH
H
S
S
13
OTBS
10
I
360
O
OTES
24OH
H
S
S
13
OTBS
10
I
393
TBSOTf
2,6-lutidine
CH2Cl2, −78 °C
95%
TBSOTf
2,6-lutidine
CH2Cl2, −78 °C
93%
Results and Discussion | 89 
2.5.6. Synthesis of the C1−C9 Carboxylic Acid 
 
Following the synthesis of vinyl iodides 360 and 393, the stannane partner 
required for the envisioned Stille cross-coupling was prepared (Scheme 118). 
Cleavage of the pivalate ester by treatment of fragment 28073 with i-Bu2AlH in 
Et2O at −78 °C afforded primary alcohol 394 in excellent yield. Subsequent 
oxidation using Dess-Martin periodinane provided aldehyde 395 quantitatively. 
Finally, carboxylic acid 396 was obtained in 88% yield by Pinnick oxidation, 
completing the desired C1−C9 stannane fragment. 
 
 
 
 
 
 
 
 
 
 
Scheme 118. Formation of Acid 396 by Reduction/Oxidation Sequence 
 
 
2.5.7. Coupling Attempts of the C1−C9 and C10−C29 Fragments 
 
It was expected that coupling of vinyl iodide 360 and stannane 396 by formation of 
the C9−C10 bond would be performed by a Stille cross-coupling. The protocol 
selected for this reaction was that developed by Fürstner and co-workers because 
of the mild conditions.53 These conditions rely on the co-catalytic effect exerted by 
copper(I), in this case copper(I) thiophene-2-carboxylate (CuTC), which 
transmetallates with tin species to form the corresponding organocopper species 
(Scheme 119). The more nucleophilic organocopper reagent then has a positive 
impact on the rate and the efficiency of the reaction.96 Because the tin/copper 
exchange is likely reversible, the phosphinate salt [Ph2PO2][NBu4] is employed as 
an essentially neutral tin scavenger97 driving the equilibrium towards the formation 
of the organocopper species. The use of this procedure circumvents problems 
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encountered with fluoride additives such as their basicity and incompatibility with 
silyl protecting groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 119. Stille-Migita Cross-coupling Proposed Mechanism 
 
Unfortunately, under these mild Stille coupling conditions, iodide 360 and 
stannane 396 were both consumed but only trace amounts of coupled carboxylic 
acid 397 could be detected within the complex mixture (Scheme 120).  
 
 
 
 
 
 
 
 
 
 
 
Scheme 120. Stille Coupling: Iodide 360 and Carboxylic Acid 396 
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unsatisfying because alcohol 398 was also obtained in trace amounts and the 
starting compounds were only partially recovered. At this point, it was thought that 
the dithiane in iodide 360 might be problematic because it could inhibit the 
oxidative addition of the vinyl iodide to the palladium by ligation to the metal.98 
 
 
 
 
 
 
 
 
 
 
Scheme 121. Stille Coupling: Iodide 360 and Alcohol 394 
 
It was therefore proposed to convert the dithiane moiety to the corresponding 
ketone prior to the Stille coupling reaction. Conditions for this transformation were 
investigated on vinyl iodide 393, the C13 epimer of fragment 360 (Table 9). 
Hydrolysis of the dithiane segment on this complex fragment proved to be 
challenging. Common methods involving mercury salts were attempted first. 
Treatment of the substrate with HgCl2 resulted in either no conversion (Entry 1) or 
partial decomposition of the starting material and the desired ketone 399 was 
obtained in just 20% yield (Entry 2). Similarly, the use of Hg(ClO4)2 in THF and 
MeOH, buffered with 2,6-lutidine, resulted in rapid decomposition of the dithiane 
fragment (Entry 3). Unexpectedly, the use of Hg(ClO4)2 and CaCO3 in a mixture of 
MeCN, THF and water at 0 °C produced ketone 400, which is O-desilylated at the 
C24 position, in 77% yield along with a small amount of the required ketone 399 
(Entry 4). An increase in the reaction time resulted in significant decomposition 
and ketone 400 was isolated in 39% yield (Entry 5). Finally, Stork's reagent 
buffered with 2,6-di-tert-butyl-4-methyl pyridine (401) was tested and this reaction 
produced a 1:1.5 mixture of ketones 399 and 400 (Entry 6). Reduction of the 
reaction temperature, limited by the presence of water in the solvent mixture, 
slowed the conversion rate (ca. 50% after two hours) and formation of both 
diketones 399 and 400 was observed from the start (Entry 7). 
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Entry 
 
Conditionsa 
 
Solvent 
 
T 
(°C) 
t 
(h) 
399b 
 
400b 
 
1 HgCl2, CaCO3 THF 23 2 − − 
2 HgCl2, CaCO3 MeCN/H2O 23 2 20% − 
3 Hg(ClO4)2, 2,6-lutidine THF/MeOH 0 0.5 − − 
4 Hg(ClO4)2, CaCO3 MeCN/THF/H2O 0 0.3 8% 77% 
5 Hg(ClO4)2, CaCO3 MeCN/THF/H2O 0 0.5 − 39% 
6 PhI(OCOCF3)2, 401 MeCN/THF/H2O 0 0.8 41% 25% 
7 PhI(OCOCF3)2, 401 MeCN/THF/H2O −15 2 31% 15% 
   (a) All reactions were performed on a 5 mg scale. 
   (b) Isolated yield. 
 
Table 9. Conditions for Hydrolysis of Dithiane 393 
 
In the light of these results, it was decided to take advantage of the formation of 
ketone 400, bearing a free allylic alcohol at C24, and join the two main fragments 
employing a Yamaguchi esterification reaction before undertaking a 
macrocyclisation reaction using the aforementioned Stille coupling.28, 32d Pleasingly, 
addition of alcohol 400 and DMAP to the Yamaguchi99 mixed anhydride generated 
by treatment of carboxylic acid 396 with acyl chloride 198 and triethylamine 
produced the ester 402 in 69% yield (Scheme 122).   
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Scheme 122. Fragment Coupling by Yamaguchi Esterification 
 
Ring closure was then attempted using aforementioned conditions for the Stille 
coupling reaction (Scheme 123). This approach appeared challenging due to the 
steric constrains involved in the formation of this congested ring.32d, 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 123. Completion Attempt of Amphidinolide F C13-Epimer 
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The intramolecular Stille cross-coupling resulted in full conversion of the starting 
material to a mixture of three inseparable products. NMR analysis of this material 
proved difficult probably due to the presence of conformational isomers. It was 
therefore decided to submit this mixture to global desilylation conditions using 
Et3N3HF complex and triethylamine in MeCN at room temperature for seven 
days. Formation of the desired triol 403 was observed by mass spectrometry but 
attempts to isolate the pure macrolactone were unsuccessful. 
 
To conclude, successful syntheses of vinyl iodides 360 and 393 were completed 
from alkyl iodide 361, dithiane 362 and aldehyde 363 using a dithiane alkylation 
reaction and a boron-mediated aldol condensation reaction. Subsequent 
hydrolysis of the dithiane moiety provided 1,4-diketone 400 bearing a free allylic 
alcohol at C24.  Coupling of the two main fragments was achieved by means of a 
Yamaguchi esterification reaction between carboxylic acid 396 and allylic alcohol 
400. However, closure of the macrocyclic core proved to be challenging and 
although there was mass spectrometry evidence to support formation of the 
desired product, no other data could be collected due to the minuscule amount of 
material available.  
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2.6. Conclusions and Future Work 
 
In conclusion, efforts to complete the total synthesis of members of the 
amphidinolide C series proved challenging but have provided valuable insights. 
During the course of this work, several synthetic strategies were investigated and 
significant progress was accomplished.  
 
First, dithiane 264 was prepared in 18 steps and with an overall yield of 6.6%, 
starting from known epoxide 284 (Scheme 124). Despite the optimisation of 
coupling conditions by use of a model system, attempts to perform the coupling 
between alkyl iodide 278 and dithiane 264 did not lead to efficient construction of 
the C17−C18 bond, and gave the disubstituted dithiane 319 in only 13% yield over 
two steps while allowing for partial recovery of both starting materials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 124. C17−C18 Bond Formation by Dithiane Alkylation 
 
Alternatively, terminal alkyne 328 could be prepared (Scheme 125). Nevertheless, 
conversion of the triple bond to the corresponding chloro(dimethyl)vinylsilane 
employing a ruthenium-catalysed hydrosilylation reaction and subsequent 
silylation of homoallylic alcohol 326 failed to form the desired Si−O bond and 
generate diene 325. Therefore, RCM could not be investigated and alcohol 326 
was entirely recovered in the process. 
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Scheme 125. Si−O Bond Formation by Silylation of Alcohol 326 
 
In a third approach, it was proposed that the challenging 1,4-diketone moiety at 
C15 and C18 would be installed by an alkyne protoborylation/oxidation sequence 
for which alkyne 344 and triflate 343 were identified as key fragments. To this end, 
alcohol adduct 356 was synthesised from commercially available glycidyl ether 
345 in 12 steps and in 10% overall yield (Scheme 126). Unfortunately, the alkyne 
counterpart 344 could not be obtained (work by Dr Filippo Romiti) and therefore 
alcohol 356 was not converted into triflate 343.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 126. Fragment Coupling by Triflate Displacement 
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Finally, the most recent strategy implemented involves an umpolung and aldol 
approach for the completion of vinyl iodide 360. This fragment was synthesised in 
19 steps and with an overall yield of 0.31% (Scheme 127).  
 
 
 
 
 
 
 
 
 
Scheme 127. Completion of Iodide 360 
 
Subsequent Yamaguchi esterification between 1,4-diketone 400 and carboxylic 
acid 396 then delivered ester 402 in good yield (Scheme 128). Closure of the 
macrolactone under Stille coupling conditions proved difficult, probably due to 
steric factors. Formation of the desired C13 epimer of amphidinolide F could only 
be supported by mass spectrometry evidence. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 128. Formation of Ester 402 by Yamaguchi Macrolactonisation 
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Future work will focus on improving the diastereoselectivity of the aldol 
condensation reaction used to build the C13−C14 bond, in order to ensure the 
viability of this strategy and provide a reliable synthesis of the vinyl iodide 
fragment. A chiral boron auxiliary such as (+)-Ipc2BCl could potentially overturn 
the dominating substrate selectivity, as suggested by the literature,101 and deliver 
the β-hydroxy ketone 385 in higher yield (Scheme 129).  
 
 
 
 
 
 
 
 
 
Scheme 129. Reagent-controlled Aldol Condensation 
 
In order to rule out the potential influence of the dithiane moiety on the Stille 
reaction and avoid the steric congestion of an intramolecular cross-coupling, 1,4-
diketone 404 bearing a TES ether at the C24 position could be prepared by careful 
optimisation of the dithiane hydrolysis conditions. The Stille coupling reaction 
would then be performed in an intermolecular fashion using the aforementioned 
diketone (Scheme 130). 
 
 
 
 
 
 
 
 
 
 
Scheme 130. Revised Stille Coupling Towards Alcohol 405 
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Coupling of the vinyl iodide and stannane fragments through a Yamaguchi 
esterification reaction was successful and so global desilylation of the resulting 
ester to provide triol 406 could be performed prior to closure of the macrocycle by 
Stille coupling to reduce the steric congestion during this transformation (Scheme 
131).  
 
 
 
 
 
 
 
 
 
Scheme 131. Revised Stille Coupling Towards Amphidinolide F 
 
Finally, the outcome of the several Stille cross-coupling reactions mentioned 
above could be improved by use of the stannane 407, which is a more reactive 
trimethylstannane equivalent102 of fragment 280 (Figure 5). 
 
 
 
 
 
Figure 5. Trimethylstannane 407 
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3. Experimental Section 
 
General Experimental 
Air and/or moisture sensitive reactions were performed under an atmosphere of 
argon in flame dried apparatus. Tetrahydrofuran (THF), toluene, acetonitrile 
(MeCN), dichloromethane (CH2Cl2) and diethyl ether (Et2O) were purified using a 
Pure-SolvTM 500 Solvent Purification System. Other dry organic solvents and 
starting materials were obtained from commercial sources and used as received 
unless specified otherwise. Petroleum ether (pet. ether) used for reactions and 
column chromatography was the 40-60 °C fraction. 
Reactions were monitored by thin layer chromatography (TLC) using Merck silica 
gel 60 covered aluminium backed plates F524. TLC plates were visualised under 
UV light and stained using either a potassium permanganate solution or an acidic 
ethanolic anisaldehyde solution. Flash column chromatography was performed 
with silica gel (Geduran Si 60 35-70 µm) as solid support.   
IR spectra were recorded using a Shimadzu FT IR-8400S ATR instrument. The IR 
spectrum of each compound (solid or liquid) was acquired directly on a thin layer 
at ambient temperature.  
All 1H NMR spectra were recorded on Bruker Avance III 400 MHz and 500 MHz 
spectrometers at ambient temperature. Data are reported as follows: chemical 
shift in ppm relative to CHCl3 (7.26) on the δ scale, integration, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, p = pentet, h = hextet, m = multiplet, br 
= broad, app = apparent or a combination of these), coupling constant(s) J (Hz) 
and assignment. All 13C NMR spectra were recorded on Bruker Avance III 400 
MHz and 500 MHz spectrometers at 101 MHz and 126 MHz at ambient 
temperature and multiplicities were obtained using a DEPT sequence. Data are 
reported as follows: chemical shift in ppm relative to CDCl3 (77.16) on the δ scale 
and assignment.  
Optical rotations were recorded using an automatic polarimeter Autopol V. 
High resolution mass spectra (HRMS) were recorded using positive chemical 
ionisation (CI+) or positive ion impact ionisation (EI+) on a Jeol MStation JMS-700 
instrument, or using positive ion electrospray (ESI+) technique on a Bruker 
micrOTOF-Q instrument. Low resolution mass spectra (LRMS) were obtained 
using the same instruments and the intensity of each peak was quoted as a 
percentage of the largest, where this information was available. 
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Melting points were recorded with an Electrothermal IA 9100 apparatus. 
 
 
(S)-tert-Butyldimethyl(2-(oxiran-2-yl)ethoxy)silane 284103 
 
 
 
 
 
 
To a suspension of NaH (1.4 g, 36 mmol, 3.0 equiv.) in THF (100 mL) at −15 °C, 
was added a solution of (R)-2-bromobutane-1,4-diol (288)61b (2.0 g, 12 mmol) in 
THF (20 mL) dropwise. The resulting mixture was stirred at −15 °C for 30 min, 
followed by the dropwise addition of a solution of TBSCl (2.1 g, 14 mmol, 1.2 
equiv.) in THF (14 mL). The resulting mixture was stirred at −15 °C for 5 min and 
at RT for 1 h. The reaction was quenched by the slow addition of a sat. aq. NH4Cl 
solution (100 mL) and the layers were separated. The aqueous phase was 
extracted with Et2O (3 × 100 mL) and the combined organic extracts were washed 
with brine (300 mL), dried over MgSO4, filtered and concentrated. Crude material 
was purified by silica gel chromatography (pet. ether/Et2O, 95:5) to afford epoxide 
284 (1.9 g, 9.6 mmol, 81%) as a colourless oil. Rf = 0.38 (pet. ether/Et2O, 95:5); 
[α]D25 −13.0 (c = 1.04, CHCl3) [lit103 [α]D27 −13.7 (c = 2.31, CHCl3)]; νmax 2930, 
2859, 1472, 1412, 1254, 1100 cm−1; 1H NMR (400 MHz, CDCl3) δ 3.80−3.75 (2H, 
m, CH2−C18), 3.05 (1H, dddd, J = 6.5, 5.0, 4.0, 2.8 Hz, CH−C20), 2.78 (1H, ddd, J 
= 5.1, 4.0, 0.3 Hz, CH−C21), 2.52 (1H, dd, J = 5.1, 2.8 Hz, CH−C21), 1.78 (1H, 
dddd, J = 14.0, 7.2, 6.4, 5.0 Hz, CH−C19), 1.69 (1H, app ddtd, J = 14.0, 6.5, 5.5, 
0.3 Hz, CH−C19), 0.90 (9H, s, CH3−t-Bu TBS), 0.07 (3H, s, CH3−TBS), 0.06 (3H, 
s, CH3−TBS); 13C NMR (101 MHz, CDCl3) δ 60.2 (CH2−C18), 50.2 (CH−C20), 47.3 
(CH2−C21), 36.1 (CH2−C19), 26.0 (CH3−t-Bu TBS), 18.4 (C−t-Bu TBS), −5.2 
(CH3−TBS), −5.3 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C10H22O2SiNa 
225.1281, found 225.1280, Δ 0.6 ppm. 
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Molecular Weight: 202,37
O
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(R)-1-((tert-Butyldimethylsilyl)oxy)hept-6-yn-3-ol 289 
 
 
 
 
 
 
To a suspension of magnesium turnings (2.2 g, 90 mmol, 2.0 equiv.) in Et2O (45 
mL) at RT, were added HgCl2 (0.12 g, 0.45 mmol, 1 mol %) and crystals of iodine 
(2 crystals). The mixture was cooled to 0 °C and propargyl bromide (80 wt % in 
toluene, 5.0 mL, 45 mmol) was added dropwise. The mixture was cooled down 
until reflux stabilised. The reaction mixture was then heated at reflux, stirred for 1 
h, and the resulting yellow solution was then allowed to cool to RT. 
To a solution of epoxide 284 (1.9 g, 9.6 mmol) in Et2O (200 mL) at −78 °C, was 
added a freshly prepared solution of propargylmagnesium bromide (1.0 M in Et2O, 
29 mL, 29 mmol, 3.0 equiv.) dropwise. The resulting mixture was stirred at −78 °C 
for 30 min and at RT for 1.5 h. The reaction mixture was cooled to 0 °C and a sat. 
aq. NH4Cl solution (200 mL) was added. The layers were separated and the 
aqueous phase was extracted with Et2O (3 × 160 mL). The combined organic 
extracts were washed with brine (400 mL), dried over MgSO4, filtered and 
concentrated. Crude material was purified by silica gel chromatography (pet. 
ether/Et2O, 80:20) to deliver alcohol 289 (1.6 g, 6.5 mmol, 68%) as a yellow oil. Rf 
= 0.37 (pet. ether/Et2O, 80:20); [α]D24 +26.9 (c = 1.11, CHCl3); νmax 3444, 3315, 
2929, 2858, 1473, 1362, 1255, 1084 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.00−3.93 
(1H, m, CH−C20), 3.91 (1H, app dt, J = 9.9, 4.7 Hz, CH−C18), 3.87−3.80 (1H, m, 
CH−C18), 3.51 (1H, d, J = 2.3 Hz, OH−C20), 2.34 (2H, ddd, J = 7.7, 6.9, 2.7 Hz, 
CH2−C22), 1.95 (1H, t, J = 2.7 Hz, CH−C24), 1.76−1.60 (4H, m, CH2−C19, 
CH2−C21), 0.90 (9H, s, CH3−t-Bu TBS), 0.08 (3H, s, CH3−TBS), 0.08 (3H, s, 
CH3−TBS); 13C NMR (101 MHz, CDCl3) δ 84.6 (C−C23), 71.0 (CH−C20), 68.5 
(CH−C24), 62.9 (CH2−C18), 38.3 (CH2−C19), 36.2 (CH2−C21), 26.0 (CH3−t-Bu 
TBS), 18.3 (C−t-Bu TBS), 14.9 (CH2−C22), −5.4 (CH3−TBS), −5.4 (CH3−TBS); 
HRMS (ESI+) [M+Na]+ calcd for C13H26O2SiNa 265.1594, found 265.1588, Δ 2.3 
ppm. 
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(R)-1,3-Bis((tert-butyldimethylsilyl)oxy)hept-6-yne 290 
 
 
 
 
 
 
To a solution of alcohol 289 (1.6 g, 6.5 mmol) in CH2Cl2 (30 mL) at 0 °C, were 
added imidazole (1.3 g, 19 mmol, 3.0 equiv.), DMAP (0.24 g, 1.9 mmol, 0.3 equiv.) 
and TBSCl (2.0 g, 13 mmol, 2.0 equiv.). The reaction mixture was stirred at RT for 
36 h, before the addition of a sat. aq. NH4Cl solution (30 mL). The layers were 
separated and the aqueous phase was extracted with CH2Cl2 (3 × 30 mL). The 
combined organic extracts were washed with brine (80 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/Et2O, 98:2) to afford alkyne 290 (2.2 g, 6.2 mmol, 
96%) as a colourless oil. Rf = 0.34 (pet. ether/Et2O, 98:2); [α]D26 +6.1 (c = 1.0, 
CHCl3); νmax 3316, 2929, 2858, 1473, 1361, 1253, 1094, 1042 cm−1; 1H NMR (500 
MHz, CDCl3) δ 3.97−3.91 (1H, m, CH−C20), 3.66 (2H, t, J = 6.6 Hz, CH2−C18), 
2.24 (2H, td, J = 7.4, 2.7 Hz, CH2−C22), 1.92 (1H, t, J = 2.7 Hz, CH−C24), 
1.75−1.59 (4H, m, CH2−C19, CH2−C21), 0.89 (9H, s, CH3−t-Bu TBS), 0.88 (9H, s, 
CH3−t-Bu TBS), 0.07 (3H, s, CH3−TBS), 0.06 (3H, s, CH3−TBS), 0.04 (6H, s, 2 × 
CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 84.7 (C−C23), 68.4 (CH−C24), 68.2 
(CH−C20), 59.8 (CH2−C18), 40.1 (CH2−C19), 36.1 (CH2−C21), 26.1 (CH3−t-Bu 
TBS), 26.0 (CH3−t-Bu TBS), 18.4 (C−t-Bu TBS), 18.2 (C−t-Bu TBS), 14.6 
(CH2−C22), −4.4 (CH3−TBS), −4.4 (CH3−TBS), −5.2 (CH3−TBS); HRMS (ESI+) 
[M+Na]+ calcd for C19H40O2Si2Na 379.2459, found 379.2441, Δ 4.8 ppm. 
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(R)-6,8-Bis((tert-butyldimethylsilyl)oxy)oct-2-yn-1-ol 291 
 
 
 
 
 
 
To a solution of alkyne 290 (3.9 g, 11 mmol) in THF (54 mL) at −78 °C, was added 
n-BuLi (2.1 M in hexanes, 5.7 mL, 12 mmol, 1.1 equiv.) dropwise. The resulting 
solution was stirred at −78 °C for 1 h, before the addition of paraformaldehyde (1.1 
g, 12 mmol, 1.2 equiv.) in one portion. The reaction mixture was allowed to warm 
to RT for 10 min and stirred at 40 °C for 45 min. The solution was allowed to cool 
to RT and a 1 M NaOH aq. solution (50 mL) was added. The biphasic mixture was 
stirred vigorously at RT for 45 min and the layers were separated. The organic 
layer was washed with a sat. aq. NH4Cl solution (50 mL) and the layers were 
separated. The aqueous phase was extracted with Et2O (3 × 50 mL). The 
combined organic extracts were washed with brine (150 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/Et2O, 80:20) to provide propargylic alcohol 291 (3.7 g, 
9.5 mmol, 88%) as a yellow oil. Rf = 0.33 (pet. ether/Et2O, 80:20); [α]D22 +5.5 (c = 
1.1, CHCl3); νmax 3353, 2929, 2857, 1473, 1361, 1254, 1093, 1005 cm−1; 1H NMR 
(500 MHz, CDCl3) δ 4.24 (2H, dt, J = 6.1, 2.1 Hz, CH2−C25), 3.94−3.88 (1H, m, 
CH−C20), 3.66 (2H, t, J = 6.6 Hz, CH2−C18), 2.27 (2H, tt, J = 7.3, 2.1 Hz, 
CH2−C22), 1.74−1.59 (4H, m, CH2−C19 and CH2−C21), 1.49 (1H, t, J = 6.1 Hz, 
OH−C25), 0.89 (9H, s, CH3−t-Bu TBS), 0.88 (9H, s, CH3−t-Bu TBS), 0.06 (3H, s, 
CH3−TBS), 0.06 (3H, s, CH3−TBS), 0.04 (6H, s, 2 × CH3−TBS); 13C NMR (101 
MHz, CDCl3) δ 86.7 (C−C23), 78.5 (C−C24), 68.3 (CH−C20), 59.8 (CH2−C18), 
51.6 (CH2−C25), 40.1 (CH2−C19), 36.1 (CH2−C21), 26.1 (CH3−t-Bu TBS), 26.0 
(CH3−t-Bu TBS), 18.4 (C−t-Bu TBS), 18.2 (C−t-Bu TBS), 14.8 (CH2−C22), −4.4 
(CH3−TBS), −4.4 (CH3−TBS), −5.2 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for 
C20H42O3Si2Na 409.2565, found 409.2566, Δ 0.4 ppm. 
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(R,Z)-6,8-Bis((tert-butyldimethylsilyl)oxy)oct-2-en-1-ol 283 
 
 
 
 
 
 
To a solution of propargylic alcohol 291 (4.5 g, 12 mmol) in pet. ether (58 mL) at 
RT, was added quinoline (1.7 mL, 14 mmol, 1.2 equiv.) slowly, followed by 
palladium on calcium carbonate (5 wt %, poisoned with lead, 0.50 g, 0.23 mmol, 2 
mol %). The reaction mixture was purged with hydrogen (3 ×), stirred at RT under 
a hydrogen atmosphere for 1.5 h and filtered through a celite pad. The solids were 
washed with Et2O (5 × 50 mL) and the filtrates concentrated. Crude material was 
purified by silica gel chromatography (pet. ether/Et2O, 80:20) to provide allylic 
alcohol 283 (4.3 g, 11 mmol, 95%) as a light yellow oil. Rf = 0.28 (pet. ether/Et2O, 
80:20); [α]D20 −5.4 (c = 1.0, CHCl3); νmax 3327, 2929, 2858, 1473, 1361, 1255, 
1092, 1051, 1005 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.64−5.57 (1H, m, CH−C24), 
5.57−5.49 (1H, m, CH−C23), 4.25−4.14 (2H, m, CH2−C25), 3.84 (1H, app p, J = 
5.7 Hz, CH−C20), 3.66 (2H, t, J = 6.5 Hz, CH2−C18), 2.22−2.03 (2H, m, 
CH2−C22), 1.69−1.62 (2H, m, CH2−C19), 1.58−1.47 (2H, m, CH2−C21), 1.31 (1H, 
t, J = 5.7 Hz, OH−C25), 0.89 (18H, s, 2 × CH3−t-Bu TBS), 0.05 (3H, s, CH3−TBS), 
0.05 (3H, s, CH3−TBS), 0.04 (6H, s, 2 × CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 
133.0 (CH−C23), 128.6 (CH−C24), 69.0 (CH−C20), 60.0 (CH2−C18), 58.7 
(CH2−C25), 40.0 (CH2−C19), 37.3 (CH2−C21), 26.1 (CH3−t-Bu TBS), 26.0 (CH3−t-
Bu TBS), 23.3 (CH2−C22), 18.4 (C−t-Bu TBS), 18.2 (C−t-Bu TBS), −4.3 
(CH3−TBS), −4.4 (CH3−TBS), −5.2 (CH3−TBS), −5.2 (CH3−TBS); HRMS (ESI+) 
[M+Na]+ calcd for C20H44O3Si2Na 411.2721, found 411.2714, Δ 1.7 ppm. 
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(R)-1,3-Bis((tert-butyldimethylsilyl)oxy)-5-((2S,3R)-3-(hydroxymethyl)oxiran-
2-yl)pentane 293 
 
 
 
 
 
 
To a suspension of 4 Å MS (1.0 g) in CH2Cl2 (21 mL) at −20 °C, were added D-(−)-
diethyltartrate (0.26 mL, 1.5 mmol, 30 mol %), Ti(Oi-Pr)4 (0.38 mL, 1.3 mmol, 25 
mol %) and t-BuOOH (1.9 M in CH2Cl2, 8.1 mL, 15 mmol, 3.0 equiv.) sequentially. 
The resulting mixture was stirred at −20 °C for 30 min, before the dropwise 
addition of allylic alcohol 283 (2.0 g, 5.1 mmol) in CH2Cl2 (6 mL) over 10 min. The 
reaction mixture was stirred at −20 °C for 24 h. The reaction was quenched by the 
addition of water (7.3 mL) at 0 °C and the mixture was stirred for 45 min while 
warming to RT. Hydrolysis of the tartrate was then effected by adding a 30% 
NaOH aq. solution saturated with NaCl (1.6 mL) and the mixture was stirred 
vigorously for 45 min. The layers were separated and the milky, aqueous phase 
was extracted with CH2Cl2 (3 × 30 mL). The combined organic extracts were 
washed with brine (90 mL), dried over MgSO4, filtered and concentrated. Crude 
material was purified by silica gel chromatography (pet. ether/EtOAc, 80:20) to 
afford epoxide 293 (1.9 g, 4.7 mmol, 91%) as a colourless oil. Rf = 0.33 (pet. 
ether/EtOAc, 80:20); [α]D25 −5.1 (c = 1.1, CHCl3); νmax 3407, 2929, 2857, 1473, 
1254, 1093, 1046 cm−1; 1H NMR (400 MHz, CDCl3) δ 3.92−3.85 (1H, m, CH−C20), 
3.82 (1H, ddd, J = 12.0, 7.2, 4.6 Hz, CH−C25), 3.70 (1H, ddd, J = 12.0, 6.6, 5.3 
Hz, CH−C25), 3.66 (2H, t, J = 6.4 Hz, CH2−C18), 3.16 (1H, ddd, J = 6.6, 4.6, 4.4 
Hz, CH−C24), 3.02 (1H, app td, J = 6.3, 4.4 Hz, CH−C23), 1.81 (1H, dd, J = 7.2, 
5.3 Hz, OH−C25), 1.78−1.47 (6H, m, CH2−C19, CH2−C21, CH2−C22), 0.89 (9H, s, 
CH3−t-Bu TBS), 0.88 (9H, s, CH3−t-Bu TBS), 0.06 (3H, s, CH3−TBS), 0.05 (3H, s, 
CH3−TBS), 0.04 (6H, s, 2 × CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 68.9 
(CH−C20), 60.9 (CH2−C25), 59.9 (CH2−C18), 57.4 (CH−C23), 56.9 (CH−C24), 
40.3 (CH2−C19), 33.9 (CH2−C21), 26.1 (CH3−t-Bu TBS), 26.0 (CH3−t-Bu TBS), 
23.8 (CH2−C22), 18.4 (C−t-Bu TBS), 18.2 (C−t-Bu TBS), −4.3 (CH3−TBS), −4.4 
(CH3−TBS), −5.2 (CH3−TBS), −5.2 (CH3−TBS); HRMS (CI+, isobutane) [M+H]+ 
calcd for C20H45O4Si2 405.2856, found 405.2851, Δ 1.3 ppm; LRMS (CI+, 
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isobutane) m/z (intensity) 405.3 (100%), 273.2 (34%). 
 
(R)-1,3-Bis((tert-butyldimethylsilyl)oxy)-5-((2S,3R)-3-ethynyloxiran-2-
yl)pentane 296 
 
 
 
 
 
 
To a solution of oxalyl chloride (1.6 mL, 19 mmol, 2.2 equiv.) in CH2Cl2 (25 mL) at 
−78 °C was added a solution of DMSO (2.9 mL, 41 mmol, 4.8 equiv.) in CH2Cl2 (4 
mL) dropwise. The resulting solution was stirred at −78 °C for 20 min, before the 
slow addition of alcohol 293 (3.4 g, 8.5 mmol) in CH2Cl2 (13 mL). The reaction 
mixture was stirred at −78 °C for 1.5 h, before the addition of Et3N (5.9 mL, 42 
mmol, 5.0 equiv.) and the mixture was stirred at RT for 1 h. The reaction was 
quenched by the addition of a sat. aq. NH4Cl solution (40 mL) and the layers were 
separated. The aqueous phase was extracted with CH2Cl2 (3 × 40 mL) and the 
combined organic extracts were washed with brine (120 mL), dried over MgSO4, 
filtered and concentrated. Crude material was directly used in the next step without 
further purification.  
To a solution of dimethyl-1-diazo-2-oxopropyl phosphonate (1.8 g, 9.3 mmol, 1.1 
equiv.) in MeOH (38 mL) at 0 °C, was added K2CO3 (1.6 g, 12 mmol, 1.4 equiv.) in 
one portion. The mixture was stirred at 0 °C for 1.5 h, before dropwise addition of 
the crude aldehyde in THF (19 mL). The resulting yellow suspension was stirred at 
0 °C for 2 h and at RT for 45 min. The reaction was quenched by the addition of a 
sat. aq. NH4Cl solution (50 mL). The white solids were filtered through a cotton 
plug and the layers were separated. The aqueous phase was extracted with Et2O 
(3 × 50 mL) and the combined organic extracts were washed with brine (150 mL), 
dried over MgSO4, filtered and concentrated. Crude material was purified by silica 
gel chromatography (pet. ether/Et2O, 95:5) to provide alkyne 296 (1.9 g, 4.6 mmol, 
55% over 2 steps) as a colourless oil. Rf = 0.28 (pet. ether/Et2O, 95:5); [α]D24 
−15.6 (c = 1.00, CHCl3); νmax 3314, 2929, 2857, 1473, 1361, 1253, 1091 cm−1; 1H 
NMR (500 MHz, CDCl3) δ 3.92−3.85 (1H, m, CH−C20), 3.70−3.64 (2H, m, 
CH2−C18), 3.42 (1H, dd, J = 4.0, 1.7 Hz, CH−C24), 3.07−3.02 (1H, m, CH−C23), 
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2.33 (1H, d, J = 1.7 Hz, CH−C26), 1.84−1.56 (6H, m, CH2−C19, CH2−C21, 
CH2−C22), 0.89 (9H, s, CH3−t-Bu TBS), 0.88 (9H, s, CH3−t-Bu TBS), 0.06 (6H, s, 
2 × CH3−TBS), 0.04 (6H, s, 2 × CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 79.0 
(C−C25), 73.6 (CH−C26), 69.0 (CH−C20), 60.0 (CH2−C18), 58.0 (CH−C23), 45.0 
(CH−C24), 40.2 (CH2−C19), 33.3 (CH2−C21), 26.1 (CH3−t-Bu TBS), 26.0 (CH3−t-
Bu TBS), 25.4 (CH2−C22), 18.4 (C−t-Bu TBS), 18.2 (C−t-Bu TBS), −4.3 
(CH3−TBS), −4.4 (CH3−TBS), −5.2 (CH3−TBS); HRMS (CI+, isobutane) [M+H]+ 
calcd for C21H43O3Si2 399.2751, found 399.2756, Δ 1.2 ppm; LRMS (CI+, 
isobutane) m/z (intensity) 399.3 (100%), 267.2 (34%). 
 
(R)-5-((2S,3R)-3-Ethynyloxiran-2-yl)pentane-1,3-diol 282 
 
 
 
 
 
 
To a solution of bis-TBS ether 296 (0.89 g, 2.2 mmol) in THF (11 mL) at 0 °C, was 
added TBAF (1.0 M in THF, 6.7 mL, 6.7 mmol, 3.0 equiv.) dropwise. The resulting 
solution was stirred at RT for 2.5 h. The reaction was quenched by the addition of 
a sat. aq. NH4Cl solution (10 mL) and the layers were separated. The aqueous 
phase was extracted with EtOAc (3 × 10 mL) and the combined organic extracts 
were washed with brine (30 mL), dried over MgSO4, filtered and concentrated. The 
residue was filtered rapidly through a short pad of silica gel (EtOAc) to give the 
crude diol 282, which was used directly in the next step without further purification. 
Rf = 0.41 (EtOAc); 1H NMR (500 MHz, CDCl3) δ 4.02−3.95 (1H, m, CH−C20), 
3.94−3.82 (2H, m, CH2−C18), 3.46 (1H, dd, J = 4.0, 1.7 Hz, CH−C24), 3.12−3.07 
(1H, m, CH−C23), 2.37 (1H, d, J = 1.7 Hz, CH−C26), 1.95−1.86 (1H, m, CH−C22), 
1.85−1.78 (1H, m, CH−C22), 1.78−1.67 (4H, m, CH2−C19, CH2−C21); 13C NMR 
(126 MHz, CDCl3) δ 78.8 (C−C25), 74.0 (CH−C26), 71.6 (CH−C20), 62.0 
(CH2−C18), 57.9 (CH−C23), 45.0 (CH−C24), 38.5 (CH2−C19), 34.0 (CH2−C21), 
25.6 (CH2−C22); HRMS (ESI+) [M+Na]+ calcd for C9H14O3Na 193.0835, found 
193.0830, Δ 2.7 ppm. 
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(R)-1-((2R,5R)-5-(2-Hydroxyethyl)tetrahydrofuran-2-yl)prop-2-yn-1-ol 281 
 
 
 
 
 
 
To a solution of crude diol 282 in CH2Cl2 (22 mL) at −40 °C, was added (1S)-(+)-
camphorsulfonic acid (52 mg, 0.22 mmol, 10 mol %). The resulting mixture was 
stirred at −40 °C for 10 min and at RT for 30 min. The reaction was quenched by 
the addition of Et3N (0.10 mL, 0.66 mmol) and the solution was concentrated. The 
residue was filtered rapidly through a short pad of silica gel (EtOAc) to give the 
crude tetrahydrofuran 281 which was used directly in the next step without further 
purification. Rf = 0.38 (EtOAc); 1H NMR (400 MHz, CDCl3) δ 4.25−4.17 (2H, m, 
CH−C20, CH−C24), 4.16−4.09 (1H, m, CH−C23), 3.79 (2H, app t, J = 5.7 Hz, 
CH2−C18), 2.69 (1H, br s, OH−C24), 2.56 (1H, br s, OH−C18), 2.44 (1H, d, J = 2.2 
Hz, CH−C26), 2.16−2.06 (2H, m, CH−C21, CH−C22), 1.91−1.82 (1H, m, 
CH−C22), 1.81−1.76 (2H, m, CH2−C19), 1.70−1.59 (1H, m, CH−C21); 13C NMR 
(126 MHz, CDCl3) δ 82.1 (C−C25), 81.8 (CH−C23), 79.7 (CH−C20), 73.9 
(CH−C26), 65.1 (CH−C24), 61.3 (CH2−C18), 37.5 (CH2−C19), 32.3 (CH2−C21), 
27.9 (CH2−C22). 
 
Triethyl(((R,E)-5-methyl-1-((2R,5R)-5-(2-
((triethylsilyl)oxy)ethyl)tetrahydrofuran-2-yl)hexa-2,4-dien-1-yl)oxy)silane 301 
 
 
 
 
 
 
To a suspension of Pd(PPh3)4 (0.13 g, 0.11 mmol, 5 mol %) in pyrrolidine (2.5 mL) 
at RT, was added 1-bromo-2-methyl-1-propene (0.68 mL, 6.7 mmol, 3.0 equiv.) 
followed, after 5 min, by the dropwise addition of crude alkyne 281 in pyrrolidine 
(2.5 mL). The resulting yellow solution was stirred at 50 °C for 16 h. The reaction 
mixture was allowed to cool to RT, followed by the addition of a sat. aq. NH4Cl 
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solution (10 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 10 mL). The combined organic extracts were dried over 
MgSO4, filtered and concentrated. Crude enyne 299 was used directly in the next 
step without further purification. 
To a solution of crude enyne 299 in THF (40 mL) at 0 °C, was added sodium 
bis(2-methoxyethoxy)aluminium hydride (≥ 65 wt % in toluene, 2.6 mL, 8.9 mmol, 
4.0 equiv.) dropwise. The resulting cloudy mixture was stirred at RT for 30 min and 
cooled to 0 °C, before the dropwise addition of a sat. aq. potassium sodium 
tartrate solution (50 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 50 mL). The combined organic extracts were washed with 
brine (150 mL), dried over MgSO4, filtered and concentrated. Crude diene 300 was 
used directly in the next step without further purification. 
To a solution of crude diol 300 in CH2Cl2 (15 mL) at −78 °C, were added 2,6-
lutidine (1.1 mL, 9.4 mmol, 6.0 equiv.) and TESOTf (1.1 mL, 4.7 mmol, 3.0 equiv.) 
sequentially. The resulting solution was stirred at −78 °C for 45 min. Water (15 
mL) was added and the biphasic mixture was allowed to warm to RT. The layers 
were separated and the aqueous phase was extracted with CH2Cl2 (3 × 15 mL). 
The combined organic extracts were dried over MgSO4, filtered and concentrated. 
Crude material was purified by silica gel chromatography (pet. ether/EtOAc, 98:2) 
to deliver bis-TES ether 301 (0.61 g, 1.4 mmol, 61% over 5 steps) as a colourless 
oil. Rf = 0.28 (pet. ether/EtOAc, 98:2); [α]D24 +13.5 (c = 2.13, CHCl3); νmax 2955, 
2911, 2876, 1460, 1414, 1379, 1238, 1086, 1005 cm−1; 1H NMR (400 MHz, CDCl3) 
δ 6.45 (1H, ddd, J = 15.2, 11.0, 1.4 Hz, CH−C26), 5.82 (1H, dm, J = 11.0 Hz, 
CH−C27), 5.54 (1H, dd, J = 15.2, 5.9 Hz, CH−C25), 4.18 (1H, app td, J = 5.9, 1.4 
Hz, CH−C24), 3.97 (1H, app ddt, J = 8.2, 7.7, 5.5 Hz, CH−C20), 3.92 (1H, app td, 
J = 7.3, 5.9 Hz, CH−C23), 3.78−3.62 (2H, m, CH2−C18), 1.96 (1H, dddd, J = 11.7, 
8.3, 5.5, 3.2 Hz, CH−C21), 1.91−1.79 (2H, m, CH−C19, CH−C22), 1.77 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.73−1.61 (2H, m, CH−C19, CH−C22), 1.46 
(1H, app ddt, J = 11.7, 9.8, 8.2 Hz, CH−C21), 0.96 (9H, t, J = 7.9 Hz, CH3−TES), 
0.95 (9H, t, J = 7.9 Hz, CH3−TES), 0.64−0.56 (12H, m, CH2−TES); 13C NMR (101 
MHz, CDCl3) δ 135.0 (C−C28), 130.1 (CH−C25), 127.6 (CH−C26), 124.9 
(CH−C27), 82.2 (CH−C23), 76.8 (CH−C20), 75.6 (CH−C24), 60.6 (CH2−C18), 
39.2 (CH2−C19), 32.5 (CH2−C21), 27.5 (CH2−C22), 26.1 (CH3−C35), 18.4 
(CH3−C29), 7.0 (CH3−TES), 6.9 (CH3−TES), 5.2 (CH2−TES), 4.6 (CH2−TES); 
HRMS (ESI+) [M+Na]+ calcd for C25H50O3Si2Na 477.3191, found 477.3198, Δ 1.5 
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ppm. 
 
(R)-1-((2R,5R)-5-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)tetrahydrofuran-2-
yl)prop-2-yn-1-ol 25726b 
 
 
 
 
 
 
To a solution of bis-TBS ether 296 (0.12 g, 0.30 mmol) in THF (2 mL) at 0 °C, was 
added TBAF (1.0 M in THF, 0.89 mL, 0.89 mmol, 3.0 equiv.) dropwise. The 
resulting solution was stirred at RT for 2.5 h. The reaction was quenched by the 
addition of a sat. aq. NH4Cl solution (2 mL). The layers were separated and the 
aqueous phase was extracted with EtOAc (3 × 2 mL). The combined organic 
extracts were washed with brine (6 mL), dried over MgSO4, filtered and 
concentrated. The residue was filtered rapidly through a short pad of silica gel 
(EtOAc) to give the crude diol 282 which was used directly in the next step without 
further purification. 
To a solution of crude diol 282 in CH2Cl2 (3 mL) at −40 °C, was added (1S)-(+)-
camphorsulfonic acid (7 mg, 0.03 mmol, 10 mol %). The resulting mixture was 
stirred at −40 °C for 10 min and at RT for 30 min. The reaction was quenched by 
the addition of Et3N (12 µL, 89 µmol) and the solution was concentrated. The 
residue was filtered rapidly through a short pad of silica gel (EtOAc) to give the 
crude tetrahydrofuran 281 which was used directly in the next step without further 
purification. 
To a solution of crude tetrahydrofuran 281 in CH2Cl2 (3 mL) at 0 °C, were added 
Et3N (40 µL, 0.31 mmol, 1.1 equiv.), TBDPSCl (80 µL, 0.31 mmol, 1.1 equiv.) and 
DMAP (4 mg, 0.03 mmol, 0.1 equiv.). The resulting solution was stirred at RT for 
15 h. The reaction was quenched by the addition of water (2 mL) and the layers 
were separated. The aqueous phase was extracted with EtOAc (3 × 3 mL) and the 
combined organic extracts were washed with brine (9 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 85:15) to afford silyl ether 257 (77 mg, 0.19 
mmol, 64% over 3 steps) as a colourless oil. Rf = 0.47 (pet. ether/EtOAc, 80:20); 
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[α]D26 −0.74 (c = 1.3, CHCl3) [lit26b [α]D26 −0.73 (c = 2.2, CHCl3)]; νmax 3408, 3306, 
2932, 2857, 1472, 1427, 1389, 1111, 1080 cm−1; 1H NMR (500 MHz, CDCl3) δ 
7.69−7.64 (4H, m, CH−Ar TBDPS), 7.45−7.36 (6H, m, CH−Ar TBDPS), 4.20−4.11 
(2H, m, CH−C20, CH−C24), 4.03 (1H, app q, J = 6.9 Hz, CH−C23), 3.81−3.71 
(2H, m, CH2−C18), 2.42 (1H, d, J = 4.5 Hz, OH−C24), 2.42 (1H, d, J = 2.0 Hz, 
CH−C26), 2.13−2.01 (2H, m, CH−C21, CH−C22), 1.89−1.77 (2H, m, CH−C19, 
CH−C22), 1.73 (1H, app ddt, J = 13.5, 7.4, 5.9 Hz, CH−C19), 1.62−1.53 (1H, m, 
CH−C21), 1.05 (9H, s, CH3−t-Bu TBDPS); 13C NMR (126 MHz, CDCl3) δ 135.7 
(CH−Ar TBDPS), 134.0 (C−Ar TBDPS), 134.0 (C−Ar TBDPS), 129.8 (CH−Ar 
TBDPS), 127.8 (CH−Ar TBDPS), 82.1 (C−C25), 81.5 (CH−C23), 77.2 (CH−C20), 
73.8 (CH−C26), 65.4 (CH−C24), 61.2 (CH2−C18), 38.5 (CH2−C19), 32.1 
(CH2−C21), 28.2 (CH2−C22), 27.0 (CH3−t-Bu TBDPS), 19.4 (C−t-Bu TBDPS); 
HRMS (CI+, isobutane) [M+H]+ calcd for C25H33O3Si 409.2199, found 409.2202, Δ 
0.8 ppm; LRMS (CI+, isobutane) m/z (intensity) 409.2 (86%), 383.2 (89%), 331.2 
(89%), 305.1 (100%), 253.1 (44%). 
 
2-((2R,5R)-5-((1E)-5-Methylhexa-1,3,5-trien-1-yl)tetrahydrofuran-2-
yl)acetaldehyde 303 
 
 
 
 
 
 
To a solution of DMSO (40 µL, 0.53 mmol, 8.0 equiv.) in CH2Cl2 (1.1 mL) at −78 
°C, was added oxalyl chloride (2.0 M in CH2Cl2, 0.13 mL, 0.26 mmol, 4.0 equiv.) 
dropwise. The solution was stirred at −78 °C for 15 min, before the addition of silyl 
ether 301 (30 mg, 66 mmol) in CH2Cl2 (0.2 mL) over 15 min. The reaction mixture 
was stirred at −60 °C for 8 h and cooled to −78 °C, before the dropwise addition of 
Et3N (0.15 mL, 1.1 mmol, 16.0 equiv.). The reaction mixture was stirred at 0 °C for 
30 min, followed by the addition of water (2.2 mL) and CH2Cl2 (2.2 mL). The layers 
were separated and the aqueous phase was extracted with CH2Cl2 (3 × 2.2 mL). 
The combined organic extracts were washed with brine (3 × 10 mL), dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 85:15) to provide a 2:3 mixture of Z and E 
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isomers 303 (8 mg, 0.04 mmol, 59%) as a colourless oil. Rf = 0.28 (pet. 
ether/EtOAc, 85:15); νmax 2923, 2857, 1723, 1620, 1457, 1374, 1261, 1057 cm−1; 
1H NMR (500 MHz, CDCl3) δ 9.82 (2.5H, app t, J = 2.1 Hz, CH−C18, CH−C18'), 
6.34−6.15 (7.5H, m, CH−C25, CH−C25', CH−C26, CH−C26', CH−C27, CH−C27'), 
5.72 (1H, dd, J = 14.9, 6.9 Hz, CH−C24'), 5.71 (1.5H, dd, J = 14.8, 6.9 Hz, 
CH−C24), 4.99 (5H, m, CH2−C29, CH2−C29'), 4.54−4.45 (3H, m, CH−C20, 
CH−C23), 4.42−4.34 (2H, m, CH−C20', CH−C23'), 2.75 (1H, ddd, J = 14.9, 7.2, 
2.1 Hz, CH−C19'), 2.71 (1.5H, ddd, J = 13.4, 7.2, 2.1 Hz, CH−C19), 2.63 (1H, ddd, 
J = 14.9, 5.5, 2.1 Hz, CH−C19'), 2.59 (1.5H, ddd, J = 13.4, 5.4, 2.1 Hz, CH−C19), 
2.25−2.06 (5H, m, CH−C21, CH−C21', CH−C22, CH−C22'), 1.87−1.84 (7.5H, m, 
CH3−C35, CH3−C35'), 1.77−1.59 (5H, m, CH−C21, CH−C21', CH−C22, CH−C22'); 
13C NMR (101 MHz, CDCl3) δ 201.3 (CH−C18), 201.2 (CH−C18'), 142.1 (C−C28), 
142.1 (C−C28'), 136.0 (CH−C27'), 136.0 (CH−C27), 134.1 (CH−C24), 134.1 
(CH−C24'), 131.6 (CH−C25'), 131.3 (CH−C25), 128.4 (CH−C26'), 128.4 
(CH−C26), 117.2 (CH2−C29'), 117.2 (CH2−C29), 80.1 (CH−C23'), 79.6 (CH−C23), 
74.4 (CH−C20'), 74.0 (CH−C20), 50.0 (CH2−C19'), 49.9 (CH2−C19), 32.9 
(CH2−C21), 32.4 (CH2−C22), 32.1 (CH2−C21'), 31.5 (CH2−C22'), 18.6 (CH3−C35, 
CH3−C35'); HRMS (ESI+) [M+Na]+ calcd for C13H18O2Na 229.1199, found 
229.1192, Δ 3.0 ppm. 
 
2-((2R,5R)-5-((R,E)-5-Methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)ethanol 304 
 
 
 
 
 
 
Note: The HFPyr stock solution was prepared by mixing HFPyr (1.0 mL, 70% HF 
in pyridine), pyridine (2.0 mL) and THF (5.0 mL). 
 
To a solution of bis-TES ether 301 (0.22 g, 0.48 mmol) in THF (48 mL) at −20 °C, 
was added a stock solution of HFPyr (1.8 mL) and the resulting mixture was 
stirred for 15 h. The reaction was quenched by the dropwise addition of a sat. aq. 
NaHCO3 solution (150 mL). The biphasic mixture was allowed to warm to RT and 
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the layers were separated. The aqueous phase was extracted with Et2O (3 × 150 
mL) and the combined organic extracts were washed with brine (400 mL), dried 
over MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 85:15) to afford alcohol 304 (0.13 g, 0.38 
mmol, 79%) as a colourless oil. Rf = 0.21 (pet. ether/EtOAc, 85:15); [α]D24 +11.4 (c 
= 2.08, CHCl3); νmax 3410, 2955, 2876, 1659, 1460, 1377, 1238, 1069, 1005 cm−1; 
1H NMR (500 MHz, CDCl3) δ 6.44 (1H, ddd, J = 15.2, 11.1, 1.3 Hz, CH−C26), 5.81 
(1H, dm, J = 11.1 Hz, CH−C27), 5.51 (1H, dd, J = 15.2, 6.2 Hz, CH−C25), 
4.19−4.06 (2H, m, CH−C20, CH−C24), 3.96 (1H, app dt, J = 8.0, 6.3 Hz, 
CH−C23), 3.84−3.71 (2H, m, CH2−C18), 3.00 (1H, dd, J = 7.0, 4.2 Hz, OH−C18), 
2.00 (1H, dddd, J = 11.9, 8.3, 5.7, 3.0 Hz, CH−C21), 1.92−1.84 (1H, m, CH−C22), 
1.77 (3H, br s, CH3−C35), 1.75 (3H, br s, CH3−C29), 1.79−1.62 (3H, m, CH2−C19, 
CH−C22), 1.54 (1H, app ddt, J = 11.9, 9.9, 8.2 Hz, CH−C21), 0.95 (9H, t, J = 8.0 
Hz, CH3−TES), 0.60 (6H, q, J = 8.0 Hz, CH2−TES); 13C NMR (101 MHz, CDCl3) δ 
135.5 (C−C28), 129.9 (CH−C25), 127.9 (CH−C26), 124.7 (CH−C27), 82.7 
(CH−C23), 80.0 (CH−C20), 75.7 (CH−C24), 62.0 (CH2−C18), 37.4 (CH2−C19), 
32.6 (CH2−C21), 27.4 (CH2−C22), 26.2 (CH3−C35), 18.4 (CH3−C29), 7.0 
(CH3−TES), 5.2 (CH2−TES); HRMS (EI+) [M]+ calcd for C19H36O3Si 340.2434, 
found 340.2431, Δ 0.9 ppm; LRMS (EI+) m/z (intensity) 340.2 (2%), 225.1 (100%), 
115.1 (18%), 87.1 (12%). 
 
2-((2R,5R)-5-((R,E)-5-Methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)acetaldehyde 302 
 
 
 
 
 
 
To a solution of alcohol 304 (0.13 g, 0.38 mmol) in CH2Cl2 (4 mL) at RT, were 
added pyridine (0.14 mL, 1.7 mmol, 4.5 equiv.) and DMP (0.24 g, 0.57 mmol, 1.5 
equiv.) sequentially. The resulting solution was stirred at RT for 1 h, before the 
addition of a sat. aq. Na2S2O3 solution (4 mL). The layers were separated and the 
organic layer was washed with a sat. aq. NaHCO3 solution (4 mL). The aqueous 
phase was extracted with CH2Cl2 (3 × 4 mL) and the combined organic extracts 
23
2221
20
O
24
25
OTES
H19
18
H
H 26
27
28
29
35
Chemical Formula: C19H34O3Si
Molecular Weight: 338,56
O
Experimental Section | 115 
were washed with brine (20 mL), dried over MgSO4, filtered and concentrated. 
Crude material was purified by silica gel chromatography (pet. ether/EtOAc, 90:10) 
to deliver aldehyde 302 (0.11 g, 0.32 mmol, 84%) as a colourless oil. Rf = 0.37 
(pet. ether/EtOAc, 90:10); 1H NMR (400 MHz, CDCl3) δ 9.80 (1H, app t, J = 2.2 
Hz, CH−C18), 6.45 (1H, ddd, J = 15.2, 11.0, 1.3 Hz, CH−C26), 5.82 (1H, dm, J = 
11.0 Hz, CH−C27), 5.53 (1H, dd, J = 15.2, 6.0 Hz, CH−C25), 4.35 (1H, app ddt, J 
= 8.4, 7.3, 5.5 Hz, CH−C20), 4.17 (1H, ddd, J = 6.0, 5.8, 1.3 Hz, CH−C24), 3.98 
(1H, app td, J = 7.3, 5.8 Hz, CH−C23), 2.66 (1H, ddd, J = 16.2, 7.3, 2.2 Hz, 
CH−C19), 2.54 (1H, ddd, J = 16.2, 5.5, 2.2 Hz, CH−C19), 2.13−2.05 (1H, m, 
CH−C22), 1.96−1.86 (1H, m, CH−C21), 1.77 (3H, br s, CH3−C35), 1.83−1.73 (1H, 
m, CH−C22), 1.75 (3H, br s, CH3−C29), 1.51 (1H, app ddt, J = 12.0, 9.6, 8.4 Hz, 
CH−C21), 0.94 (9H, t, J = 7.9 Hz, CH3−TES), 0.59 (6H, q, J = 7.9 Hz, CH2−TES). 
 
2-((2R,5R)-5-((R)-1-Hydroxyprop-2-yn-1-yl)tetrahydrofuran-2-yl)ethyl pivalate 
298 
 
 
 
 
 
 
To a solution of bis-TBS ether 296 (0.92 g, 2.3 mmol) in THF (15 mL) at 0 °C, was 
added TBAF (1.0 M in THF, 6.9 mL, 6.9 mmol, 3.0 equiv.) dropwise. The resulting 
solution was stirred at RT for 2.5 h. The reaction was quenched by the addition of 
a sat. aq. NH4Cl solution (15 mL). The layers were separated and the aqueous 
phase was extracted with EtOAc (3 × 15 mL). The combined organic extracts were 
washed with brine (45 mL), dried over MgSO4, filtered and concentrated. The 
residue was filtered rapidly through a short pad of silica gel (EtOAc) to give the 
crude diol 282 which was used directly in the next step without further purification. 
To a solution of crude diol 282 in CH2Cl2 (23 mL) at −40 °C, was added (1S)-(+)-
camphorsulfonic acid (53 mg, 0.23 mmol, 10 mol %). The resulting mixture was 
stirred at −40 °C for 10 min and at RT for 30 min. The reaction was quenched by 
the addition of Et3N (0.10 mL, 0.69 mmol) and the solution was concentrated. The 
residue was filtered rapidly through a short pad of silica gel (EtOAc) to give the 
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crude tetrahydrofuran 281 which was used directly in the next step without further 
purification. 
To a solution of crude tetrahydrofuran 281 in CH2Cl2 (12 mL) at 0 °C, were added 
pyridine (0.28 mL, 3.5 mmol, 1.5 equiv.) and, after 5 min, PivCl (0.31 mL, 2.5 
mmol, 1.1 equiv.). The resulting solution was stirred at 0 °C for 10 min and at RT 
for 22 h. The reaction was quenched by the addition of a sat. aq. NaHCO3 solution 
(9 mL). The layers were separated and the aqueous phase was extracted with 
EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (30 
mL), dried over MgSO4, filtered and concentrated. Crude material was purified by 
silica gel chromatography (pet. ether/EtOAc, 70:30) to provide pivalate 298 (0.44 
g, 1.7 mmol, 76% over 3 steps) as a colourless oil. Rf = 0.49 (pet. ether/EtOAc, 
70:30); [α]D24 −12.6 (c = 1.04, CHCl3); νmax 3447, 3284, 2972, 1724, 1481, 1398, 
1367, 1286, 1156, 1038 cm−1; 1H NMR (500 MHz, CDCl3) δ 4.23−4.12 (3H, m, 
CH2−C18, CH−C24), 4.09 (1H, app q, J = 7.0 Hz, CH−C23), 4.07−4.00 (1H, m, 
CH−C20), 2.53 (1H, d, J = 4.3 Hz, OH−C24), 2.43 (1H, d, J = 2.2 Hz, CH−C26), 
2.16−2.00 (2H, m, CH−C21, CH−C22), 1.95−1.87 (1H, m, CH−C19), 1.86−1.77 
(2H, m, CH−C19, CH−C22), 1.65−1.56 (1H, m, CH−C21), 1.19 (9H, s, CH3−t-Bu 
Piv); 13C NMR (126 MHz, CDCl3) δ 178.6 (C−Piv), 81.9 (C−C25), 81.5 (CH−C23), 
77.0 (CH−C20), 73.7 (CH−C26), 65.1 (CH−C24), 61.7 (CH2−C18), 38.7 (C−t-Bu 
Piv), 34.5 (CH2−C19), 32.0 (CH2−C21), 28.0 (CH2−C22), 27.2 (CH3−t-Bu Piv); 
HRMS (CI+, isobutane) [M+H]+ calcd for C14H23O4 255.1596, found 255.1593, Δ 
1.3 ppm; LRMS (CI+, isobutane) m/z (intensity) 255.19 (100%), 229.18 (17%). 
 
2-((2R,5R)-5-((R)-1-Hydroxy-5-methylhex-4-en-2-yn-1-yl)tetrahydrofuran-2-
yl)ethyl pivalate 305 
 
 
 
 
 
 
To a suspension of Pd(PPh3)4 (10 mg, 10 µmol, 5 mol %) in pyrrolidine (300 µL) at 
RT, was added 1-bromo-2-methyl-1-propene (60 µL, 0.60 mmol, 3.0 equiv.) 
followed, after 5 min, by the dropwise addition of alkyne 298 (50 mg, 0.20 mmol) in 
pyrrolidine (300 µL). The resulting yellow solution was stirred at 50 °C for 16 h. 
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The reaction mixture was allowed to cool to RT, before the addition of a sat. aq. 
NH4Cl solution (2 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 3 mL). The combined organic extracts were dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 80:20) to afford enyne 305 (50 mg, 0.16 mmol, 
82%) as a light yellow oil. Rf = 0.26 (pet. ether/EtOAc, 80:20); [α]D27 +12.6 (c = 
2.32, CHCl3); νmax 3443, 2969, 1726, 1481, 1397, 1285, 1155, 1032 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 5.28−5.25 (1H, m, CH−C27), 4.37−4.32 (1H, m, CH−C24), 
4.22−4.12 (2H, m, CH2−C18), 4.12−4.00 (2H, m, CH−C20, CH−C23), 2.49 (1H, d, 
J = 4.0 Hz, OH−C24), 2.18−1.99 (2H, m, CH−C21, CH−C22), 1.96−1.87 (1H, m, 
CH−C19), 1.88 (3H, br s, CH3−C35), 1.87−1.78 (2H, m, CH−C19, CH−C22), 1.80 
(3H, br s, CH3−C29), 1.65−1.54 (1H, m, CH−C21), 1.19 (9H, s, CH3−t-Bu Piv); 13C 
NMR (126 MHz, CDCl3) δ 178.7 (C−Piv), 149.7 (C−C28), 104.7 (CH−C27), 89.0 
(C−C25), 83.9 (C−C26), 82.1 (CH−C23), 76.9 (CH−C20), 66.2 (CH−C24), 61.9 
(CH2−C18), 38.9 (C−t-Bu Piv), 34.7 (CH2−C19), 32.2 (CH2−C21), 28.3 (CH2−C22), 
27.3 (CH3−t-Bu Piv), 24.9 (CH3−C29), 21.2 (CH3−C35); HRMS (ESI+) [M+Na]+ 
calcd for C18H28O4Na 331.1880, found 331.1870, Δ 3.0 ppm. 
 
2-((2R,5R)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-5-methylhex-4-en-2-yn-1-
yl)tetrahydrofuran-2-yl)ethyl pivalate 306 
 
 
 
 
 
 
To a solution of alcohol 305 (0.17 g, 0.56 mmol) in CH2Cl2 (6 mL) at −78 °C, were 
added 2,6-lutidine (0.17 mL, 1.5 mmol, 2.6 equiv.) and TBSOTf (0.17 mL, 0.73 
mmol, 1.3 equiv.) sequentially. The resulting solution was stirred at −78 °C for 30 
min and water (2 mL) was added. The biphasic mixture was allowed to warm to 
RT and the layers were separated. The aqueous phase was extracted with CH2Cl2 
(3 × 3 mL) and the combined organic extracts were washed with brine (10 mL), 
dried over MgSO4, filtered and concentrated. Crude material was purified by silica 
gel chromatography (pet. ether/EtOAc, 95:5) to give TBS ether 306 (0.23 g, 0.53 
mmol, 94%) as a colourless oil. Rf = 0.26 (pet. ether/EtOAc, 95:5); [α]D25 −13.1 (c 
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= 2.40, CHCl3); νmax 2930, 2857, 1730, 1479, 1285, 1252, 1155, 1071 cm−1; 1H 
NMR (500 MHz, CDCl3) δ 5.27−5.23 (1H, m, CH−C27), 4.51 (1H, dd, J = 5.8, 1.4 
Hz, CH−C24), 4.20−4.04 (4H, m, CH2−C18, CH−C20, CH−C23), 2.11−2.03 (2H, 
m, CH−C21, CH−C22), 2.01−1.93 (1H, m, CH−C22), 1.93−1.84 (1H, m, CH−C19), 
1.87 (3H, br s, CH3−C35), 1.83−1.74 (1H, m, CH−C19), 1.79 (3H, br s, CH3−C29), 
1.56−1.48 (1H, m, CH−C21), 1.18 (9H, s, CH3−t-Bu Piv), 0.90 (9H, s, CH3−t-Bu 
TBS), 0.12 (3H, s, CH3−TBS), 0.11 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) 
δ 178.6 (C−Piv), 148.7 (C−C28), 105.1 (CH−C27), 90.6 (C−C25), 83.3 (C−C26), 
81.8 (CH−C23), 76.8 (CH−C20), 67.0 (CH−C24), 62.1 (CH2−C18), 38.8 (C−t-Bu 
Piv), 34.8 (CH2−C19), 32.3 (CH2−C21), 28.0 (CH2−C22), 27.3 (CH3−t-Bu Piv), 
26.0 (CH3−t-Bu TBS), 24.9 (CH3−C29), 21.1 (CH3−C35), 18.5 (C−t-Bu TBS), −4.5 
(CH3−TBS), −4.8 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C24H42O4SiNa 
445.2745, found 445.2734, Δ 2.3 ppm. 
 
2-((2R,5R)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-5-methylhex-4-en-2-yn-1-
yl)tetrahydrofuran-2-yl)ethanol 307 
 
 
 
 
 
 
To a solution of pivalate 306 (0.48 g, 1.1 mmol) in Et2O (16 mL) at −20 °C, was 
added LiAlH4 (0.11 g, 2.8 mmol, 2.5 equiv.) in one portion. The resulting solution 
was stirred at −20 °C for 20 min, before the dropwise addition of water (0.11 mL), 
a 15% NaOH aq. solution (0.11 mL) and water (0.33 mL). The mixture was stirred 
vigorously at RT for 20 min. The solids were filtered through a cotton plug and the 
filtrate was concentrated. Crude material was purified by silica gel chromatography 
(pet. ether/EtOAc, 80:20) to give alcohol 307 (0.37 g, 1.1 mmol, 96%) as a 
colourless oil. Rf = 0.30 (pet. ether/EtOAc, 80:20); [α]D26 −17.5 (c = 2.00, CHCl3); 
νmax 3410, 2929, 2857, 1473, 1463, 1334, 1251, 1069 cm−1; 1H NMR (500 MHz, 
CDCl3) δ 5.27−5.25 (1H, m, CH−C27), 4.48 (1H, dd, J = 6.1, 1.7 Hz, CH−C24), 
4.23−4.16 (1H, m, CH−C20), 4.10 (1H, ddd, J = 7.6, 6.5, 6.1 Hz, CH−C23), 
3.82−3.73 (2H, m, CH2−C18), 2.90 (1H, dd, J = 7.0, 4.2 Hz, OH−C18), 2.11−2.03 
(2H, m, CH−C21, CH−C22), 1.98−1.88 (1H, m, CH−C22), 1.87 (3H, br s, 
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CH3−C35), 1.79 (3H, br s, CH3−C29), 1.78−1.73 (2H, m, CH2−C19), 1.62−1.54 
(1H, m, CH−C21), 0.90 (9H, s, CH3−t-Bu Piv), 0.13 (3H, s, CH3−TBS), 0.11 (3H, s, 
CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 148.9 (C−C28), 105.0 (CH−C27), 90.4 
(C−C25), 83.4 (C−C26), 82.3 (CH−C23), 80.4 (CH−C20), 66.9 (CH−C24), 62.0 
(CH2−C18), 37.3 (CH2−C19), 32.5 (CH2−C21), 27.8 (CH2−C22), 25.9 (CH3−t-Bu 
TBS), 24.9 (CH3−C29), 21.1 (CH3−C35), 18.4 (C−t-Bu TBS), −4.5 (CH3−TBS), 
−4.8 (CH3−TBS); HRMS (CI+, isobutane) [M+H]+ calcd for C19H35O3Si 339.2355, 
found 339.2351, Δ 1.2 ppm; LRMS (CI+, isobutane) m/z (intensity) 339.1 (19%), 
263.1 (27%), 207.1 (100%), 135.0 (23%). 
 
2-((2R,5R)-5-((R)-1-((tert-Butyldimethylsilyl)oxy)-5-methylhex-4-en-2-yn-1-
yl)tetrahydrofuran-2-yl)acetaldehyde 308 
 
 
 
 
 
 
To a solution of alcohol 307 (0.27 g, 0.79 mmol) in CH2Cl2 (11 mL) at RT, were 
added pyridine (0.39 mL, 4.8 mmol, 6.0 equiv.) and DMP (0.67 g, 1.6 mmol, 2.0 
equiv.) sequentially. The resulting solution was stirred at RT for 1 h, before the 
addition of a sat. aq. Na2S2O3 solution (10 mL). The layers were separated and the 
organic layer was washed with a sat aq. NaHCO3 solution (10 mL). The aqueous 
phase was extracted with CH2Cl2 (3 × 10 mL) and the combined organic extracts 
were washed with brine (40 mL), dried over MgSO4, filtered and concentrated. 
Crude material was purified by silica gel chromatography (pet. ether/EtOAc, 90:10) 
to deliver aldehyde 308 (0.24 g, 0.71 mmol, 89%) as a colourless oil. Rf = 0.38 
(pet. ether/EtOAc, 90:10); 1H NMR (400 MHz, CDCl3) δ 9.80 (1H, dd, J = 2.5, 2.1 
Hz, CH−C18), 5.28−5.25 (1H, m, CH−C27), 4.54 (1H, dd, J = 5.8, 1.5 Hz, 
CH−C24), 4.47 (1H, app ddt, J = 8.6, 7.2, 5.5 Hz, CH−C20), 4.10 (1H, app td, J = 
7.1, 5.8 Hz, CH−C23), 2.68 (1H, ddd, J = 16.2, 7.2, 2.5 Hz, CH−C19), 2.56 (1H, 
ddd, J = 16.2, 5.5, 2.1 Hz, CH−C19), 2.24−2.16 (1H, m, CH−C21), 2.14−1.98 (2H, 
m, CH2−C22), 1.88 (3H, br s, CH3−C35), 1.80 (3H, br s, CH3−C29), 1.56 (1H, app 
ddt, J = 12.1, 9.4, 8.6 Hz, CH−C21), 0.90 (9H, s, CH3−t-Bu TBS), 0.12 (3H, s, 
CH3−TBS), 0.11 (3H, s, CH3−TBS). 
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(((R,E)-1-((2R,5R)-5-((1,3-Dithian-2-yl)methyl)tetrahydrofuran-2-yl)-5-
methylhexa-2,4-dien-1-yl)oxy)triethylsilane 264 
 
 
 
 
 
 
To a suspension of MgBr2•OEt2 (0.24 g, 0.92 mmol, 1.3 equiv.) in Et2O (5 mL) at 
RT, was added 1,3-propanedithiol (86 µL, 0.85 mmol, 1.2 equiv.) followed by a 
solution of aldehyde 308 (0.24 g, 0.71 mmol) in Et2O (2 mL). The resulting mixture 
was stirred at RT for 1.5 h and water (7 mL) was added. The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 7 mL). The 
combined organic extracts were washed with brine (20 mL), dried over MgSO4, 
filtered and concentrated. Crude material was used directly in the next step without 
further purification. 
To a solution of the crude TBS ether in THF (7 mL) at 0 °C, was added TBAF (1.0 
M in THF, 1.4 mL, 1.4 mmol, 2.0 equiv.) dropwise. The resulting solution was 
stirred at RT for 1 h, before the addition of water (7 mL). The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 7 mL). The 
combined organic extracts were washed with brine (20 mL), dried over MgSO4, 
filtered and concentrated. Crude material was used directly in the next step without 
further purification. 
To a solution of the crude enyne in THF (10 mL) at 0 °C, was added sodium bis(2-
methoxyethoxy)aluminium hydride (≥ 65 wt % in toluene, 0.67 mL, 2.2 mmol, 4.5 
equiv.) dropwise. The resulting cloudy mixture was stirred at RT for 30 min and 
cooled to 0 °C, before the dropwise addition of a sat. aq. potassium sodium 
tartrate solution (20 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with 
brine (50 mL), dried over MgSO4, filtered and concentrated. Crude material was 
used directly in the next step without further purification. 
To a solution of crude allylic alcohol 309 in CH2Cl2 (10 mL) at −78 °C, were added 
2,6-lutidine (0.17 mL, 1.5 mmol, 3.0 equiv.) and TESOTf (0.17 mL, 0.74 mmol, 1.5 
equiv.) sequentially. The resulting solution was stirred at −78 °C for 30 min, before 
the addition of water (8 mL) and the biphasic mixture allowed to warm to RT. The 
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layers were separated and the aqueous phase was extracted with CH2Cl2 (3 × 8 
mL). The combined organic extracts were washed with brine (35 mL), dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 98:2) to deliver TES ether 264 (0.14 g, 0.33 
mmol, 46% over 4 steps) as a colourless oil. Rf = 0.36 (pet. ether/EtOAc, 95:5); 
[α]D29 +27.1 (c = 1.10, CHCl3); νmax 2930, 2874, 1458, 1377, 1242, 1117, 1069, 
1005 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.46 (1H, ddd, J = 15.1, 11.0, 1.1 Hz, 
CH−C26), 5.82 (1H, dm, J = 11.0 Hz, CH−C27), 5.52 (1H, dd, J = 15.1, 5.8 Hz, 
CH−C25), 4.21 (1H, dd, J = 9.6, 4.9 Hz, CH−C18), 4.24−4.15 (2H, m, CH−C20, 
CH−C24), 3.93 (1H, ddd, J = 8.0, 7.1, 6.3 Hz, CH−C23), 2.94−2.77 (4H, m, 2 × 
CH2−CA), 2.16−2.06 (1H, m, CH−CB), 2.03−1.78 (5H, m, CH−CB, CH2−C19, 
CH−C21, CH−C22), 1.77 (3H, br s, CH3−C35), 1.75 (3H, br s, CH3−C29), 1.68 
(1H, app ddt, J = 12.6, 9.0, 8.0 Hz, CH−C22), 1.45 (1H, app dtd, J = 11.8, 9.0, 8.1 
Hz, CH−C21), 0.96 (9H, t, J = 7.9 Hz, CH3−TES), 0.62 (6H, q, J = 7.9 Hz, 
CH2−TES); 13C NMR (126 MHz, CDCl3) δ 135.2 (C−C28), 129.9 (CH−C25), 127.7 
(CH−C26), 124.9 (CH−C27), 82.4 (CH−C23), 75.6 (CH−C24), 75.5 (CH−C20), 
44.7 (CH−C18), 41.8 (CH2−C19), 32.3 (CH2−C21), 30.7 (CH2−CA), 30.2 (CH2−CA), 
27.4 (CH2−C22), 26.2 (CH2−CB), 26.1 (CH3−C35), 18.4 (CH3−C29), 7.1 
(CH3−TES), 5.1 (CH2−TES); HRMS (ESI+) [M+Na]+ calcd for C22H40O2S2SiNa 
451.2131, found 451.2110, Δ 4.7 ppm. 
 
2-((2R,5R)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2-
yl)acetaldehyde 311 
 
 
 
 
 
 
To a solution of alcohol 310 (0.86 g, 2.2 mmol) in CH2Cl2 (25 mL) at RT, were 
added [bis(acetoxy)iodo]benzene (0.76 g, 2.4 mmol, 1.05 equiv.) and TEMPO (70 
mg, 0.45 mmol, 20 mol %) sequentially. The resulting solution was stirred at RT for 
6 h, before the addition of water (15 mL). The layers were separated and the 
aqueous phase was extracted with CH2Cl2 (3 × 15 mL). The combined organic 
extracts were washed with brine (45 mL), dried over MgSO4, filtered and 
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concentrated. Crude material was purified by silica gel chromatography (pet. 
ether/EtOAc, 80:20) to give aldehyde 311 (0.76 g, 2.0 mmol, 88%) as a yellow oil. 
Rf = 0.53 (pet. ether/EtOAc, 80:20); 1H NMR (400 MHz, CDCl3) δ 9.80 (1H, dd, J = 
2.6, 2.0 Hz, CH−C5), 7.71−7.64 (4H, m, CH−Ar TBDPS), 7.45−7.34 (6H, m, 
CH−Ar TBDPS), 4.41 (1H, dddd, J = 8.3, 7.4, 5.8, 5.3 Hz, CH−C7), 4.17 (1H, app 
tt, J = 7.0, 4.6 Hz, CH−C10), 3.67 (1H, dd, J = 10.7, 4.6 Hz, CH−C11), 3.64 (1H, 
dd, J = 10.7, 4.6 Hz, CH−C11), 2.66 (1H, ddd, J = 16.1, 7.4, 2.6 Hz, CH−C6), 2.56 
(1H, ddd, J = 16.1, 5.3, 2.0 Hz, CH−C6), 2.17 (1H, dddd, J = 12.1, 8.1, 5.8, 3.8 Hz, 
CH−C8), 2.03 (1H, dddd, J = 12.4, 8.3, 7.0, 3.8 Hz, CH−C9), 1.90 (1H, dddd, J = 
12.4, 9.0, 8.1, 7.0 Hz, CH−C9), 1.57 (1H, app ddt, J = 12.1, 9.0, 8.3 Hz, CH−C8), 
1.05 (9H, s, CH3−t-Bu TBDPS); 13C NMR (101 MHz, CDCl3) δ 201.5 (CH−C5), 
135.8 (CH−Ar TBDPS), 133.7 (C−Ar TBDPS), 129.8 (CH−Ar TBDPS), 127.8 
(CH−Ar TBDPS), 79.6 (CH−C10), 74.4 (CH−C7), 66.5 (CH2−C11), 49.7 (CH2−C6), 
32.3 (CH2−C8), 27.9 (CH2−C9), 27.0 (CH3−t-Bu TBDPS), 19.4 (C−t-Bu TBDPS); 
HRMS (ESI+) [M+Na]+ calcd for C23H30O3SiNa 405.1856, found 405.1839, Δ 4.4 
ppm. 
 
(2R,5R)-2-((2,2-Dimethyl-1,1-diphenylpropoxy)methyl)-5-(1,3-dithian-2-
ylmethyl)oxolane 312 
 
 
 
 
 
 
To a solution of aldehyde 311 (0.76 g, 2.0 mmol) in CH2Cl2 (10 mL) at 0 °C, were 
added 1,3-propanedithiol (0.24 mL, 2.4 mmol, 1.2 equiv.) and MgBr2OEt2 (0.51 g, 
2.0 mmol, 1.0 equiv.) sequentially. The resulting solution was stirred at 0 °C for 5 
min and at RT for 28 h. The reaction was quenched by the addition of a sat. aq. 
NaHCO3 solution (10 mL). The layers were separated and the aqueous phase was 
extracted with CH2Cl2 (3 × 10 mL). The combined organic extracts were washed 
with brine (30 mL), dried over MgSO4, filtered and concentrated. Crude material 
was purified by silica gel chromatography (pet. ether/EtOAc, 90:10) to give 
dithiane 312 (0.87 g, 1.9 mmol, 93%) as a colourless solid. Rf = 0.48 (pet. 
ether/EtOAc, 90:10); [α]D26 −11.5 (c = 1.01, CHCl3); mp = 69.3−70.0 °C; νmax 3071, 
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2931, 2857, 2362, 1473, 1427, 1265, 1112, 1078 cm−1; 1H NMR (500 MHz, CDCl3) 
δ 7.73−7.67 (4H, m, CH−Ar TBDPS), 7.45−7.36 (6H, m, CH−Ar TBDPS), 
4.32−4.25 (1H, m, CH−C7), 4.21 (1H, dd, J = 9.4, 5.0 Hz, CH−C5), 4.18−4.11 (1H, 
m, CH−C10), 3.67 (1H, ddd, J = 10.5, 4.8, 0.4 Hz, CH−C11), 3.62 (1H, ddd, J = 
10.5, 5.2, 0.6 Hz, CH−C11), 2.94−2.78 (4H, m, 2 × CH2−C12), 2.14−1.99 (3H, m, 
CH−C8, CH−C9, CH−C13), 1.96 (1H, ddd, J = 13.7, 8.8, 5.0 Hz, CH−C6), 
1.93−1.79 (3H, m, CH−C6, CH−C9, CH−C13), 1.52 (1H, app dq, J = 11.9, 8.2 Hz, 
CH−C8), 1.07 (9H, s, CH3−t-Bu TBDPS); 13C NMR (126 MHz, CDCl3) δ 135.8 
(CH−Ar TBDPS), 135.8 (CH−Ar TBDPS), 133.9 (C−Ar TBDPS), 133.8 (C−Ar 
TBDPS), 129.7 (CH−Ar TBDPS), 127.7 (CH−Ar TBDPS), 79.1 (CH−C10), 75.7 
(CH−C7), 66.6 (CH2−C11), 44.6 (CH−C5), 41.9 (CH2−C6), 32.0 (CH2−C8), 30.6 
(CH2−C12), 30.2 (CH2−C12), 28.2 (CH2−C9), 27.0 (CH3−t-Bu TBDPS), 26.1 
(CH2−C13), 19.4 (C−t-Bu TBDPS); HRMS (ESI+) [M+Na]+ calcd for 
C26H36O2S2SiNa 495.1818, found 495.1802, Δ 3.3 ppm. 
 
3-(2-(((2R,5R)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2-
yl)methyl)-1,3-dithian-2-yl)-2-methylpropyl pivalate 317 
 
 
 
 
 
 
To a solution of dithiane 312 (dried by azeotropic distillation with benzene (4 ×), 
0.12 g, 0.25 mmol, 1.8 equiv.) in a 9:1 mixture of THF and HMPA (0.80 mL) at −78 
°C, was added t-BuLi (titrated at 1.4 M in pentane, 0.20 mL, 0.25 mmol, 1.8 equiv.) 
dropwise. The resulting red solution was stirred at −78 °C for 10 min, before the 
slow addition of a solution of iodide 314 (dried by azeotropic distillation with 
benzene (4 ×), 40 mg, 0.14 mmol) in THF (0.60 mL). The reaction mixture was 
stirred at −78 °C for 1 h, before the addition of aqueous pH 7 buffer (1 mL). The 
biphasic mixture was allowed to warm to RT and the layers were separated. The 
aqueous phase was extracted with Et2O (3 × 2 mL) and the combined organic 
extracts were washed with brine (6 mL), dried over MgSO4, filtered and 
concentrated. Crude material was purified by silica gel chromatography (pet. 
ether/EtOAc, 90:10) to afford dithiane 317 (0.05 g, 0.07 mmol, 54%) as a 1:1 
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mixture of diastereomers, as a colourless oil. Rf = 0.33 (pet. ether/EtOAc, 90:10); 
νmax 3071, 2931, 2858, 1724, 1427, 1397, 1284, 1163, 1112, 1084 cm−1; 1H NMR 
(500 MHz, CDCl3) δ 7.71−7.66 (8H, m, CH−Ar TBDPS), 7.43−7.34 (12H, m, 
CH−Ar TBDPS), 4.33−4.25 (2H, m, CH−C7), 4.17−4.09 (2H, m, CH−C10), 4.05 
(1H, dd, J = 10.6, 4.3 Hz, CH−C1), 4.04 (1H, dd, J = 10.6, 4.3 Hz, CH−C1), 3.93 
(1H, dd, J = 10.6, 7.0 Hz, CH−C1), 3.88 (1H, dd, J = 10.6, 7.0 Hz, CH−C1), 
3.67−3.58 (4H, m, CH2−C11), 2.93−2.71 (8H, m, 2 × CH2−C12), 2.28−1.75 (20H, 
m, CH−C2, CH2−C3, CH2−C6, CH−C8, CH2−C9, CH2−C13), 1.63−1.53 (2H, m, 
CH−C8), 1.20 (9H, s, CH3−t-Bu Piv), 1.19 (9H, s, CH3−t-Bu Piv), 1.07 (6H, d, J = 
6.7 Hz, CH3−C4), 1.05 (18H, s, CH3−t-Bu TBDPS); 13C NMR (126 MHz, CDCl3) δ 
178.7 (C−Piv), 178.6 (C−Piv), 135.8 (CH−Ar TBDPS), 135.8 (CH−Ar TBDPS), 
135.8 (CH−Ar TBDPS), 133.9 (C−Ar TBDPS), 133.8 (C−Ar TBDPS), 129.7 
(CH−Ar TBDPS), 127.8 (CH−Ar TBDPS), 127.8 (CH−Ar TBDPS), 79.1 (CH−C10), 
79.1 (CH−C10), 76.6 (CH−C7), 76.3 (CH−C7), 69.8 (CH2−C1), 69.8 (CH2−C1), 
66.8 (CH2−C11), 66.7 (CH2−C11), 53.0 (C−C5), 52.8 (C−C5), 45.4 (CH2−C6), 45.4 
(CH2−C6), 42.9 (CH2−C3), 42.3 (CH2−C3), 39.0 (C−t-Bu Piv), 39.0 (C−t-Bu Piv), 
34.0 (CH2−C8), 34.0 (CH2−C8), 29.8 (CH−C2), 29.7 (CH−C2), 28.4 (CH2−C9), 
28.2 (CH2−C9), 27.4 (CH3−t-Bu Piv), 27.0 (CH3−t-Bu TBDPS), 26.6 (CH2−C12), 
26.5 (CH2−C12), 26.5 (CH2−C12), 26.4 (CH2−C12), 25.2 (CH2−C13), 25.1 
(CH2−C13), 19.9 (CH3−C4), 19.7 (CH3−C4), 19.4 (C−t-Bu TBDPS); HRMS (ESI+) 
[M+Na]+ calcd for C35H52O4S2SiNa 651.2968, found 651.2947, Δ 3.3 ppm. 
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(2S,3S,5S,6R,7E,10R,11R)-5-,11-bis((tert-Butyldimethylsilyl)oxy)-11-
((2R,4R,5S)-5-(2-((2,2-dimethylpropanoyl)oxy)ethyl)-4-methyloxolan-2-yl)-
6,7,10-trimethyl-2-((2-(((2R,5R)-5-((1R,2E)-5-methyl-1-((triethylsilyl)oxy)dien-1-
yl)oxolan-2-yl)methyl)-1,3-dithian-2-yl)methyl)-9- methylideneundec-7-en-3-yl 
pivalate 319 
 
 
 
 
 
 
 
 
 
Note: 1H NMR and mass experiments were recorded by Dr Filippo Romiti. 
 
To a solution of dithiane 264 (dried by azeotropic distillation with benzene (4 ×), 50 
mg, 0.12 mmol, 1.5 equiv.) in a 4.5:1 mixture of THF and HMPA (0.43 mL) at −78 
°C, was added t-BuLi (titrated at 2.5 M in hexanes, 47 µL, 0.12 mmol, 1.5 equiv.) 
dropwise. The resulting red solution was stirred at −78 °C for 10 min, followed by 
the slow addition of a solution of iodide 27873 (dried by azeotropic distillation with 
benzene (4 ×), 81 mg, 78 µmol) in THF (0.35 mL). The reaction mixture was 
stirred at −78 °C for 1 h, before the addition of aqueous pH 7 buffer (2 mL). The 
biphasic mixture was allowed to warm to RT and the layers were separated. The 
aqueous phase was extracted with Et2O (3 × 2 mL) and the combined organic 
extracts were dried over MgSO4, filtered and concentrated. Crude material was 
purified by silica gel chromatography (pet. ether/EtOAc, 95:5) to afford recovered 
dithiane 264 (21 mg, 49 µmol, 42%), recovered iodide 278 (40 mg, 39 µmol, 50%) 
and desired dithiane 319 (14 mg, 10 µmol, 13% over 2 steps) as a colourless oil. 
Rf = 0.31 (pet. ether/EtOAc, 95:5); [α]D28 +8.7 (c = 0.70, CHCl3); νmax 2956, 2930, 
2878, 2857, 1728, 1462, 1283, 1252, 1160, 1079, 1005 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 6.45 (1H, ddd, J = 15.3, 10.9, 0.9 Hz, CH−C26), 5.86−5.81 (1H, m, 
CH−C27), 5.72 (1H, br s, CH−C10), 5.55 (1H, dd, J = 15.3, 5.8 Hz, CH−C25), 5.28 
(1H, dd, J = 2.2, 1.3 Hz, CH−C31), 5.06−5.01 (1H, m, CH−C15), 4.91−4.89 (1H, 
m, CH−C31), 4.23−4.16 (2H, m, CH−C1, CH−C24), 4.16−4.04 (4H, m, CH−C1, 
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CH−C6, CH−C8, CH−C20), 3.94 (1H, app dt, J = 7.3, 5.9 Hz, CH−C23), 3.86 (1H, 
app dt, J = 8.2, 5.1 Hz, CH−C3), 3.79−3.73 (1H, m, CH−C13), 3.50 (1H, dd, J = 
7.0, 3.0 Hz, CH−C7), 2.93−2.84 (1H, m, CH−CA), 2.81−2.71 (3H, m, CH−CA, 
CH2−CA), 2.40−2.33 (1H, m, CH−C12), 2.27 (1H, dd, J = 15.0, 4.5 Hz, CH−C19), 
2.22−2.08 (3H, m, CH−C4, CH2−C17), 2.06−1.45 (14H, m, CH2−C2, CH2−C5, 
CH2−C14, CH−C16, CH−C19, CH2−C21, CH2−C22, CH2−CB), 1.77 (6H, br s, 
CH3−C29, CH3−C35), 1.75 (3H, d, J = 0.6 Hz, CH3−C32), 1.19 (9H, s, CH3−t-Bu 
Piv), 1.19 (9H, s, CH3−t-Bu Piv), 1.04 (3H, d, J = 6.9 Hz, CH3−C33), 1.03 (3H, d, J 
= 6.9 Hz, CH3−C34), 0.95 (9H, t, J = 7.9 Hz, CH3−TES), 0.91 (18H, s, 2 × CH3−t-
Bu TBS), 0.90 (3H, d, J = 6.2 Hz, CH3−C30), 0.88 (9H, s, CH3−t-Bu TBS), 0.60 
(6H, q, J = 7.9 Hz, CH2−TES), 0.11 (3H, s, CH3−TBS), 0.08 (3H, s, CH3−TBS), 
0.07 (3H, s, CH3−TBS), 0.05 (3H, s, CH3−TBS), 0.01 (6H, s, 2 × CH3−TBS); 
HRMS (ESI+) [M+Na]+ calcd for C72H136O10S2Si4Na 1359.8544, found 1359.8398. 
 
Triethyl(((R,E)-5-methyl-1-((2R,5R)-5-(prop-2-yn-1-yl)tetrahydrofuran-2-
yl)hexa-2,4-dien-1-yl)oxy)silane 328 
 
 
 
 
 
 
To a solution of dimethyl-1-diazo-2-oxopropyl phosphonate (0.12 g, 0.64 mmol, 
2.0 equiv.) in MeOH (2 mL) at 0 °C, was added K2CO3 (88 mg, 0.64 mmol, 2.0 
equiv.). The mixture was stirred at 0 °C for 1 h, before the dropwise addition of 
aldehyde 302 (0.11 g, 0.32 mmol) in THF (1 mL). The resulting yellow suspension 
was stirred at 0 °C for 1 h and at RT for 45 min. The reaction was quenched by the 
addition of a sat. aq. NH4Cl solution (3 mL) and Et2O (3 mL) was added. The 
layers were separated and the aqueous phase was extracted with Et2O (3 × 3 
mL). The combined organic extracts were washed with brine (10 mL), dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 99:1) to provide alkyne 328 (66 mg, 0.20 
mmol, 61%) as a colourless oil. Rf = 0.32 (pet. ether/EtOAc, 98:2); [α]D26 +31 (c = 
0.33, CHCl3); νmax 3314, 2955, 2876, 1659, 1460, 1379, 1238, 1115, 1074, 1005 
cm−1; 1H NMR (400 MHz, CDCl3) δ 6.46 (1H, ddd, J = 15.2, 11.0, 1.4 Hz, 
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CH−C26), 5.83 (1H, dm, J = 11.0 Hz, CH−C27), 5.54 (1H, dd, J = 15.2, 5.8 Hz, 
CH−C25), 4.22 (1H, ddd, J = 5.8, 5.5, 1.4 Hz, CH−C24), 4.12−4.05 (1H, m, 
CH−C20), 4.04 (1H, app td, J = 7.1, 5.5 Hz, CH−C23), 2.46 (1H, ddd, J = 16.6, 
5.1, 2.7 Hz, CH−C19), 2.33 (1H, ddd, J = 16.6, 7.2, 2.7 Hz, CH−C19), 2.04 (1H, 
dddd, J = 11.9, 8.1, 5.8, 3.9 Hz, CH−C21), 1.96 (1H, app t, J = 2.7 Hz, CH−C17), 
1.95−1.88 (1H, m, CH−C22), 1.82−1.72 (1H, m, CH−C22), 1.77 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.72−1.62 (1H, m, CH−C21), 0.95 (9H, t, J = 
7.9 Hz, CH3−TES), 0.60 (6H, q, J = 7.9 Hz, CH2−TES); 13C NMR (101 MHz, 
CDCl3) δ 135.2 (C−C28), 129.8 (CH−C25), 127.8 (CH−C26), 124.9 (CH−C27), 
83.0 (CH−C23), 81.4 (C−C18), 77.7 (CH−C20), 75.1 (CH−C24), 69.6 (CH−C17), 
31.4 (CH2−C21), 27.0 (CH2−C22), 26.1 (CH3−C35), 25.5 (CH2−C19), 18.4 
(CH3−C29), 7.0 (CH3−TES), 5.1 (CH2−TES); HRMS (ESI+) [M+Na]+ calcd for 
C20H34O2SiNa 357.2220, found 357.2225, Δ 1.3 ppm. 
 
(3-Cyclohexylprop-1-en-2-yl)dimethyl(pent-4-en-2-yloxy)silane 335 
 
 
 
 
 
 
To a solution of 3-cyclohexyl-1-propyne (0.12 mL, 0.80 mmol) in CH2Cl2 (1.6 mL) 
at 0 °C, was added chlorodimethylsilane (89 µL, 0.80 mmol, 1.0 equiv.) dropwise, 
followed by [Cp*Ru(MeCN)3]PF6 (4 mg, 0.01 mmol, 1 mol %). The resulting yellow 
solution was stirred at RT for 1 h, before the addition of a solution of 4-penten-2-ol 
(82 µL, 0.80 mmol, 1.0 equiv.) and Et3N (0.17 mL, 1.2 mmol, 1.5 equiv.) in CH2Cl2 
(3.2 mL). The reaction mixture was stirred at RT for 17 h, diluted with toluene (6 
mL), filtered through a pad of celite and concentrated. Crude material was purified 
by silica gel chromatography (pet. ether/EtOAc, 99:1) to afford silyl ether 335 (0.16 
g, 0.61 mmol, 76%) as a colourless oil. Rf = 0.32 (pet. ether/EtOAc, 99:1); νmax 
3078, 2922, 2853, 1641, 1449, 1375, 1250, 1128, 1088, 1044, 1001 cm−1; 1H 
NMR (400 MHz, CDCl3) δ 5.79 (1H, app ddt, J = 17.4, 10.3, 7.1 Hz, CH−C4), 5.57 
(1H, dt, J = 3.1, 1.4 Hz, CH−C11), 5.47 (1H, dt, J = 3.1, 0.9 Hz, CH−C11), 
5.07−5.03 (1H, m, CH−12), 5.05−4.98 (1H, m, CH−12), 3.84 (1H, app h, J = 6.1 
Hz, CH−C2), 2.24 (1H, app dddt, J = 14.0, 7.1, 6.1, 1.3 Hz, CH−C3), 2.15 (1H, app 
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dddt, J = 14.0, 7.1, 6.1, 1.2 Hz, CH−C3), 2.04 (2H, ddd, J = 7.1, 1.4, 0.9 Hz, 
CH2−C6), 1.77−1.60 (5H, m, 2 × CH−C8, 2 × CH−C9, CH−C10), 1.43 (1H, ttt, J = 
10.8, 7.1, 3.4 Hz, CH−C7), 1.27−1.15 (3H, m, 2 × CH−C9, CH−C10), 1.13 (3H, d, 
J = 6.1 Hz, CH3−C1), 0.92−0.75 (2H, m, 2 × CH−C8), 0.18 (3H, s, CH3−Si), 0.18 
(3H, s, CH3−Si); 13C NMR (101 MHz, CDCl3) δ 149.5 (C−C5), 135.6 (CH−C4), 
127.0 (CH2−C11), 116.8 (CH2−C12), 68.6 (CH−C2), 44.6 (CH2−C6), 44.3 
(CH2−C3), 36.6 (CH−C7), 33.6 (2 × CH2−C8), 26.8 (CH2−C10), 26.6 (2 × 
CH2−C9), 23.4 (CH3−C1), −0.9 (CH3−Si), −1.0 (CH3−Si); HRMS (CI+, isobutane) 
[M+H]+ calcd for C16H31OSi 267.2144, found 267.2139, Δ 2.1 ppm; LRMS (CI+, 
isobutane) m/z (intensity) 267.1 (86%), 225.1 (15%), 143.1 (23%), 73.1 (100%). 
 
((2R,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-
yl)methanol 347 
 
 
 
 
 
 
To a solution of alcohol 346 (6.0 g, 26 mmol) in i-PrOH (220 mL) at RT, was added 
Co(nmp)2 (1.5 g, 2.6 mmol, 10 mol %) and the mixture was purged with O2 for 30 
min. The flask headspace was evacuated and refilled with O2 (3 ×), before the 
addition of t-BuOOH (5 M in decane, 0.52 mL, 2.6 mmol, 10 mol %). The resulting 
mixture was stirred at 55 °C under O2 (1 atm) for 18 h and the solution was 
allowed to cool to RT, then purged with argon. The mixture was concentrated to a 
tenth of its volume by rotary evaporation (20 °C, 40 mbar) and partitioned between 
Et2O (70 mL) and a 1 M HCl aq. solution (90 mL). The layers were separated and 
the aqueous phase was extracted with Et2O (3 × 90 mL). The combined organic 
extracts were washed with water (3 × 120 mL), brine (250 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 80:20) to deliver 2,5-trans tetrahydrofyran 347 
(3.7 g, 15 mmol, 58%) as a colourless oil. Rf = 0.34 (pet. ether/EtOAc, 80:20); 
[α]D25 −4.10 (c = 1.44, CHCl3) [lit for enantiomer104 [α]D25 +4.5 (c = 0.88, CHCl3)]; 
νmax 3443, 2955, 2928, 2859, 1472, 1464, 1362, 1254, 1086, 1007 cm−1; 1H NMR 
(500 MHz, CDCl3) δ 4.12 (1H, app dtd, J = 7.4, 6.1, 3.3 Hz, CH−C23), 4.07 (1H, 
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app tt, J = 7.0, 4.8 Hz, CH−C20), 3.68−3.64 (1H, m, CH−C24), 3.63 (1H, dd, J = 
10.7, 4.8 Hz, CH−C19), 3.60 (1H, dd, J = 10.7, 4.8 Hz, CH−C19), 3.48 (1H, dd, J = 
11.5, 6.1 Hz, CH−C24), 2.03−1.89 (3H, m, CH−C21, CH−C22, OH−C24), 
1.81−1.73 (1H, m, CH−C21), 1.73−1.65 (1H, m, CH−C22), 0.90 (9H, s, CH3−t-Bu 
TBS), 0.06 (6H, s, 2 × CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 80.0 (CH−C20), 
79.8 (CH−C23), 66.0 (CH2−C19), 65.1 (CH2−C24), 28.4 (CH2−C21), 27.5 
(CH2−C22), 26.1 (CH3−t-Bu TBS), 18.5 (C−t-Bu TBS), −5.1 (CH3−TBS), −5.1 
(CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C12H26O3SiNa 269.1543, found 
269.1535, Δ 3.1 ppm. 
 
1-((2R,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)prop-
2-yn-1-ol 349 
 
 
 
 
 
 
To a solution of alcohol 347 (3.2 g, 13 mmol) in CH2Cl2 (87 mL) at RT, was added 
pyridine (4.1 mL, 51 mmol, 3.9 equiv.), followed by a portionwise addition of DMP 
(7.2 g, 17 mmol, 1.3 equiv.). The resulting mixture was stirred at RT for 2.5 h, 
before the addition of a 1:1 mixture of a sat. aq. Na2S2O3 solution and a sat. aq. 
NaHCO3 solution (180 mL). The biphasic mixture was stirred vigorously for 10 min 
and the layers were separated. The aqueous phase was extracted with Et2O (3 × 
150 mL) and the combined organic extracts were washed with brine (400 mL), 
dried over MgSO4, filtered and concentrated. Crude material was used directly in 
the next step without further purification. 
To a solution of trimethylsilylacetylene (8.6 mL, 62 mmol, 4.8 equiv.) in Et2O (62 
mL) at 0 °C, was added i-PrMgCl (titrated at 1.6 M in THF, 33 mL, 52 mmol, 4.0 
equiv.) dropwise via an addition funnel. The brown suspension was stirred at 0 °C 
for 1 h and transferred by cannula to a solution of aldehyde 348 in Et2O (130 mL) 
at 0 °C. The resulting yellow suspension was stirred at RT for 2.5 h and cooled to 
0 °C. The reaction was quenched by the slow addition of a 3:1 mixture of a sat. aq. 
NH4Cl solution and water (400 mL). The layers were separated and the aqueous 
phase was extracted with Et2O (3 × 250 mL). The combined organic extracts were 
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washed with brine (700 mL), dried over MgSO4, filtered and concentrated. Crude 
material was used directly in the next step without further purification. 
To a solution of the crude alkyne in wet MeOH (87 mL) at RT, was added K2CO3 
(3.6 g, 26 mmol, 2.0 equiv.) in one portion. The resulting suspension was stirred at 
RT for 2 h, after which volatiles were removed in vacuo, and the residue 
partitioned between CH2Cl2 (80 mL) and a sat. aq. NH4Cl solution (80 mL). The 
layers were separated and the aqueous phase was extracted with Et2O (3 × 80 
mL). The combined organic extracts were washed with brine (240 mL), dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 85:15) to give propargylic alcohol 349 (2.6 g, 
9.5 mmol, 73% over 3 steps) as a 1.3:1 mixture of diastereomers, as a yellow oil. 
Rf = 0.28 (pet. ether/EtOAc, 85:15); νmax 3414, 3312, 2955, 2928, 2857, 1472, 
1464, 1389, 1362, 1254, 1078, 1005 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.43 
(1.0H, ddd, J = 5.9, 3.6, 2.3 Hz), 4.20 (1.3H, ddd, J = 6.8, 4.7, 2.2 Hz), 4.21−4.07 
(4.6H, m), 3.66−3.59 (4.6H, m), 2.50 (1.3H, d, J = 4.7 Hz), 2.44 (1.3H, d, J = 2.2 
Hz), 2.43 (1.0H, d, J = 2.3 Hz), 2.39 (1.0H, d, J = 5.9 Hz), 2.16−1.95 (5.9H, m), 
1.88−1.75 (3.3H, m), 0.89 (9.0H, s), 0.89 (12H, s), 0.06 (14H, s); 13C NMR (101 
MHz, CDCl3) δ 82.4, 82.2, 82.0, 81.7, 81.3, 80.5, 74.1, 73.8, 65.9, 65.7, 65.3, 64.6, 
28.1, 28.0, 28.0, 26.6, 26.1, 26.1, 18.5, 18.5, −5.1, −5.1, −5.2, −5.2; HRMS (ESI+) 
[M+Na]+ calcd for C14H26O3SiNa 293.1543, found 293.1532, Δ 3.8 ppm. 
 
1-((2R,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-5-
methylhex-4-en-2-yn-1-ol 350 
 
 
 
 
 
 
To a suspension of Pd(PPh3)4 (0.22 g, 0.19 mmol, 5 mol %) in pyrrolidine (4.5 mL) 
at RT, was added 1-bromo-2-methyl-1-propene (1.2 mL, 11 mmol, 3.0 equiv.). The 
resulting suspension was stirred at RT for 5 min, before the addition of a solution 
of alkyne 349 (1.0 g, 3.8 mmol) in pyrrolidine (4.5 mL). The reaction mixture was 
stirred at 50 °C for 15 h and allowed to cool to RT. The solution was diluted with 
Et2O (40 mL) and a sat. aq. NH4Cl solution (50 mL) was slowly added. The layers 
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were separated and the aqueous phase was extracted with Et2O (3 × 40 mL). The 
combined organic extracts were washed with brine (120 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 90:10) to deliver enyne 350 (1.0 g, 3.2 mmol, 
83%) as a 1.3:1 mixture of diastereomers, as a yellow oil. Rf = 0.26 (pet. 
ether/EtOAc, 90:10); νmax 3418, 2953, 2928, 2857, 1462, 1381, 1254, 1086, 1005 
cm−1; 1H NMR (400 MHz, CDCl3) δ 5.29−5.25 (2.3H, m), 4.60 (1.0H, ddd, J = 5.6, 
3.3, 1.9 Hz), 4.34 (1.3H, ddd, J = 7.0, 4.1, 1.7 Hz), 4.22−4.15 (2.0H, m), 4.13−4.06 
(2.6H, m), 3.66−3.58 (4.6H, m), 2.48 (1.3H, d, J = 4.1 Hz), 2.33 (1.0H, d, J = 5.6 
Hz), 2.16−1.96 (5.6H, m), 1.88 (6.9H, br s), 1.86−1.75 (3.6H, m), 1.80 (6.9H, br s), 
0.89 (9.0H, s), 0.89 (12H, s), 0.06 (14H, s); 13C NMR (101 MHz, CDCl3) δ 149.6, 
149.6, 104.8, 104.7, 89.1, 89.0, 84.0, 83.8, 82.8, 82.1, 81.2, 80.4, 66.2, 66.0, 65.8, 
65.3, 28.3, 28.2, 28.1, 26.6, 26.1, 26.1, 24.9, 21.2, 21.2, 18.5, 18.5, −5.1, −5.1, 
−5.2, −5.2; HRMS (ESI+) [M+Na]+ calcd for C18H32O3SiNa 347.2013, found 
347.2005, Δ 2.2 ppm. 
 
(E)-1-((2R,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-5-
methylhexa-2,4-dien-1-ol 351 
 
 
 
 
 
 
To a solution of enyne 350 (2.2 g, 6.6 mmol) in THF (66 mL) at 0 °C, was added 
sodium bis(2-methoxyethoxy)aluminium hydride (≥ 60 wt % in toluene, 8.6 mL, 27 
mmol, 4.0 equiv.) dropwise. The resulting cloudy mixture was stirred at RT for 2 h 
and cooled to 0 °C, before the dropwise addition of a sat. aq. potassium sodium 
tartrate solution (100 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 90 mL). The combined organic extracts were washed with 
brine (250 mL), dried over MgSO4, filtered and concentrated. Crude material was 
purified by silica gel chromatography (pet. ether/EtOAc, 90:10) to deliver diene 
351 (2.0 g, 6.3 mmol, 94%) as a 1.2:1 mixture of diastereomers, as a colourless 
oil. νmax 3435, 2955, 2928, 2857, 1661, 1471, 1462, 1377, 1362, 1254, 1080, 1005 
cm−1; 1H NMR (500 MHz, CDCl3) δ 6.52 (1.2H, ddd, J = 15.2, 11.0, 1.1 Hz), 6.50 
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(1.0H, ddd, J = 15.3, 11.0, 1.1 Hz), 5.82 (2.2H, dm, J = 11.0 Hz), 5.48 (1.0H, dd, J 
= 15.3, 6.6 Hz), 5.47 (1.2H, dd, J = 15.2, 6.9 Hz), 4.34 (1.0H, dddd, J = 6.6, 3.5, 
3.1, 1.1 Hz), 4.10 (1.0H, app tt, J = 6.8, 4.9 Hz), 4.07 (1.2H, app tdd, J = 6.9, 5.1, 
4.7 Hz), 4.01 (1.0H, ddd, J = 7.8, 7.1, 3.5 Hz), 3.94 (1.2H, app tdd, J = 6.9, 2.9, 1.1 
Hz), 3.87 (1.2H, app q, J = 6.9 Hz), 3.64 (1.2H, dd, J = 10.7, 4.7 Hz), 3.62 (1.0H, 
dd, J = 10.7, 4.9 Hz), 3.59 (1.2H, dd, J = 10.7, 5.1 Hz), 3.59 (1.0H, dd, J = 10.7, 
4.9 Hz), 2.55 (1.2H, d, J = 2.9 Hz), 2.15 (1.0H, d, J = 3.1 Hz), 2.02−1.91 (3.4H, m), 
1.88−1.82 (2.0H, m), 1.77 (6.6H, br s), 1.76 (6.6H, br s), 1.76−1.62 (3.4H, m), 0.89 
(9.0H, s), 0.89 (11H, s), 0.06 (7.2H, s), 0.06 (6.0H, s); 13C NMR (126 MHz, CDCl3) 
δ 136.5, 136.3, 129.3, 128.8, 128.6, 128.2, 124.6, 124.6, 82.9, 82.5, 80.7, 79.9, 
75.6, 73.5, 66.1, 65.9, 28.4, 28.3, 28.0, 26.2, 26.1, 26.1, 25.6, 18.6, 18.5, 18.5, 
18.5, −5.1, −5.1, −5.1; HRMS (ESI+) [M+Na]+ calcd for C18H34O3SiNa 349.2169, 
found 349.2153, Δ 4.8 ppm. 
 
(E)-1-((2R,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-5-
methylhexa-2,4-dien-1-one 352 
 
 
 
 
 
 
To a solution of allylic alcohol 351 (494 mg, 1.51 mmol) in CH2Cl2 (10 mL) at RT, 
was added DMP (834 mg, 1.97 mmol, 1.3 equiv.) in one portion. The resulting 
mixture was stirred at RT for 1 h, followed by the addition of a 1:1 mixture of a sat. 
aq. Na2S2O3 solution and a sat. aq. NaHCO3 solution (20 mL). The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 20 mL). The 
combined organic extracts were washed with brine (60 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 95:5) to deliver enone 352 (333 mg, 1.03 
mmol, 68%) as a colourless oil. Rf = 0.34 (pet. ether/EtOAc, 90:10); 1H NMR (500 
MHz, CDCl3) δ 7.62 (1H, dd, J = 15.2, 11.7 Hz, CH−C26), 6.42 (1H, d, J = 15.2 Hz, 
CH−C25), 6.03 (1H, dm, J = 11.7 Hz, CH−C27), 4.56 (1H, dd, J = 7.9, 6.2 Hz, 
CH−C23), 4.22 (1H, app tt, J = 6.7, 4.5 Hz, CH−C20), 3.67 (2H, d, J = 4.5 Hz, 
CH2−C19), 2.29−2.22 (1H, m, CH−C22), 1.99−1.92 (2H, m, CH−C21, CH−C22), 
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1.92 (3H, br s, CH3−C35), 1.89 (3H, br s, CH3−C29), 1.86−1.79 (1H, m, CH−C21), 
0.90 (9H, s, CH3−t-Bu TBS), 0.07 (3H, s, CH3−TBS), 0.07 (3H, s, CH3−TBS). 
 
(R,E)-1-((2R,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-
5-methylhexa-2,4-dien-1-ol 353 
 
 
 
 
 
 
To a solution of enone 352 (333 mg, 1.03 mmol) in MeOH (10 mL) at −78 °C, were 
added CeCl37H2O (535 mg, 1.44 mmol, 1.4 equiv.) and NaBH4 (54 mg, 1.4 mmol, 
1.4 equiv.) sequentially. The resulting mixture was stirred at −78 °C for 45 min and 
concentrated. The residue was partitioned between Et2O (30 mL) and a sat. aq. 
NH4Cl solution (30 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 30 mL). The combined organic extracts were washed with 
brine (100 mL), dried over MgSO4, filtered and concentrated. Crude material was 
purified by silica gel chromatography (pet. ether/EtOAc, 95:5) to deliver allylic 
alcohol 353 (0.20 g, 0.61 mmol, 60%) as a colourless oil. Rf = 0.33 (pet. 
ether/EtOAc, 90:10); [α]D21 +13.6 (c = 1.29, CHCl3); νmax 3457, 2955, 2928, 2857, 
1661, 1462, 1385, 1254, 1081, 1005 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.52 (1H, 
ddd, J = 15.1, 11.0, 1.1 Hz, CH−C26), 5.82 (1H, dm, J = 11.0 Hz, CH−C27), 5.47 
(1H, dd, J = 15.1, 6.9 Hz, CH−C25), 4.07 (1H, app tdd, J = 6.9, 5.0, 4.7 Hz, 
CH−C20), 3.94 (1H, app tdd, J = 6.9, 2.9, 1.1 Hz, CH−C24), 3.87 (1H, app q, J = 
6.9 Hz, CH−C23), 3.64 (1H, dd, J = 10.6, 4.7 Hz, CH−C19), 3.59 (1H, dd, J = 10.6, 
5.0 Hz, CH−C19), 2.54 (1H, d, J = 2.9 Hz, OH−C24), 2.02−1.91 (2H, m, CH−C21, 
CH−C22), 1.77 (3H, br s, CH3−C35), 1.76 (3H, br s, CH3−C29), 1.80−1.72 (1H, m, 
CH−C21), 1.70−1.62 (1H, m, CH−C22), 0.89 (9H, s, CH3−t-Bu TBS), 0.06 (6H, s, 
2 × CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 136.5 (C−C28), 129.3 (CH−C26), 
128.6 (CH−C25), 124.6 (CH−C27), 82.9 (CH−C23), 79.9 (CH−C20), 75.6 
(CH−C24), 65.9 (CH2−C19), 28.4 (CH2−C21), 28.0 (CH2−C22), 26.2 (CH3−C35), 
26.1 (CH3−t-Bu TBS), 18.5 (CH3−C29), 18.5 (C−t-Bu TBS), −5.1 (CH3−TBS), −5.1 
(CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C18H34O3SiNa 349.2169, found 
349.2176, Δ 2.0 ppm. 
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(R,E)-1-((2R,5R)-5-(Hydroxymethyl)tetrahydrofuran-2-yl)-5-methylhexa-2,4-
dien-1-ol 354 
 
 
 
 
 
 
To a solution of TBS ether 353 (0.43 g, 1.3 mmol) in THF (13 mL) at 0 °C, was 
added TBAF (1.0 M in THF, 1.6 mL, 1.6 mmol, 1.2 equiv.) dropwise. The resulting 
solution was stirred at RT for 1 h. The reaction was quenched by the addition of a 
sat. aq. NH4Cl solution (10 mL). The layers were separated and the aqueous 
phase was extracted with EtOAc (4 × 10 mL). The combined organic extracts were 
dried over MgSO4, filtered and concentrated. Crude material was purified by silica 
gel chromatography (EtOAc) to give diol 354 (0.28 g, 1.3 mmol, quant.) as a 
colourless oil. Rf = 0.41 (EtOAc); [α]D25 +9.13 (c = 2.24, CHCl3); νmax 3399, 2967, 
2915, 2872, 1661, 1445, 1377, 1298, 1229, 1190, 1044 cm−1; 1H NMR (500 MHz, 
CDCl3) δ 6.53 (1H, ddd, J = 15.2, 11.0, 1.1 Hz, CH−C26), 5.82 (1H, dm, J = 11.0 
Hz, CH−C27), 5.48 (1H, dd, J = 15.2, 6.9 Hz, CH−C25), 4.17−4.11 (1H, m, 
CH−C20), 3.99 (1H, app td, J = 6.9, 1.1 Hz, CH−C24), 3.94−3.88 (1H, m, 
CH−C23), 3.69 (1H, dd, J = 11.7, 3.2 Hz, CH−C19), 3.51 (1H, dd, J = 11.7, 5.9 Hz, 
CH−C19), 2.03−1.93 (2H, m, CH−C21, CH−C22), 1.78 (3H, br s, CH3−C35), 1.77 
(3H, br s, CH3−C29), 1.76−1.67 (2H, m, CH−C21, CH−C22); 13C NMR (126 MHz, 
CDCl3) δ 136.8 (C−C28), 129.5 (CH−C26), 128.2 (CH−C25), 124.5 (CH−C27), 
83.0 (CH−C23), 80.0 (CH−C20), 75.7 (CH−C24), 64.9 (CH2−C19), 28.4 
(CH2−C22), 27.7 (CH2−C21), 26.2 (CH3−C35), 18.5 (CH3−C29); HRMS (ESI+) 
[M+Na]+ calcd for C12H20O3Na 235.1305, found 235.1299, Δ 2.3 ppm. 
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Triethyl(((R,E)-5-methyl-1-((2R,5R)-5-
(((triethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)hexa-2,4-dien-1-yl)oxy)silane 
355 
 
 
 
 
 
 
To a solution of diol 354 (261 mg, 1.23 mmol) in CH2Cl2 (12 mL) at −78 °C, were 
added 2,6-lutidine (0.85 mL, 7.4 mmol, 6.0 equiv.) and TESOTf (0.83 mL, 3.7 
mmol, 3.0 equiv.) sequentially. The resulting solution was stirred at −78 °C for 1 h, 
before the addition of water (10 mL) and the biphasic mixture was allowed to warm 
to RT. The layers were separated and the aqueous phase was extracted with 
CH2Cl2 (3 × 10 mL). The combined organic extracts were dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 98:2) to deliver bis-TES ether 355 (507 mg, 
1.15 mmol, 94%) as a colourless oil. Rf = 0.26 (pet. ether/EtOAc, 98:2); [α]D24 
+26.2 (c = 2.43, CHCl3); νmax 2953, 2911, 2876, 1458, 1414, 1379, 1238, 1123, 
1086, 1005 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.45 (1H, ddd, J = 15.2, 11.0, 1.4 
Hz, CH−C26), 5.82 (1H, dm, J = 11.0 Hz, CH−C27), 5.56 (1H, dd, J = 15.2, 5.9 
Hz, CH−C25), 4.22 (1H, app td, J = 5.9, 1.4 Hz, CH−C24), 4.04−3.94 (2H, m, 
CH−C20, CH−C23), 3.62 (1H, dd, J = 10.5, 4.9 Hz, CH−C19), 3.52 (1H, dd, J = 
10.5, 5.6 Hz, CH−C19), 1.94−1.83 (2H, m, CH−C21, CH−C22), 1.77 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.76−1.60 (2H, m, CH−C21, CH−C22), 0.95 
(9H, t, J = 7.9 Hz, CH3−TES), 0.95 (9H, t, J = 7.9 Hz, CH3−TES), 0.60 (12H, q, J = 
7.9 Hz, 2 × CH2−TES); 13C NMR (126 MHz, CDCl3) δ 135.0 (C−C28), 130.1 
(CH−C25), 127.5 (CH−C26), 124.9 (CH−C27), 82.9 (CH−C23), 80.1 (CH−C20), 
75.1 (CH−C24), 65.8 (CH2−C19), 28.6 (CH2−C21), 26.8 (CH2−C22), 26.2 
(CH3−C35), 18.4 (CH3−C29), 7.0 (CH3−TES), 6.9 (CH3−TES), 5.1 (CH2−TES), 4.6 
(CH2−TES); HRMS (ESI+) [M+Na]+ calcd for C24H48O3Si2Na 463.3034, found 
463.3018, Δ 3.4 ppm. 
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((2R,5R)-5-((R,E)-5-Methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)methanol 356 
 
 
 
 
 
 
Note: The HFPyr stock solution was prepared by mixing HFPyr (1.0 mL, 70% HF 
in pyridine), pyridine (2.0 mL) and THF (5.0 mL). 
 
To a solution of bis-TES ether 355 (487 mg, 1.10 mmol) in THF (110 mL) at −20 
°C, was added a stock solution of HFPyr (4.0 mL) and the resulting mixture was 
stirred for 20 h. The reaction was quenched by the slow addition of a sat. aq. 
Na2CO3 solution (50 mL) followed by the slow addition of a sat. aq. NaHCO3 
solution (250 mL) until gas evolution ceased. The biphasic mixture was allowed to 
warm to RT and the layers were separated. The aqueous phase was extracted 
with Et2O (3 × 300 mL) and the combined organic extracts were dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 85:15) to afford alcohol 356 (0.28 g, 0.85 
mmol, 77%) as a colourless oil. Rf = 0.27 (pet. ether/EtOAc, 85:15); [α]D24 +11.5 (c 
= 2.78, CHCl3); νmax 3424, 2953, 2876, 1659, 1458, 1379, 1238, 1119, 1067, 1005 
cm−1; 1H NMR (400 MHz, CDCl3) δ 6.46 (1H, ddd, J = 15.2, 11.0, 1.4 Hz, 
CH−C26), 5.82 (1H, dm, J = 11.0 Hz, CH−C27), 5.54 (1H, dd, J = 15.2, 6.1 Hz, 
CH−C25), 4.18 (1H, app td, J = 6.1, 1.4 Hz, CH−C24), 4.08 (1H, app dtd, J = 7.9, 
6.0, 3.2 Hz, CH−C20), 3.99−3.92 (1H, m, CH−C23), 3.64 (1H, ddd, J = 11.6, 6.9, 
3.2 Hz, CH−C19), 3.46 (1H, app dt, J = 11.6, 6.0 Hz, CH−C19), 1.91 (1H, dd, J = 
6.9, 6.0 Hz, OH−C19), 1.95−1.85 (2H, m, CH−C21, CH−C22), 1.77 (3H, br s, 
CH3−C35), 1.76 (3H, br s, CH3−C29), 1.81−1.69 (1H, m, CH−C22), 1.69−1.59 (1H, 
m, CH−C21), 0.95 (9H, t, J = 7.9 Hz, CH3−TES), 0.61 (6H, q, J = 7.9 Hz, 
CH2−TES); 13C NMR (126 MHz, CDCl3) δ 135.5 (C−C28), 129.8 (CH−C25), 127.8 
(CH−C26), 124.7 (CH−C27), 83.0 (CH−C23), 79.8 (CH−C20), 75.6 (CH−C24), 
65.1 (CH2−C19), 27.7 (CH2−C22), 27.6 (CH2−C21), 26.2 (CH3−C35), 18.4 
(CH3−C29), 7.0 (CH3−TES), 5.1 (CH2−TES); HRMS (ESI+) [M+Na]+ calcd for 
C18H34O3SiNa 349.2169, found 349.2173, Δ 1.1 ppm. 
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5-(Tetrahydrofuran-2-yl)pent-3-yn-1-yl pivalate 358 
 
 
 
 
 
 
To a solution of tetrahydrofurfuryl alcohol (0.24 mL, 2.5 mmol) in CH2Cl2 (25 mL) 
at −78 °C, was added 2,6-lutidine (0.85 mL, 7.3 mmol, 3.00 equiv.) and Tf2O (0.43 
mL, 2.6 mmol, 1.05 equiv.) sequentially. The resulting mixture was stirred at −78 
°C for 30 min, diluted with pentane (25 mL) and a sat. aq. NaHCO3 solution (25 
mL) was added. The layers were separated and the aqueous phase was extracted 
with pentane (2 × 15 mL). The combined organic extracts were washed with a sat. 
aq. CuSO4 solution (60 mL), brine (60 mL), dried over MgSO4, filtered and 
concentrated. The residue was filtered rapidly through a short pad of silica gel 
(pentane/Et2O, 50:50) to give the crude triflate which was used directly in the next 
step without further purification. 
To a solution of i-Pr2NH (0.34 mL, 2.5 mmol, 1.0 equiv.) in THF (12 mL) at 0 °C, 
was added n-BuLi (titrated at 2.28 M in hexanes, 1.1 mL, 2.5 mmol, 1.0 equiv.). 
The resulting mixture was stirred at 0 °C for 15 min, cooled to −78 °C, and known 
alkyne 35782 (0.34 g, 2.5 mmol, 1.0 equiv.) was added dropwise. The solution was 
stirred at −78 °C for 30 min, before adding the triflate as a solution in a 3:2 mixture 
of THF and HMPA (6 mL). The reaction mixture was stirred at −78 °C for 15 min, 
before the addition of a sat. aq. NH4Cl solution (20 mL). The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 20 mL). The 
combined organic extracts were washed with brine (60 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/Et2O, 90:10) to deliver alkyne 358 (0.39 g, 1.7 mmol, 
68% over 2 steps) as a colourless oil. Rf = 0.35 (pet. ether/EtOAc, 90:10); νmax 
2970, 2872, 1730, 1481, 1283, 1152, 1069 cm−1; 1H NMR (500 MHz, CDCl3) δ 
4.12 (2H, t, J = 6.9 Hz, CH2−C1), 3.98 (1H, app qd, J = 6.8, 5.4 Hz, CH−C6), 3.90 
(1H, ddd, J = 8.3, 7.2, 6.2 Hz, CH−C9), 3.75 (1H, ddd, J = 8.3, 7.5, 6.4 Hz, 
CH−C9), 2.49 (2H, tt, J = 6.9, 2.4 Hz, CH2−C2), 2.41 (1H, ddt, J = 16.5, 5.4, 2.4 
Hz, CH−C5), 2.33 (1H, ddt, J = 16.5, 6.8, 2.4 Hz, CH−C5), 2.02 (1H, dddd, J = 
12.1, 8.3, 6.8, 5.3 Hz, CH−C7), 1.97−1.82 (2H, m, CH2−C8), 1.67 (1H, app ddt, J = 
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12.1, 8.5, 6.8 Hz, CH−C7), 1.20 (9H, s, CH3−t-Bu Piv); 13C NMR (126 MHz, 
CDCl3) δ 178.5 (C−Piv), 100.1 (C−C3), 78.5 (C−C4), 77.6 (CH−C6), 68.6 
(CH2−C9), 62.7 (CH2−C1), 38.9 (C−t-Bu Piv), 30.8 (CH2−C7), 27.3 (CH3−t-Bu Piv), 
25.9 (CH2−C8), 25.7 (CH2−C5), 19.4 (CH2−C2); HRMS (ESI+) [M+Na]+ calcd for 
C14H22O3Na 261.1461, found 261.1462, Δ 0.4 ppm. 
 
5-(Tetrahydrofuran-2-yl)pent-3-yn-1-ol 359 
 
 
 
 
 
 
To a solution of pivalate 358 (0.34 g, 1.4 mmol) in Et2O (14 mL) at −78 °C, was 
added i-Bu2AlH (1.0 M in CH2Cl2, 5.7 mL, 5.7 mmol, 4.0 equiv.) dropwise. The 
resulting solution was stirred at −78 °C for 30 min, before the dropwise addition of 
a sat. aq. potassium sodium tartrate solution (25 mL). The biphasic mixture was 
stirred vigorously at RT for 30 min. The layers were separated and the aqueous 
phase was extracted with EtOAc (3 × 20 mL). The combined organic extracts were 
dried over MgSO4, filtered and concentrated. Crude material was purified by silica 
gel chromatography (pet. ether/EtOAc, 50:50) to afford alcohol 359 (0.17 g, 1.1 
mmol, 78%) as a colourless oil. Rf = 0.27 (pet. ether/EtOAc, 50:50); νmax 3389, 
2932, 2874, 1422, 1182, 1055 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.00 (1H, app p, 
J = 6.8 Hz, CH−C6), 3.90 (1H, ddd, J = 8.3, 7.1, 6.2 Hz, CH−C9), 3.76 (1H, ddd, J 
= 8.3, 7.4, 6.2 Hz, CH−C9), 3.68 (2H, t, J = 6.1 Hz, CH2−C1), 2.46−2.37 (4H, m, 
CH2−C2, CH2−C5), 2.03 (1H, dddd, J = 11.8, 8.4, 6.8, 5.2 Hz, CH−C7), 2.00−1.84 
(3H, m, OH−C1, CH2−C8), 1.66 (1H, app ddt, J = 11.8, 8.3, 6.8 Hz, CH−C7); 13C 
NMR (101 MHz, CDCl3) δ 79.4 (C−C3), 78.0 (C−C4), 77.7 (CH−C6), 68.6 
(CH2−C9), 61.4 (CH2−C1), 30.9 (CH2−C7), 25.9 (CH2−C8), 25.7 (CH2−C5), 23.4 
(CH2−C2); HRMS (ESI+) [M+Na]+ calcd for C9H14O2Na 177.0886, found 177.0883, 
Δ 1.4 ppm. 
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tert-Butyl(((2R,5R)-5-((R,E)-1-((tert-butyldimethylsilyl)oxy)-5-methylhexa-2,4-
dien-1-yl)tetrahydrofuran-2-yl)methoxy)dimethylsilane 364 
 
 
 
 
 
 
To a solution of alcohol 353 (0.59 g, 1.8 mmol) in CH2Cl2 (18 mL) at −78 °C, were 
added 2,6-lutidine (0.54 mL, 4.7 mmol, 2.6 equiv.) and TBSOTf (0.54 mL, 2.3 
mmol, 1.3 equiv.) sequentially. The resulting solution was stirred at −78 °C for 1 h, 
before the addition of water (18 mL) and the biphasic mixture was allowed to warm 
to RT. The layers were separated and the aqueous phase was extracted with Et2O 
(3 × 15 mL). The combined organic extracts were washed with brine (50 mL), 
dried over MgSO4, filtered and concentrated. Crude material was purified by silica 
gel chromatography (pet. ether/EtOAc, 98:2) to deliver bis-TBS ether 364 (0.75 g, 
1.7 mmol, 94%) as a colourless oil. Rf = 0.38 (pet. ether/EtOAc, 98:2); [α]D25 +30.8 
(c = 1.19, CHCl3); νmax 2955, 2928, 2857, 1472, 1462, 1387, 1362, 1254, 1125, 
1088, 1005 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.46 (1H, ddd, J = 15.2, 11.0, 1.5 
Hz, CH−C26), 5.83 (1H, dm, J = 11.0 Hz, CH−C27), 5.56 (1H, dd, J = 15.2, 5.4 
Hz, CH−C25), 4.23 (1H, app td, J = 5.4, 1.5 Hz, CH−C24), 4.02−3.95 (2H, m, 
CH−C20, CH−C23), 3.62 (1H, dd, J = 10.5, 4.7 Hz, CH−C19), 3.54 (1H, dd, J = 
10.5, 5.4 Hz, CH−C19), 1.92−1.83 (2H, m, CH−C21, CH−C22), 1.77 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.74−1.61 (2H, m, CH−C21, CH−C22), 0.90 
(9H, s, CH3−t-Bu TBS), 0.89 (9H, s, CH3−t-Bu TBS), 0.06 (3H, s, CH3−TBS), 0.05 
(6H, s, 2 × CH3−TBS), 0.04 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 
134.9 (C−C28), 130.0 (CH−C25), 127.4 (CH−C26), 124.9 (CH−C27), 82.9 
(CH−C23), 80.1 (CH−C20), 75.1 (CH−C24), 66.1 (CH2−C19), 28.5 (CH2−C21), 
26.8 (CH2−C22), 26.1 (CH3−C35), 26.1 (CH3−t-Bu TBS), 26.0 (CH3−t-Bu TBS), 
18.5 (C−t-Bu TBS), 18.5 (C−t-Bu TBS), 18.4 (CH3−C29), −4.5 (CH3−TBS), −4.6 
(CH3−TBS), −5.1 (CH3−TBS), −5.1 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for 
C24H48O3Si2Na 463.3034, found 463.3019, Δ 3.2 ppm. 
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((2R,5R)-5-((R,E)-1-((tert-Butyldimethylsilyl)oxy)-5-methylhexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)methanol 365 
 
 
 
 
 
 
Note: The HFPyr stock solution was prepared by mixing HFPyr (1.0 mL, 70% HF 
in pyridine), pyridine (2.0 mL) and THF (5.0 mL). 
 
To a solution of bis-TBS ether 364 (746 mg, 1.69 mmol) in THF (169 mL) at 0 °C, 
was added a stock solution of HFPyr (19 mL) and the resulting mixture was 
stirred for 24 h, after which more HFPyr (19 mL) was added. After another 36 h, 
the reaction was quenched by the slow addition of a sat. aq. Na2CO3 solution (60 
mL) followed by the slow addition of a sat. aq. NaHCO3 solution (540 mL) until gas 
evolution ceased. The biphasic mixture was allowed to warm to RT and the layers 
were separated. The aqueous phase was extracted with Et2O (3 × 400 mL) and 
the combined organic extracts were washed with brine (800 mL), dried over 
MgSO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 85:15) to afford alcohol 365 (474 mg, 1.45 
mmol, 86%) as a colourless oil. Rf = 0.23 (pet. ether/EtOAc, 85:15); [α]D26 +18.6 (c 
= 0.765, CHCl3); νmax 3449, 2955, 2928, 2857, 1659, 1472, 1379, 1362, 1254, 
1119, 1067 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.47 (1H, ddd, J = 15.2, 11.0, 1.4 
Hz, CH−C26), 5.83 (1H, dm, J = 11.0 Hz, CH−C27), 5.55 (1H, dd, J = 15.2, 5.7 
Hz, CH−C25), 4.20 (1H, app td, J = 5.7, 1.4 Hz, CH−C24), 4.07 (1H, app dtd, J = 
8.0, 6.0, 3.3 Hz, CH−C20), 4.00−3.93 (1H, m, CH−C23), 3.64 (1H, ddd, J = 11.6, 
6.9, 3.3 Hz, CH−C19), 3.46 (1H, app dt, J = 11.6, 6.0 Hz, CH−C19), 1.94−1.85 
(2H, m, CH−C21, CH−C22), 1.89 (1H, dd, J = 6.9, 6.0 Hz, OH−C19), 1.77 (3H, br 
s, CH3−C35), 1.81−1.71 (1H, m, CH−C22), 1.75 (3H, br s, CH3−C29), 1.69−1.60 
(1H, m, CH−C21), 0.91 (9H, s, CH3−t-Bu TBS), 0.07 (3H, s, CH3−TBS), 0.05 (3H, 
s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 135.4 (C−C28), 129.8 (CH−C25), 
127.7 (CH−C26), 124.8 (CH−C27), 82.9 (CH−C23), 79.8 (CH−C20), 75.5 
(CH−C24), 65.1 (CH2−C19), 27.6 (CH2−C21), 27.5 (CH2−C22), 26.2 (CH3−C35), 
26.0 (CH3−t-Bu TBS), 18.5 (C−t-Bu TBS), 18.4 (CH3−C29), −4.4 (CH3−TBS), −4.6 
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(CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C18H34O3SiNa 349.2169, found 
349.2161, Δ 2.5 ppm. 
 
Methyl (2R,3R)-3-hydroxy-2-methylbutanoate 36783 
 
 
 
 
 
 
To a solution of i-Pr2NH (16.8 mL, 120 mmol, 2.0 equiv.) in THF (120 mL) at 0 °C, 
was added n-BuLi (titrated at 2.32 M in hexanes, 51.7 mL, 120 mmol, 2.0 equiv.) 
dropwise over 10 min. The solution was stirred at 0 °C for 10 min before being 
cooled to −78 °C, and (R)-methyl-3-hydroxybutanoate (6.7 mL, 60 mmol) was 
slowly added over 5 min. The resulting mixture was stirred for 30 min and a 
solution of MeI (4.2 mL, 68 mmol, 1.1 equiv.) in HMPA (20 mL) was added 
dropwise over 15 min. The reaction mixture was stirred at −78 °C for 15 min, 
warmed to 0 °C and stirred for 30 min. The reaction was quenched by the addition 
of a cold sat. aq. NH4Cl solution (100 mL). The layers were separated and the 
aqueous phase was extracted with Et2O (4 × 100 mL). The combined organic 
extracts were dried over MgSO4, filtered and concentrated. Crude material was 
purified by silica gel chromatography (pet. ether/EtOAc, 75:25) to afford β-hydroxy 
ester 367 (5.1 g, 39 mmol, 65%) as a colourless oil. Rf = 0.37 (pet. ether/EtOAc, 
60:40); [α]D26 −27.0 (c = 2.29, CHCl3) [lit83 [α]D26 −31.4 (c = 1.21, CHCl3)]; νmax 
3435, 2976, 2953, 1717, 1437, 1379, 1261, 1198, 1173, 1111, 1045 cm−1; 1H 
NMR (400 MHz, CDCl3) δ 3.88 (1H, dqd, J = 7.2, 6.4, 5.8 Hz, CH−C15), 3.72 (3H, 
s, CH3−CO2Me), 2.61 (1H, d, J = 5.8 Hz, OH−C15), 2.46 (1H, app p, J = 7.2 Hz, 
CH−C16), 1.22 (3H, d, J = 6.4 Hz, CH3−C14), 1.19 (3H, d, J = 7.2 Hz, CH3−C34); 
13C NMR (101 MHz, CDCl3) δ 176.5 (C−C17), 69.6 (CH−C15), 51.9 
(CH3−CO2Me), 47.0 (CH−C16), 20.9 (CH3−C14), 14.3 (CH3−C34); HRMS (CI+) 
[M+H]+ calcd for C6H13O3 133.0865, found 133.0867, Δ 1.7 ppm. 
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(2R,3R)-Methyl 3-((1RS-ethoxy)ethoxy)-2-methylbutanoate 368 
 
 
 
 
 
 
To a solution of β-hydroxy ester 367 (2.0 g, 15 mmol) in CH2Cl2 (150 mL) at 0 °C, 
were added ethyl vinyl ether (4.4 mL, 45 mmol, 3.0 equiv.) and PPTS (0.38 g, 1.5 
mmol, 10 mol %) sequentially. The resulting mixture was stirred at 0 °C for 5 min 
and at RT for 1.5 h, then diluted with Et2O (450 mL) and washed with brine (350 
mL). The layers were separated and the organic phase was dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 95:5) to afford EE acetal 368 (2.9 g, 14 mmol, 
94%) as a 1.1:1 mixture of diastereomers, as a colourless oil. Rf = 0.38 (pet. 
ether/EtOAc, 90:10); [α]D26 −25.2 (c = 1.61, CHCl3); νmax 2978, 2938, 1738, 1435, 
1379, 1335, 1260, 1200, 1126, 1076, 1055 cm−1; 1H NMR (500 MHz, CDCl3) δ 
4.75 (1.0H, q, J = 5.4 Hz, CH−CD'), 4.69 (1.1H, q, J = 5.3 Hz, CH−CD), 3.96 (1.0H, 
dq, J = 7.3, 6.3 Hz, CH−C15'), 3.87 (1.1H, dq, J = 7.3, 6.3 Hz, CH−C15), 3.67 
(6.3H, s, CH3−CO2Me, CH3−CO2Me'), 3.61 (1.0H, dq, J = 9.2, 7.1 Hz, CH−CE'), 
3.61 (1.1H, dq, J = 9.2, 7.1 Hz, CH−CE), 3.48 (1.1H, dq, J = 9.2, 7.1 Hz, CH−CE), 
3.41 (1.0H, dq, J = 9.2, 7.1 Hz, CH−CE'), 2.64 (1.0H, app p, J = 7.3 Hz, CH−C16'), 
2.60 (1.1H, app p, J = 7.3 Hz, CH−C16), 1.29 (3.0H, d, J = 5.4 Hz, CH3−CC'), 1.24 
(3.3H, d, J = 5.3 Hz, CH3−CC), 1.21−1.16 (9.6H, m, CH3−C14, CH3−CF, CH3−CF'), 
1.13 (3.0H, d, J = 7.3 Hz, CH3−C34'), 1.12 (3.0H, d, J = 6.3 Hz, CH3−C14'), 1.10 
(3.3H, d, J = 7.3 Hz, CH3−C34); 13C NMR (126 MHz, CDCl3) δ 175.6 (C−C17), 
175.5 (C−C17'), 100.5 (CH−CD), 98.3 (CH−CD'), 75.2 (CH−C15), 72.5 (CH−C15'), 
60.3 (CH2−CE'), 60.1 (CH2−CE), 51.7 (CH3−CO2Me, CH3−CO2Me'), 46.0 
(CH−C16'), 46.0 (CH−C16), 20.8 (CH3−CC'), 20.6 (CH3−CC), 18.2 (CH3−C14), 17.1 
(CH3−C14'), 15.5 (CH3−CF), 15.4 (CH3−CF'), 12.6 (CH3−C34), 12.6 (CH3−C34'); 
HRMS (ESI+) [M+Na]+ calcd for C10H20O4Na 227.1254, found 227.1245, Δ 3.9 
ppm.  
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(2S,3R)-3-((1RS-Ethoxy)ethoxy)-2-methylbutan-1-ol 369 
 
 
 
 
 
 
To a suspension of LiAlH4 (0.62 g, 16 mmol, 2.5 equiv.) in Et2O (55 mL) at 0 °C, 
was slowly added a solution of methyl ester 368 (1.3 g, 6.6 mmol) in Et2O (11 mL). 
The resulting mixture was stirred at 0 °C for 30 min. The reaction was quenched 
by the dropwise addition of water (0.62 mL), a 15% NaOH aq. solution (0.62 mL) 
and water (1.9 mL), sequentially, at 0 °C. The mixture was stirred vigorously at RT 
for 30 min and filtered through a cotton plug to remove the white solids. The filtrate 
was concentrated and the crude material was used directly in the next step without 
further purification. Rf = 0.46 (pet. ether/EtOAc, 60:40); νmax 3437, 2976, 2880, 
1449, 1377, 1337, 1126, 1078, 1051 cm−1; 1H NMR (500 MHz, CDCl3) δ 4.71 
(1.1H, q, J = 5.3 Hz, CH−CD), 4.69 (1.0H, q, J = 5.2 Hz, CH−CD'), 3.84 (1.0H, ddd, 
J = 11.2, 6.3, 3.3 Hz, CH−C17'), 3.70−3.61 (3.2H, m, CH−C15', CH−C17, CH−CE), 
3.61−3.44 (6.3H, m, CH−C15, CH−C17, CH−C17', CH−CE, CH2−CE'), 3.15 (1.0H, 
app t, J = 6.3 Hz, OH−C17'), 2.57−2.54 (1.1H, m, OH−C17), 1.73 (1.1H, app hd, J 
= 6.9, 3.9 Hz, CH−C16), 1.69−1.59 (1.0H, m, CH−C16'), 1.33 (3.3H, d, J = 5.3 Hz, 
CH3−CC), 1.31 (3.0H, d, J = 5.2 Hz, CH3−CC'), 1.24 (3.3H, d, J = 6.2 Hz, 
CH3−C14), 1.22 (3.0H, t, J = 7.0 Hz, CH3−CF'), 1.20 (3.3H, t, J = 7.1 Hz, CH3−CF), 
1.17 (3.0H, d, J = 6.1 Hz, CH3−C14'), 0.94 (3.0H, d, J = 7.0 Hz, CH3−C34'), 0.93 
(3.3H, d, J = 6.9 Hz, CH3−C34); 13C NMR (126 MHz, CDCl3) δ 100.3 (CH−CD), 
98.4 (CH−CD'), 78.1 (CH−C15), 75.8 (CH−C15'), 66.4 (CH2−C17), 66.0 
(CH2−C17'), 61.3 (CH2−CE'), 60.6 (CH2−CE), 41.5 (CH−C16'), 41.2 (CH−C16), 
20.8 (CH3−CC'), 20.6 (CH3−CC), 19.1 (CH3−C14), 18.4 (CH3−C14'), 15.4 
(CH3−CF'), 15.4 (CH3−CF), 14.6 (CH3−C34'), 14.0 (CH3−C34); HRMS (ESI+) 
[M+Na]+ calcd for C9H20O3Na 199.1305, found 199.1304, Δ 0.2 ppm. 
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2-((2S,3R)-3-((1RS-Ethoxy)ethoxy)-2-methylbutyl)-1,3-dithiane 362 
 
 
 
 
 
 
Note: The alkyl iodide intermediate is light-sensitive and all manipulations were 
performed in the dark. 
 
To a solution of crude alcohol 369 in THF (42 mL) at 0 °C, were added PPh3 (3.3 
g, 13 mmol, 2.0 equiv.) and imidazole (1.7 g, 25 mmol, 4.0 equiv.) sequentially. 
The resulting mixture was stirred at 0 °C for 10 min, before the portionwise 
addition of iodine (3.2 g, 13 mmol, 2.0 equiv.). The brown solution was stirred at 0 
°C for 10 min and at RT for 1 h. The reaction was quenched by the addition of a 
sat. aq. Na2S2O3 solution (35 mL) and the layers were separated. The aqueous 
phase was extracted with Et2O (3 × 35 mL) and the combined organic extracts 
were washed with brine (100 mL), dried over MgSO4, filtered and concentrated. 
The residue was filtered rapidly through a short pad of silica gel (pet. ether/EtOAc, 
95:5) to give the crude alkyl iodide which was used directly in the next step without 
further purification. 
To a solution of 1,3-dithiane (1.5 g, 12 mmol, 2.0 equiv.) in a 5:1 mixture of THF 
and HMPA (35 mL) at −20 °C, was added n-BuLi (titrated at 2.35 M in hexanes, 
5.0 mL, 12 mmol, 1.9 equiv.) dropwise. The resulting dark yellow solution was 
stirred at −20 °C for 1 h, before the slow addition of a solution of the crude iodide 
(dried by azeotropic distillation with benzene (4 ×)) in THF (8 mL). The reaction 
mixture was stirred at −20 °C for 1.5 h, before the slow addition of a sat. aq. NH4Cl 
solution (45 mL) and the biphasic mixture was allowed to warm to RT. The layers 
were separated and the aqueous phase was extracted with Et2O (3 × 45 mL). The 
combined organic extracts were washed with brine (120 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 90:10) to deliver dithiane 362 (1.3 g, 4.6 mmol, 
71% over 3 steps) as a 1.1:1 mixture of diastereomers, as a colourless oil. Rf = 
0.45 (pet. ether/EtOAc, 90:10); [α]D24 −6.34 (c = 1.96, CHCl3); νmax 2975, 2933, 
2898, 1424, 1377, 1276, 1127, 1079, 1056 cm−1; 1H NMR (500 MHz, CDCl3) δ 
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4.74 (1.0H, q, J = 5.3 Hz, CH−CD'), 4.71 (1.1H, q, J = 5.3 Hz, CH−CD), 4.08 (1.0H, 
dd, J = 9.4, 5.6 Hz, CH−C18'), 4.07 (1.1H, dd, J = 9.3, 5.6 Hz, CH−C18), 
3.67−3.55 (4.2H, m, CH−C15, CH−C15', CH−CE, CH−CE'), 3.49 (1.1H, qd, J = 7.1, 
4.0 Hz, CH−CE), 3.47 (1.0H, qd, J = 7.1, 4.0 Hz, CH−CE'), 2.94−2.78 (8.4H, m, 2 × 
CH2−CA, 2 × CH2−CA'), 2.16−2.09 (2.1H, m, CH−CB, CH−CB'), 2.05−1.96 (2.1H, m, 
CH−C16, CH−C16'), 1.92−1.82 (3.1H, m, CH−C17', CH−CB, CH−CB'), 1.79 (1.1H, 
ddd, J = 14.1, 9.3, 4.8 Hz, CH−C17), 1.53 (1.1H, ddd, J = 14.1, 9.2, 5.6 Hz, 
CH−C17), 1.52 (1.0H, ddd, J = 14.2, 9.2, 5.6 Hz, CH−C17'), 1.30 (3.3H, d, J = 5.3 
Hz, CH3−CC), 1.29 (3.0H, d, J = 5.3 Hz, CH3−CC'), 1.20 (3.3H, t, J = 7.1 Hz, 
CH3−CF), 1.19 (3.0H, t, J = 7.1 Hz, CH3−CF'), 1.11 (3.3H, d, J = 6.4 Hz, CH3−C14), 
1.06 (3.0H, d, J = 6.3 Hz, CH3−C14'), 0.95 (3.0H, d, J = 6.8 Hz, CH3−C34'), 0.92 
(3.3H, d, J = 6.8 Hz, CH3−C34); 13C NMR (126 MHz, CDCl3) δ 99.6 (CH−CD), 97.9 
(CH−CD'), 76.2 (CH−C15), 74.3 (CH−C15'), 60.1 (CH2−CE), 60.1 (CH2−CE'), 45.9 
(CH−C18'), 45.8 (CH−C18), 38.6 (CH2−C17), 38.5 (CH2−C17'), 35.4 (CH−C16'), 
34.6 (CH−C16), 30.7 (CH2−CA, CH2−CA'), 30.4 (CH2−CA), 30.4 (CH2−CA'), 26.3 
(CH2−CB'), 26.2 (CH2−CB), 20.8 (CH3−CC'), 20.8 (CH3−CC), 16.8 (CH3−C14), 16.1 
(CH3−C14'), 15.5 (CH3−CF, CH3−CF'), 15.0 (CH3−C34'), 14.4 (CH3−C34); HRMS 
(ESI+) [M+Na]+ calcd for C13H26O2S2Na 301.1266, found 301.1258, Δ 2.7 ppm. 
 
(S)-Methyl 3-((tert-butyldiphenylsilyl)oxy)-2-methylpropanoate 37185 
 
 
 
 
 
 
To a solution of methyl (S)-(+)-3-hydroxy-2-methylpropionate (1.0 g, 8.5 mmol) in 
CH2Cl2 (11 mL) at 0 °C, were added imidazole (0.75 g, 11 mmol, 1.3 equiv.) and 
TBDPSCl (2.2 mL, 8.5 mmol, 1.0 equiv.) sequentially. The resulting mixture was 
stirred at RT for 18 h, before the addition of water (20 mL). The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 20 mL). The 
combined organic extracts were washed with brine (60 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 98:2) to afford TBDPS ether 371 (2.9 g, 8.2 
mmol, 97%) as a colourless oil. Rf = 0.23 (pet. ether/EtOAc, 98:2); [α]D20 +16.9 (c 
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= 1.44, CHCl3) [lit85 [α]D20 +16.9 (c = 1.11, CHCl3)]; νmax 2932, 2859, 1742, 1472, 
1429, 1389, 1362, 1258, 1200, 1111, 1088, 1026 cm−1; 1H NMR (500 MHz, CDCl3) 
δ 7.70−7.62 (4H, m, CH−Ar TBDPS), 7.45−7.36 (6H, m, CH−Ar TBDPS), 3.82 (1H, 
dd, J = 9.8, 7.0 Hz, CH−C13), 3.72 (1H, dd, J = 9.8, 5.8 Hz, CH−C13), 3.69 (3H, s, 
CH3−CO2Me), 2.72 (1H, app pd, J = 7.0, 5.8 Hz, CH−C12), 1.16 (3H, d, J = 7.0 
Hz, CH3−C33), 1.03 (9H, s, CH3−t-Bu TBDPS); 13C NMR (126 MHz, CDCl3) δ 
175.5 (C−C11), 135.7 (CH−Ar TBDPS), 135.7 (CH−Ar TBDPS), 133.7 (C−Ar 
TBDPS), 133.6 (C−Ar TBDPS), 129.8 (CH−Ar TBDPS), 127.8 (CH−Ar TBDPS), 
66.1 (CH2−C13), 51.7 (CH3−CO2Me), 42.5 (CH−C12), 26.9 (CH3−t-Bu TBDPS), 
19.4 (C−t-Bu TBDPS), 13.6 (CH3−C33); HRMS (ESI+) [M+Na]+ calcd for 
C21H28O3SiNa 379.1700, found 379.1687, Δ 3.3 ppm. 
 
(R)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropan-1-ol 372105 
 
 
 
 
 
 
To a solution of methyl ester 371 (2.9 g, 8.2 mmol) in CH2Cl2 (41 mL) at −78 °C, 
was added i-Bu2AlH (1.0 M in hexane, 18 mL, 18 mmol, 2.2 equiv.) dropwise. The 
resulting solution was stirred at −78 °C for 5 min and at RT for 6 h. The reaction 
mixture was cooled to 0 °C and MeOH (5 mL) was added dropwise, followed by a 
sat. aq. potassium sodium tartrate solution (50 mL). The biphasic mixture was 
stirred vigorously at RT for 10 h and the layers were separated. The aqueous 
phase was extracted with Et2O (3 × 50 mL) and the combined organic extracts 
were washed with brine (200 mL), dried over MgSO4, filtered and concentrated. 
Crude material was purified by silica gel chromatography (pet. ether/EtOAc, 90:10) 
to afford alcohol 372 (2.3 g, 7.0 mmol, 86%) as a colourless oil. Rf = 0.28 (pet. 
ether/EtOAc, 90:10); [α]D24 +4.75 (c = 1.26, CHCl3) [lit105 [α]D22 +4.7 (c = 0.89, 
CHCl3)]; νmax 3379, 2931, 2858, 1473, 1428, 1391, 1112, 1039 cm−1; 1H NMR (400 
MHz, CDCl3) δ 7.70−7.65 (4H, m, CH−Ar TBDPS), 7.48−7.36 (6H, m, CH−Ar 
TBDPS), 3.73 (1H, dd, J = 10.0, 4.5 Hz, CH−C13), 3.68 (2H, dd, J = 6.2, 5.3 Hz, 
CH2−C11), 3.60 (1H, dd, J = 10.0, 7.7 Hz, CH−C13), 2.53−2.49 (1H, br s, 
OH−C11), 2.06−1.94 (1H, m, CH−C12), 1.06 (9H, s, CH3−t-Bu TBDPS), 0.83 (3H, 
HO
11
12
13
33
OTBDPS Chemical Formula: C20H28O2Si
Molecular Weight: 328,52
Experimental Section | 147 
d, J = 7.0 Hz, CH3−C33); 13C NMR (126 MHz, CDCl3) δ 135.7 (CH−Ar TBDPS), 
135.7 (CH−Ar TBDPS), 133.4 (C−Ar TBDPS), 133.3 (C−Ar TBDPS), 129.9 
(CH−Ar TBDPS), 127.9 (CH−Ar TBDPS), 68.9 (CH2−C11), 67.8 (CH2−C13), 37.5 
(CH−C12), 27.0 (CH3−t-Bu TBDPS), 19.3 (C−t-Bu TBDPS), 13.3 (CH3−C33); 
HRMS (ESI+) [M+Na]+ calcd for C20H28O2SiNa 351.1751, found 351.1734, Δ 4.9 
ppm. 
 
(S)-3-((tert-Butyldiphenylsilyl)oxy)-2-methylpropanal 37385 
 
 
 
 
 
 
To a solution of alcohol 372 (1.8 g, 5.5 mmol) in CH2Cl2 (37 mL) at RT, was added 
DMP (2.7 g, 6.3 mmol, 1.15 equiv.) portionwise. The resulting mixture was stirred 
at RT for 1.5 h, before the addition of a sat. aq. Na2S2O3 solution (50 mL). The 
layers were separated and the organic layer was washed with a sat. aq. NaHCO3 
solution (50 mL). The aqueous phase was extracted with Et2O (3 × 50 mL) and the 
combined organic extracts were washed with brine (200 mL), dried over MgSO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 95:5) to deliver aldehyde 373 (1.6 g, 4.9 mmol, 
88%) as a colourless oil. Rf = 0.41 (pet. ether/EtOAc, 90:10); [α]D27 +24.0 (c = 
1.27, CHCl3) [lit85 [α]D20 +20.0 (c = 2.42, CHCl3)]; νmax 2932, 2859, 1736, 1472, 
1427, 1111, 1036 cm−1; 1H NMR (500 MHz, CDCl3) δ 9.77 (1H, d, J = 1.6 Hz, 
CH−C11), 7.67−7.62 (4H, m, CH−Ar TBDPS), 7.47−7.37 (6H, m, CH−Ar TBDPS), 
3.90 (1H, dd, J = 10.4, 5.0 Hz, CH−C13), 3.84 (1H, dd, J = 10.4, 6.4 Hz, CH−C13), 
2.57 (1H, qddd, J = 7.0, 6.4, 5.0, 1.6 Hz, CH−C12), 1.10 (3H, d, J = 7.0 Hz, 
CH3−C33), 1.04 (9H, s, CH3−t-Bu TBDPS); 13C NMR (126 MHz, CDCl3) δ 204.6 
(C−C11), 135.7 (CH−Ar TBDPS), 133.3 (C−Ar TBDPS), 130.0 (CH−Ar TBDPS), 
130.0 (CH−Ar TBDPS), 127.9 (CH−Ar TBDPS), 64.3 (CH2−C13), 49.0 (CH−C12), 
26.9 (CH3−t-Bu TBDPS), 19.4 (C−t-Bu TBDPS), 10.5 (CH3−C33); HRMS (ESI+) 
[M+Na]+ calcd for C20H26O2SiNa 349.1594, found 349.1579, Δ 4.4 ppm. 
 
 
H 11
12
13
33
OTBDPS
Chemical Formula: C20H26O2Si
Molecular Weight: 326,50
O
Experimental Section | 148 
(R)-tert-Butyl((4,4-dibromo-2-methylbut-3-en-1-yl)oxy)diphenylsilane 374106 
 
 
 
 
 
 
To a solution of PPh3 (5.1 g, 20 mmol, 4.0 equiv.) in CH2Cl2 (35 mL) at RT, was 
added CBr4 (3.2 g, 9.7 mmol, 2.0 equiv.) portionwise. The resulting mixture was 
cooled to −78 °C, before the addition of a solution of aldehyde 373 (1.6 g, 4.9 
mmol) and Et3N (0.68 mL, 4.9 mmol, 1.0 equiv.) in CH2Cl2 (15 mL). The yellow 
suspension was stirred at −78 °C for 30 min and at RT for 1 h, and pet. ether (130 
mL) was added. The suspension was stirred at RT for 10 min, filtered through a 
pad of celite and the filter cake was washed with pet. ether (3 × 45 mL). The 
filtrate was concentrated and the crude material was purified by silica gel 
chromatography (pet. ether/Et2O, 100:1) to deliver dibromo olefin 374 (2.2 g, 4.5 
mmol, 93%) as a colourless oil. Rf = 0.41 (pet. ether/EtOAc, 90:10); [α]D25 −12.5 (c 
= 1.25, CHCl3) [lit106 [α]D25 −14 (c = 0.58, CHCl3)]; νmax 3071, 2930, 2859, 1616, 
1589, 1472, 1427, 1389, 1111, 1026 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.70−7.62 
(4H, m, CH−Ar TBDPS), 7.47−7.36 (6H, m, CH−Ar TBDPS), 6.27 (1H, d, J = 9.3 
Hz, CH−C11), 3.57 (1H, dd, J = 9.9, 5.8 Hz, CH−C13), 3.53 (1H, dd, J = 9.9, 6.1 
Hz, CH−C13), 2.75−2.65 (1H, m, CH−C12), 1.06 (9H, s, CH3−t-Bu TBDPS), 1.04 
(3H, d, J = 6.8 Hz, CH3−C33); 13C NMR (126 MHz, CDCl3) δ 141.6 (CH−C11), 
135.8 (CH−Ar TBDPS), 135.8 (CH−Ar TBDPS), 133.7 (C−Ar TBDPS), 133.6 
(C−Ar TBDPS), 129.8 (CH−Ar TBDPS), 129.8 (CH−Ar TBDPS), 127.8 (CH−Ar 
TBDPS), 88.8 (C−C10), 66.9 (CH2−C13), 41.2 (CH−C12), 27.0 (CH3−t-Bu 
TBDPS), 19.4 (C−t-Bu TBDPS), 15.7 (CH3−C33); HRMS (ESI+) [M+Na]+ calcd for 
C21H26OSi79Br81BrNa 504.9991, found 504.9975, Δ 3.3 ppm. 
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(R)-tert-Butyl((2-methylbut-3-yn-1-yl)oxy)diphenylsilane 37586 
 
 
 
 
 
 
To a solution of dibromo olefin 374 (1.7 g, 3.6 mmol) in THF (36 mL) at −78 °C, 
was added n-BuLi (titrated at 2.40 M in hexanes, 3.0 mL, 7.3 mmol, 2.05 equiv.) 
dropwise. The resulting mixture was stirred at −78 °C for 1.5 h, before the addition 
of a sat. aq. NH4Cl solution (30 mL). The layers were separated and the aqueous 
phase was extracted with Et2O (3 × 30 mL). The combined organic extracts were 
washed with brine (120 mL), dried over MgSO4, filtered and concentrated. Crude 
material was purified by silica gel chromatography (pet. ether/Et2O, 100:1) to 
afford alkyne 375 (1.1 g, 3.5 mmol, 98%) as a colourless oil. Rf = 0.26 (pet. ether); 
[α]D25 +5.55 (c = 1.21, CHCl3) [lit86 [α]D25 +5.6 (c = 1.0, CHCl3)]; νmax 3308, 2932, 
2859, 1589, 1472, 1427, 1389, 1113, 1018 cm−1; 1H NMR (500 MHz, CDCl3) δ 
7.70−7.65 (4H, m, CH−Ar TBDPS), 7.45−7.35 (6H, m, CH−Ar TBDPS), 3.73 (1H, 
dd, J = 9.6, 5.7 Hz, CH−C13), 3.55 (1H, dd, J = 9.6, 7.6 Hz, CH−C13), 2.70−2.62 
(1H, m, CH−C12), 2.03 (1H, d, J = 2.5 Hz, CH−C10), 1.23 (3H, d, J = 6.9 Hz, 
CH3−C33), 1.06 (9H, s, CH3−t-Bu TBDPS); 13C NMR (126 MHz, CDCl3) δ 135.8 
(CH−Ar TBDPS), 135.8 (CH−Ar TBDPS), 133.7 (C−Ar TBDPS), 133.7 (C−Ar 
TBDPS), 129.8 (CH−Ar TBDPS), 127.8 (CH−Ar TBDPS), 86.7 (C−C11), 69.2 
(CH−C10), 67.6 (CH2−C13), 29.0 (CH−C12), 27.0 (CH3−t-Bu TBDPS), 19.5 (C−t-
Bu TBDPS), 17.5 (CH3−C33); HRMS (ESI+) [M+Na]+ calcd for C21H26OSiNa 
345.1645, found 345.1630, Δ 4.5 ppm. 
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(R,E)-tert-Butyl((4-iodo-2,3-dimethylbut-3-en-1-yl)oxy)diphenylsilane 376 
 
 
 
 
 
 
Note: Vinyl iodides are generally light-sensitive and so all manipulations were 
performed in the dark. 
 
To a solution of Cp2ZrCl2 (1.0 g, 3.4 mmol, 1.5 equiv.) in 1,2-dichloroethane (13 
mL) at RT, was added AlMe3 (2.0 M in hexanes, 4.6 mL, 9.2 mmol, 4.0 equiv.) 
dropwise. The resulting yellow solution was stirred at RT for 30 min, before the 
dropwise addition of a solution of alkyne 375 (0.74 g, 2.3 mmol) in 1,2-
dichloroethane (6 mL). The reaction mixture was stirred at RT for 24 h and cooled 
to −30 °C. A solution of iodine (1.2 g, 4.6 mmol, 2.0 equiv.) in THF (10 mL) was 
added dropwise, until the red-brown color remained. The solution was stirred at 
−30 °C for 30 min, before the dropwise addition of a sat. aq. potassium sodium 
tartrate solution (50 mL) and CH2Cl2 (25 mL). The biphasic mixture was stirred 
vigorously at RT for 1 h and the layers were separated. The aqueous phase was 
extracted with Et2O (3 × 75 mL) and the combined organic extracts were washed 
with brine (250 mL), dried over MgSO4, filtered and concentrated. Crude material 
was purified by silica gel chromatography (pet. ether/Et2O, 100:1) to afford vinyl 
iodide 376 (1.0 g, 2.2 mmol, 96%) as a colourless oil. Rf = 0.32 (pet. ether); [α]D25 
+9.3 (c = 0.90, CHCl3); νmax 3071, 2961, 2930, 2859, 1472, 1427, 1389, 1271, 
1111 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.68−7.61 (4H, m, CH−Ar TBDPS), 
7.46−7.35 (6H, m, CH−Ar TBDPS), 5.96 (1H, app p, J = 1.1 Hz, CH−C10), 3.56 
(1H, dd, J = 10.0, 7.0 Hz, CH−C13), 3.53 (1H, dd, J = 10.0, 6.2 Hz, CH−C13), 
2.65−2.54 (1H, m, CH−C12), 1.70 (3H, d, J = 1.1 Hz, CH3−C32), 1.04 (9H, s, 
CH3−t-Bu TBDPS), 1.01 (3H, d, J = 6.9 Hz, CH3−C33); 13C NMR (126 MHz, 
CDCl3) δ 149.7 (C−C11), 135.8 (CH−Ar TBDPS), 135.8 (CH−Ar TBDPS), 133.9 
(C−Ar TBDPS), 133.8 (C−Ar TBDPS), 129.8 (CH−Ar TBDPS), 129.8 (CH−Ar 
TBDPS), 127.8 (CH−Ar TBDPS), 127.8 (CH−Ar TBDPS), 76.6 (CH−C10), 66.8 
(CH2−C13), 45.7 (CH−C12), 27.0 (CH3−t-Bu TBDPS), 21.7 (CH3−C32), 19.4 (C−t-
Bu TBDPS), 15.7 (CH3−C33); HRMS (ESI+) [M+Na]+ calcd for C22H29IOSiNa 
11
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487.0925, found 487.0911, Δ 2.8 ppm. 
 
(R,E)-4-Iodo-2,3-dimethylbut-3-en-1-ol 377 
 
 
 
 
 
 
To a solution of TBS ether 376 (1.0 g, 2.2 mmol) in THF (22 mL) at 0 °C, was 
added TBAF (1.0 M in THF, 3.3 mL, 3.3 mmol, 1.5 equiv.) dropwise. The resulting 
solution was stirred at RT for 1 h, before the addition of a 1:1 mixture of a sat. aq. 
NH4Cl solution and water (20 mL). The layers were separated and the aqueous 
phase was extracted with EtOAc (3 × 20 mL). The combined organic extracts were 
washed with brine (60 mL), dried over MgSO4, filtered and concentrated. Crude 
material was purified by silica gel chromatography (pet. ether/EtOAc, 80:20) to 
afford alcohol 377 (0.46 g, 2.0 mmol, 92%) as a colourless oil. Rf = 0.34 (pet. 
ether/EtOAc, 80:20); [α]D24 +12.0 (c = 5.38, CHCl3); νmax 3329, 2963, 2930, 2874, 
1613, 1452, 1377, 1267, 1157, 1034 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.08−6.05 
(1H, m, CH−C10), 3.58−3.47 (2H, m, CH2−C13), 2.66−2.58 (1H, m, CH−C12), 
1.81 (3H, d, J = 1.1 Hz, CH3−C32), 1.35−1.27 (1H, m, OH−C13), 1.04 (3H, d, J = 
6.9 Hz, CH3−C33); 13C NMR (126 MHz, CDCl3) δ 149.1 (C−C11), 77.1 (CH−C10), 
65.5 (CH2−C13), 46.1 (CH−C12), 21.2 (CH3−C32), 15.6 (CH3−C33); HRMS (ESI+) 
[M+Na]+ calcd for C6H11IONa 248.9747, found 248.9755, Δ 3.4 ppm. 
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tert-Butyl(((R,E)-1-((2R,5R)-5-(iodomethyl)tetrahydrofuran-2-yl)-5-
methylhexa-2,4-dien-1-yl)oxy)dimethylsilane 361 
 
 
 
 
 
 
Note: The alkyl iodide product is light-sensitive and all manipulations were 
performed in the dark. 
 
To a solution of alcohol 365 (0.25 g, 0.76 mmol) in THF (7.6 mL) at 0 °C, were 
added PPh3 (337 mg, 1.29 mmol, 1.7 equiv.) and imidazole (154 mg, 2.27 mmol, 
3.0 equiv.) sequentially. The resulting mixture was stirred at 0 °C for 10 min, 
before the portionwise addition of iodine (288 mg, 1.13 mmol, 1.5 equiv.). The 
brown solution was stirred at 0 °C for 10 min and at RT for 2 h. The reaction was 
quenched by the addition of a sat. aq. Na2S2O3 solution (8 mL) and the layers 
were separated. The aqueous phase was extracted with Et2O (3 × 8 mL) and the 
combined organic extracts were washed with brine (30 mL), dried over MgSO4, 
filtered and concentrated. The residue was filtered rapidly through a short pad of 
silica gel (pet. ether/EtOAc, 95:5) to give the crude alkyl iodide 361 which was 
used directly in the next step without further purification. Rf = 0.32 (pet. 
ether/EtOAc, 98:2); 1H NMR (500 MHz, CDCl3) δ 6.47 (1H, ddd, J = 15.2, 11.1, 1.4 
Hz, CH−C26), 5.83 (1H, dm, J = 11.1 Hz, CH−C27), 5.53 (1H, dd, J = 15.2, 5.6 
Hz, CH−C25), 4.22 (1H, app td, J = 5.6, 1.4 Hz, CH−C24), 4.08 (1H, app td, J = 
7.1, 5.6 Hz, CH−C23), 4.03 (1H, app tdd, J = 7.3, 6.2, 4.8 Hz, CH−C20), 3.25 (1H, 
dd, J = 9.8, 4.8 Hz, CH−C19), 3.16 (1H, dd, J = 9.8, 7.3 Hz, CH−C19), 2.11 (1H, 
dddd, J = 12.3, 8.5, 6.2, 4.1 Hz, CH−C21), 1.95 (1H, dddd, J = 12.6, 8.5, 7.1, 4.1 
Hz, CH−C22), 1.80 (1H, app dtd, J = 12.6, 8.5, 7.1 Hz, CH−C22), 1.78 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.62 (1H, app dtd, J = 12.3, 8.5, 7.3 Hz, 
CH−C21), 0.90 (9H, s, CH3−t-Bu TBS), 0.07 (3H, s, CH3−TBS), 0.05 (3H, s, 
CH3−TBS). 
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tert-Butyl(((1R,E)-1-((2R,5R)-5-((2-((2S,3R)-3-((1RS-ethoxy)ethoxy)-2-
methylbutyl)-1,3-dithian-2-yl)methyl)tetrahydrofuran-2-yl)-5-methylhexa-2,4-
dien-1-yl)oxy)dimethylsilane 380 
 
 
 
 
 
 
 
 
To a solution of dithiane 362 (dried by azeotropic distillation with benzene (4 ×), 
421 mg, 1.51 mmol, 2.0 equiv.) in a 9:1 mixture of THF and HMPA (15 mL) at −78 
°C, was added t-BuLi (titrated at 1.85 M in pentane, 820 µL, 1.51 mmol, 2.0 equiv.) 
dropwise. The resulting dark orange solution was stirred at −78 °C for 10 min, 
before the slow addition of a precooled solution of crude alkyl iodide 361 (dried by 
azeotropic distillation with benzene (4 ×)) in THF (2.5 mL). The dark green/black 
reaction mixture was stirred at −78 °C for 45 min, before the slow addition of a sat. 
aq. NH4Cl solution (18 mL) and the biphasic mixture was allowed to warm to RT. 
The layers were separated and the aqueous phase was extracted with Et2O (3 × 
20 mL). The combined organic extracts were washed with brine (60 mL), dried 
over MgSO4, filtered and concentrated. The residue was filtered through a short 
pad of silica gel (pet. ether/EtOAc, 90:10) to deliver the crude mixture (450 mg) 
consisting of a roughly 1:2 mixture of EE acetal 380 (ca. 0.39 mmol) and excess 
dithiane 362 (ca. 0.79 mmol) as a colourless oil. An analytical sample of the 
desired product could be obtained by treatment with TBAF in THF at RT and 
purification of the resulting alcohol by silica-gel chromatography to remove 
dithiane 362, followed by a TBS reprotection using TBSOTf and 2,6-lutidine in 
CH2Cl2 at −78 °C. However, the crude mixture was generally used directly in the 
next step without further purification. Rf = 0.42 (pet. ether/EtOAc, 90:10); νmax 
2957, 2928, 2857, 1659, 1462, 1443, 1377, 1337, 1252, 1123, 1078, 1003 cm−1; 
1H NMR (500 MHz, CDCl3) δ 6.45 (1H, ddd, J = 15.1, 11.0, 1.5 Hz), 6.44 (1H, ddd, 
J = 15.1, 11.1, 1.4 Hz), 5.83 (2H, dm, J = 11.0 Hz), 5.57 (2H, dd, J = 15.1, 5.7 Hz), 
4.79 (1H, q, J = 5.3 Hz), 4.75 (1H, q, J = 5.3 Hz), 4.23−4.18 (2H, m), 4.17−4.10 
(2H, m), 4.00−3.92 (2H, m), 3.75−3.62 (4H, m), 3.54−3.44 (2H, m), 2.94−2.69 (8H, 
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m), 2.29−2.25 (1H, m), 2.24 (1H, dd, J = 8.3, 5.5 Hz), 2.20−2.07 (6H, m), 2.02 (1H, 
dd, J = 15.1, 3.5 Hz), 2.02−1.91 (2H, m), 1.92−1.83 (5H, m), 1.77 (6H, br s), 1.75 
(6H, br s), 1.76−1.70 (2H, m), 1.67 (2H, dd, J = 15.1, 5.8 Hz), 1.55−1.46 (2H, m), 
1.31 (3H, d, J = 7.4 Hz), 1.30 (3H, d, J = 7.5 Hz), 1.20 (3H, t, J = 7.0 Hz), 1.20 
(3H, t, J = 7.1 Hz), 1.11 (3H, d, J = 6.4 Hz), 1.06 (3H, d, J = 6.2 Hz), 1.05 (3H, d, J 
= 6.7 Hz), 1.02 (3H, d, J = 6.9 Hz), 0.90 (18H, s), 0.06 (6H, s), 0.04 (6H, s); 13C 
NMR (126 MHz, CDCl3) δ 134.9, 134.9, 130.2, 127.5, 127.5, 124.9, 124.9, 99.1, 
98.3, 81.8, 81.8, 76.8, 76.8, 75.5, 75.5, 75.4, 60.7, 60.5, 53.5, 53.3, 45.0, 45.0, 
42.8, 34.5, 34.2, 34.2, 33.4, 29.9, 27.3, 27.2, 26.5, 26.5, 26.5, 26.1, 26.1, 25.2, 
25.2, 21.2, 21.0, 18.4, 16.9, 16.0, 15.8, 15.6, 15.5, 15.5, −4.3, −4.3, −4.6; HRMS 
(ESI+) [M+Na]+ calcd for C31H58O4S2SiNa 609.3438, found 609.3413, Δ 4.0 ppm. 
 
(2R,3S)-4-(2-(((2R,5R)-5-((R,E)-1-((tert-Butyldimethylsilyl)oxy)-5-methylhexa-
2,4-dien-1-yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)-3-methylbutan-2-ol 
381 
 
 
 
 
 
 
 
To a solution of crude 380 in a 3:1 mixture of EtOH and CH2Cl2 (59 mL) at RT, 
was added PPTS (45 mg, 0.18 mmol, 15 mol %). The resulting solution was stirred 
at RT for 9 h, before the addition of Et3N (75 µL, 0.54 mmol) and the mixture was 
concentrated. Crude material was purified by silica gel chromatography (pet. 
ether/EtOAc, 85:15) to deliver alcohol 381 (0.17 g, 0.33 mmol, 44% over 3 steps) 
as a colourless oil. Rf = 0.20 (pet. ether/EtOAc, 85:15); [α]D19 +16 (c = 0.49, 
CHCl3); νmax 3435, 2955, 2928, 2857, 1661, 1462, 1377, 1252, 1113, 1084, 1005 
cm−1; 1H NMR (500 MHz, CDCl3) δ 6.45 (1H, ddd, J = 15.2, 11.0, 1.4 Hz, 
CH−C26), 5.83 (1H, dm, J = 11.0 Hz, CH−C27), 5.56 (1H, dd, J = 15.2, 5.6 Hz, 
CH−C25), 4.20 (1H, app td, J = 5.6, 1.4 Hz, CH−C24), 4.16 (1H, app dq, J = 9.0, 
5.3 Hz, CH−C20), 3.97 (1H, app td, J = 7.3, 5.6 Hz, CH−C23), 3.67 (1H, app pd, J 
= 6.1, 5.5 Hz, CH−C15), 2.91−2.71 (4H, m, 2 × CH2−CA), 2.24 (1H, dd, J = 15.0, 
5.3 Hz, CH−C19), 2.18 (1H, dd, J = 15.0, 5.3 Hz, CH−C19), 2.17 (1H, dd, J = 15.0, 
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2.6 Hz, CH−C17), 2.10 (1H, dddd, J = 11.8, 7.9, 5.3, 2.6 Hz, CH−C21), 2.00−1.82 
(4H, m, CH−C16, CH−C22, CH2−CB), 1.77 (3H, br s, CH3−C35), 1.75 (3H, br s, 
CH3−C29), 1.76−1.69 (1H, m, CH−C22), 1.67 (1H, dd, J = 15.0, 6.2 Hz, CH−C17), 
1.55 (1H, d, J = 5.5 Hz, OH−C15), 1.56−1.47 (1H, m, CH−C21), 1.15 (3H, d, J = 
6.1 Hz, CH3−C14), 1.05 (3H, d, J = 6.9 Hz, CH3−C34), 0.90 (9H, s, CH3−t-Bu 
TBS), 0.06 (3H, s, CH3−TBS), 0.04 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) 
δ 134.9 (C−C28), 130.2 (CH−C25), 127.5 (CH−C26), 124.9 (CH−C27), 81.9 
(CH−C23), 76.8 (CH−C20), 75.5 (CH−C24), 72.5 (CH−C15), 53.2 (C−C18), 45.3 
(CH2−C19), 43.0 (CH2−C17), 37.0 (CH−C16), 34.3 (CH2−C21), 27.3 (CH2−C22), 
26.5 (CH2−CA), 26.4 (CH2−CA), 26.1 (CH3−C35), 26.1 (CH3−t-Bu TBS), 25.1 
(CH2−CB), 19.7 (CH3−C14), 18.4 (CH3−C29, C−t-Bu TBS), 17.9 (CH3−C34), −4.3 
(CH3−TBS), −4.6 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C27H50O3S2SiNa 
537.2863, found 537.2838, Δ 4.6 ppm. 
 
(S)-4-(2-(((2R,5R)-5-((R,E)-1-((tert-Butyldimethylsilyl)oxy)-5-methylhexa-2,4-
dien-1-yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)-3-methylbutan-2-one 
382 
 
 
 
 
 
 
 
To a solution of alcohol 381 (0.17 g, 0.33 mmol) in CH2Cl2 (3.3 mL) at 0 °C, were 
added DMSO (0.33 mL, 4.7 mmol, 14.0 equiv.), Et3N (0.32 mL, 2.3 mmol, 7.0 
equiv.) and SO3Pyr (0.29 g, 1.8 mmol, 5.5 equiv.) sequentially. The resulting 
mixture was stirred at 0 °C for 24 h, after which more DMSO (0.17 mL, 2.3 mmol, 
7.0 equiv.), Et3N (0.16 mL, 1.2 mmol, 3.5 equiv.) and SO3Pyr (0.15 g, 0.93 mmol, 
2.8 equiv.) were added. The reaction mixture was stirred at 0 °C for another 24 h, 
before the addition of a sat. aq. NH4Cl solution (4 mL) and the layers were 
separated. The aqueous phase was extracted with Et2O (3 × 5 mL) and the 
combined organic extracts were washed with brine (15 mL), dried over Na2SO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 95:5) to deliver ketone 382 (0.13 g, 0.26 mmol, 
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78%) as a colourless oil. Rf = 0.23 (pet. ether/EtOAc, 95:5); [α]D25 +26.1 (c = 1.52, 
CHCl3); νmax 2955, 2928, 2857, 1711, 1661, 1460, 1443, 1424, 1362, 1348, 1252, 
1115, 1084, 1005 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.43 (1H, ddd, J = 15.2, 
11.0, 1.4 Hz, CH−C26), 5.82 (1H, dm, J = 11.0 Hz, CH−C27), 5.55 (1H, dd, J = 
15.2, 5.7 Hz, CH−C25), 4.24−4.17 (2H, m, CH−C20, CH−C24), 3.99 (1H, app td, J 
= 7.3, 4.9 Hz, CH−C23), 3.03 (1H, ddd, J = 14.5, 9.1, 0.7 Hz, CH−C17), 3.00 (1H, 
ddd, J = 14.3, 11.2, 2.7 Hz, CH−CA), 2.84 (1H, dqd, J = 9.1, 7.2, 1.4 Hz, CH−C16), 
2.77 (1H, ddd, J = 14.3, 11.2, 2.7 Hz, CH−CA), 2.66 (1H, dddd, J = 14.3, 5.8, 3.1, 
1.0 Hz, CH−CA), 2.48 (1H, dddd, J = 14.3, 5.8, 3.1, 1.0 Hz, CH−CA), 2.25 (3H, s, 
CH3−C14), 2.08 (1H, dd, J = 15.0, 7.4 Hz, CH−C19), 2.05−1.97 (2H, m, CH−C21, 
CH−CB), 1.98 (1H, ddd, J = 15.0, 3.1, 0.7 Hz, CH−C19), 1.89 (1H, dd, J = 14.5, 1.4 
Hz, CH−C17), 1.89−1.69 (3H, m, CH2−C22, CH−CB), 1.77 (3H, br s, CH3−C35), 
1.75 (3H, br s, CH3−C29), 1.48 (1H, app ddt, J = 12.0, 10.0, 8.5 Hz, CH−C21), 
1.08 (3H, d, J = 7.2 Hz, CH3−C34), 0.90 (9H, s, CH3−t-Bu TBS), 0.05 (3H, s, 
CH3−TBS), 0.04 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 212.6 (C−C15), 
135.0 (C−C28), 130.1 (CH−C25), 127.6 (CH−C26), 124.8 (CH−C27), 82.2 
(CH−C23), 75.3 (CH−C24), 75.1 (CH−C20), 51.9 (C−C18), 45.6 (CH2−C19), 43.6 
(CH−C16), 40.7 (CH2−C17), 34.0 (CH2−C21), 30.1 (CH3−C14), 26.9 (CH2−CA), 
26.7 (CH2−C22), 26.1 (CH3−C35), 26.1 (CH2−CA), 26.0 (CH3−t-Bu TBS), 25.1 
(CH2−CB), 18.9 (CH3−C34), 18.4 (CH3−C29), 18.4 (C−t-Bu TBS), −4.3 (CH3−TBS), 
−4.6 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C27H48O3S2SiNa 535.2706, 
found 535.2680, Δ 4.8 ppm. 
 
(S)-4-(2-(((2R,5R)-5-((R,E)-1-Hydroxy-5-methylhexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)-3-methylbutan-2-one 383 
 
 
 
 
 
 
 
 
To a solution of TBS ether 382 (0.13 g, 0.26 mmol) in THF (6.5 mL) at 0 °C, was 
added TBAF (1.0 M in THF, 0.52 mL, 0.52 mmol, 2.0 equiv.) dropwise. The 
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resulting solution was stirred at RT for 5 h. The reaction was quenched by the 
addition of water (7 mL) and the layers were separated. The aqueous phase was 
extracted with EtOAc (3 × 7 mL) and the combined organic extracts were washed 
with brine (25 mL), dried over Na2SO4, filtered and concentrated. Crude material 
was purified by silica gel chromatography (pet. ether/EtOAc, 70:30) to give alcohol 
383 (0.10 g, 0.26 mmol, quant.) as a colourless oil. Rf = 0.44 (pet. ether/EtOAc, 
70:30); [α]D26 +13.2 (c = 1.32, CHCl3); νmax 3451, 2963, 2924, 1709, 1661, 1443, 
1422, 1375, 1350, 1261, 1169, 1080, 1044, 1020 cm−1; 1H NMR (500 MHz, CDCl3) 
δ 6.52 (1H, ddd, J = 15.2, 11.0, 1.2 Hz, CH−C26), 5.81 (1H, dm, J = 11.0 Hz, 
CH−C27), 5.45 (1H, dd, J = 15.2, 6.8 Hz, CH−C25), 4.29−4.22 (1H, m, CH−C20), 
3.97 (1H, dddd, J = 7.1, 6.8, 2.9, 1.2 Hz, CH−C24), 3.89 (1H, app q, J = 7.1 Hz, 
CH−C23), 3.09 (1H, dd, J = 14.6, 9.4 Hz, CH−C17), 2.98 (1H, ddd, J = 14.4, 10.7, 
2.8 Hz, CH−CA), 2.88 (1H, dqd, J = 9.4, 7.2, 1.5 Hz, CH−C16), 2.77 (1H, ddd, J = 
14.4, 10.7, 2.8 Hz, CH−CA), 2.68 (1H, dddd, J = 14.4, 6.2, 3.1, 0.7 Hz, CH−CA), 
2.57 (1H, d, J = 2.9 Hz, OH−C24), 2.54 (1H, dddd, J = 14.4, 6.2, 3.1, 0.7 Hz, 
CH−CA), 2.26 (3H, s, CH3−C14), 2.14−2.07 (1H, m, CH−C21), 2.10 (1H, dd, J = 
15.3, 7.7 Hz, CH−C19), 2.03 (1H, dd, J = 15.3, 3.0 Hz, CH−C19), 2.04−1.91 (2H, 
m, CH−C22, CH−CB), 1.88−1.78 (1H, m, CH−CB), 1.80 (1H, dd, J = 14.6, 1.5 Hz, 
CH−C17), 1.77 (3H, br s, CH3−C35), 1.76 (3H, br s, CH3−C29), 1.70−1.60 (1H, m, 
CH−C22), 1.61−1.52 (1H, m, CH−C21), 1.08 (3H, d, J = 7.2 Hz, CH3−C34); 13C 
NMR (126 MHz, CDCl3) δ 212.2 (C−C15), 136.6 (C−C28), 129.4 (CH−C26), 128.2 
(CH−C25), 124.5 (CH−C27), 82.5 (CH−C23), 75.5 (CH−C24), 74.9 (CH−C20), 
52.0 (C−C18), 45.3 (CH2−C19), 43.5 (CH−C16), 41.3 (CH2−C17), 34.1 
(CH2−C21), 30.0 (CH3−C14), 27.8 (CH2−C22), 26.9 (CH2−CA), 26.2 (CH3−C35), 
26.1 (CH2−CA), 25.0 (CH2−CB), 19.1 (CH3−C34), 18.5 (CH3−C29); HRMS (ESI+) 
[M+Na]+ calcd for C21H34O3S2Na 421.1842, found 421.1826, Δ 3.8 ppm. 
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(S)-3-Methyl-4-(2-(((2R,5R)-5-((R,E)-5-methyl-1-((triethylsilyl)oxy)hexa-2,4-
dien-1-yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)butan-2-one 384 
 
 
 
 
 
 
 
 
To a solution of alcohol 383 (0.10 g, 0.26 mmol) in CH2Cl2 (6.5 mL) at −78 °C, was 
added 2,6-lutidine (90 µL, 0.78 mmol, 3.0 equiv.) and, after 5 min, TESOTf (88 µL, 
0.39 mmol, 1.5 equiv.). The resulting solution was stirred at −78 °C for 45 min, 
before the addition of water (7 mL) and the biphasic mixture was allowed to warm 
to RT. The layers were separated and the aqueous phase was extracted with Et2O 
(3 × 7 mL). The combined organic extracts were washed with brine (25 mL), dried 
over Na2SO4, filtered and concentrated. Crude material was purified by silica gel 
chromatography (pet. ether/EtOAc, 95:5) to deliver TES ether 384 (0.12 g, 0.23 
mmol, 89%) as a colourless oil. Rf = 0.28 (pet. ether/EtOAc, 95:5); [α]D25 +26.8 (c 
= 1.00, CHCl3); νmax 2957, 2876, 1711, 1659, 1458, 1443, 1422, 1375, 1348, 1238, 
1167, 1115, 1082, 1005 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.43 (1H, ddd, J = 
15.2, 10.9, 1.3 Hz, CH−C26), 5.82 (1H, dm, J = 10.9 Hz, CH−C27), 5.53 (1H, dd, J 
= 15.2, 6.1 Hz, CH−C25), 4.24−4.15 (2H, m, CH−C20, CH−C24), 3.98 (1H, ddd, J 
= 7.6, 7.4, 5.3 Hz, CH−C23), 3.03 (1H, ddd, J = 14.5, 9.0, 1.0 Hz, CH−C17), 3.01 
(1H, ddd, J = 14.2, 11.0, 2.7 Hz, CH−CA), 2.84 (1H, dqd, J = 9.0, 7.1, 1.3 Hz, 
CH−C16), 2.77 (1H, ddd, J = 14.2, 11.3, 2.8 Hz, CH−CA), 2.66 (1H, dddd, J = 14.2, 
5.4, 3.1, 0.9 Hz, CH−CA), 2.47 (1H, dddd, J = 14.2, 5.8, 3.1, 0.9 Hz, CH−CA), 2.25 
(3H, s, CH3−C14), 2.09 (1H, dd, J = 15.0, 7.4 Hz, CH−C19), 2.06−1.98 (2H, m, 
CH−C21, CH−CB), 1.97 (1H, ddd, J = 15.0, 3.3, 1.0 Hz, CH−C19), 1.90 (1H, dd, J 
= 14.5, 1.3 Hz, CH−C17), 1.88−1.78 (2H, m, CH−C22, CH−CB), 1.77 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.70 (1H, dddd, J = 12.6, 10.1, 7.9, 7.6 Hz, 
CH−C22), 1.48 (1H, app ddt, J = 12.0, 10.1, 8.4 Hz, CH−C21), 1.09 (3H, d, J = 7.1 
Hz, CH3−C34), 0.95 (9H, t, J = 7.9 Hz, CH3−TES), 0.59 (6H, q, J = 7.9 Hz, 
CH2−TES); 13C NMR (126 MHz, CDCl3) δ 212.6 (C−C15), 135.2 (C−C28), 130.1 
(CH−C25), 127.8 (CH−C26), 124.8 (CH−C27), 82.4 (CH−C23), 75.6 (CH−C24), 
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75.0 (CH−C20), 51.9 (C−C18), 45.6 (CH2−C19), 43.7 (CH−C16), 40.6 (CH2−C17), 
34.1 (CH2−C21), 30.1 (CH3−C14), 27.1 (CH2−C22), 26.9 (CH2−CA), 26.1 
(CH3−C35), 26.1 (CH2−CA), 25.1 (CH2−CB), 18.9 (CH3−C34), 18.4 (CH3−C29), 7.1 
(CH3−TES), 5.2 (CH2−TES); HRMS (ESI+) [M+Na]+ calcd for C27H48O3S2SiNa 
535.2706, found 535.2690, Δ 3.0 ppm. 
 
(R,E)-4-Iodo-2,3-dimethylbut-3-enal 363 
 
 
 
 
 
 
Note: Aldehyde 363 was prone to decomposition and was therefore used in the 
next step as soon as possible. 
 
To a solution of alcohol 377 (70 mg, 0.31 mmol) in CH2Cl2 (3 mL) at RT, were 
added NaHCO3 (0.16 g, 1.9 mmol, 6.0 equiv.) and DMP (0.20 g, 0.46 mmol, 1.5 
equiv.) sequentially. The resulting mixture was stirred at RT for 1.5 h, before the 
addition of a 1:1 mixture of a sat. aq. Na2S2O3 solution and a sat. aq. NaHCO3 
solution (6 mL). The biphasic mixture was stirred vigorously for 10 min and the 
layers were separated. The aqueous phase was extracted with Et2O (3 × 6 mL) 
and the combined organic extracts were dried over MgSO4, filtered and 
concentrated. Crude material was used directly in the next step without further 
purification. 
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(2S,5S,6R,E)-5-Hydroxy-8-iodo-2,6,7-trimethyl-1-(2-(((2R,5R)-5-((R,E)-5-
methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-yl)tetrahydrofuran-2-yl)methyl)-
1,3-dithian-2-yl)oct-7-en-3-one 385 
and 
(2S,5R,6R,E)-5-Hydroxy-8-iodo-2,6,7-trimethyl-1-(2-(((2R,5R)-5-((R,E)-5-
methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-yl)tetrahydrofuran-2-yl)methyl)-
1,3-dithian-2-yl)oct-7-en-3-one 386 
 
 
 
 
 
 
 
 
Note: Starting materials were divided into three equal batches and the resulting 
crude mixtures were combined for purification. 
 
To a solution of ketone 384 (dried by azeotropic distillation with benzene (4 ×), 46 
mg, 90 µmol) in Et2O (900 µL) at 0 °C, were added Et3N (20 µL, 0.14 mmol, 1.6 
equiv.) and Cy2BCl (29 µL, 0.14 mmol, 1.5 equiv.) sequentially. The resulting 
mixture was stirred at 0 °C for 1 h (a white precipitate formed) and cooled to −78 
°C. A solution of crude aldehyde 363 (dried by azeotropic distillation with benzene 
(4 ×)) in Et2O (450 µL) was added and the mixture was stirred at −78 °C for 1.5 h, 
before the addition of aqueous pH 7 buffer (3 mL). The biphasic mixture was 
stirred at 0 °C for 30 min and the layers were separated. The aqueous phase was 
extracted with Et2O (3 × 4 mL) and the combined organic extracts were dried over 
Na2SO4, filtered and concentrated. A diastereomeric mixture of aldol products 386 
and 385 (2.2:1 dr) was observed by 1H NMR analysis of the crude mixture 
(integration of the signal corresponding to CH−C10). Crude material was purified 
by silica gel chromatography (pet. ether/CH2Cl2/Et2O, 49:49:2) to afford in the 
order of elution, (S)-β-hydroxy ketone 385 (20 mg, 27 µmol, 10%) and (R)-β-
hydroxy ketone 386 (0.11 g, 0.15 mmol, 55%) as colourless oils.   
(S)-β-hydroxy ketone 385: Rf = 0.29 (pet. ether/CH2Cl2/Et2O, 49:49:2, eluted 
twice); νmax 3501, 2930, 2874, 1697, 1659, 1456, 1375, 1263, 1080, 1017 cm−1; 1H 
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NMR (500 MHz, CDCl3) δ 6.42 (1H, ddd, J = 15.3, 11.0, 1.4 Hz, CH−C26), 6.01 
(1H, br s, CH−C10), 5.81 (1H, dm, J = 11.0 Hz, CH−C27), 5.52 (1H, dd, J = 15.3, 
6.2 Hz, CH−C25), 4.23−4.15 (2H, m, CH−C20, CH−C24), 4.02−3.93 (2H, m, 
CH−C13, CH−C23), 3.15 (1H, d, J = 3.1 Hz, OH−C13), 3.03 (1H, dd, J = 14.4, 8.9 
Hz, CH−C17), 2.98 (1H, ddd, J = 14.0, 10.9, 2.7 Hz, CH−CA), 2.85−2.79 (1H, m, 
CH−C16), 2.76−2.69 (3H, m, CH2−C14, CH−CA), 2.66 (1H, dddd, J = 14.0, 5.4, 
2.7, 0.8 Hz, CH−CA), 2.51 (1H, app p, J = 7.1 Hz, CH−C12), 2.50−2.44 (1H, m, 
CH−CA), 2.06 (1H, dd, J = 15.0, 7.6 Hz, CH−C19), 2.03−1.96 (3H, m, CH−C19, 
CH−C21, CH−CB), 1.94 (1H, dd, J = 14.4, 1.0 Hz, CH−C17), 1.90−1.78 (2H, m, 
CH−C22, CH−CB), 1.84 (3H, d, J = 1.1 Hz, CH3−C32), 1.77 (3H, br s, CH3−C35), 
1.75 (3H, br s, CH3−C29), 1.70 (1H, app ddt, J = 12.6, 10.1, 7.8 Hz, CH−C22), 
1.47 (1H, app ddt, J = 12.0, 10.1, 8.4 Hz, CH−C21), 1.09 (3H, d, J = 7.2 Hz, 
CH3−C34), 1.03 (3H, d, J = 7.1 Hz, CH3−C33), 0.94 (9H, t, J = 7.9 Hz, CH3−TES), 
0.59 (6H, q, J = 7.9 Hz, CH2−TES); 13C NMR (126 MHz, CDCl3) δ 215.5 (C−C15), 
149.8 (C−C11), 135.3 (C−C28), 130.0 (CH−C25), 127.8 (CH−C26), 124.8 
(CH−C27), 82.5 (CH−C23), 76.9 (CH−C10), 75.6 (CH−C24), 74.9 (CH−C20), 69.8 
(CH−C13), 51.9 (C−C18), 48.4 (CH−C12), 46.0 (CH2−C14), 45.5 (CH2−C19), 44.0 
(CH−C16), 40.4 (CH2−C17), 34.0 (CH2−C21), 27.0 (CH2−C22), 26.8 (CH2−CA), 
26.2 (CH3−C35), 26.1 (CH2−CA), 25.0 (CH2−CB), 21.4 (CH3−C32), 19.0 
(CH3−C34), 18.4 (CH3−C29), 15.6 (CH3−C33), 7.1 (CH3−TES), 5.2 (CH2−TES); 
HRMS (ESI+) [M+Na]+ calcd for C33H57IO4S2SiNa 759.2404, found 759.2369, Δ 
4.7 ppm. 
(R)-β-hydroxy ketone 386: Rf = 0.24 (pet. ether/CH2Cl2/Et2O, 49:49:2, eluted 
twice); [α]D30 +24.5 (c = 2.00, CHCl3); νmax 3499, 2928, 2874, 1703, 1659, 1454, 
1377, 1261, 1080, 1017 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.42 (1H, ddd, J = 
15.3, 11.0, 1.4 Hz, CH−C26), 6.03 (1H, br s, CH−C10), 5.81 (1H, dm, J = 11.0 Hz, 
CH−C27), 5.52 (1H, dd, J = 15.3, 6.1 Hz, CH−C25), 4.22−4.16 (2H, m, CH−C20, 
CH−C24), 4.01−3.96 (1H, m, CH−C23), 3.90−3.83 (1H, m, CH−C13), 3.37 (1H, d, 
J = 3.4 Hz, OH−C13), 3.04−2.95 (2H, m, CH−C17, CH−CA), 2.86 (1H, dd, J = 
18.1, 2.2 Hz, CH−C14), 2.83−2.77 (1H, m, CH−C16), 2.75−2.63 (2H, m, 2 × 
CH−CA), 2.49 (1H, dd, J = 18.1, 9.0 Hz, CH−C14), 2.49−2.42 (2H, m, CH−C12, 
CH−CA), 2.05 (1H, dd, J = 15.1, 7.5 Hz, CH−C19), 2.05−1.97 (3H, m, CH−C19, 
CH−C21, CH−CB), 1.95 (1H, dd, J = 14.6, 1.2 Hz, CH−C17), 1.90−1.78 (2H, m, 
CH−C22, CH−CB), 1.77 (3H, br s, CH3−C35), 1.75 (3H, br s, CH3−C29), 1.75 (3H, 
br s, CH3−C32), 1.70 (1H, app ddt, J = 12.7, 10.2, 7.8 Hz, CH−C22), 1.48 (1H, app 
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ddt, J = 12.0, 10.2, 8.6 Hz, CH−C21), 1.13 (3H, d, J = 6.8 Hz, CH3−C33), 1.06 
(3H, d, J = 7.1 Hz, CH3−C34), 0.95 (9H, t, J = 8.0 Hz, CH3−TES), 0.59 (6H, q, J = 
8.0 Hz, CH2−TES); 13C NMR (126 MHz, CDCl3) δ 216.2 (C−C15), 149.9 (C−C11), 
135.3 (C−C28), 130.0 (CH−C25), 127.8 (CH−C26), 124.8 (CH−C27), 82.5 
(CH−C23), 76.9 (CH−C10), 75.6 (CH−C24), 74.9 (CH−C20), 70.1 (CH−C13), 51.8 
(C−C18), 49.0 (CH−C12), 47.3 (CH2−C14), 45.6 (CH2−C19), 43.6 (CH−C16), 41.1 
(CH2−C17), 34.0 (CH2−C21), 27.0 (CH2−C22), 27.0 (CH2−CA), 26.2 (CH3−C35), 
26.1 (CH2−CA), 25.0 (CH2−CB), 21.5 (CH3−C32), 18.9 (CH3−C34), 18.4 
(CH3−C29), 15.5 (CH3−C33), 7.1 (CH3−TES), 5.2 (CH2−TES); HRMS (ESI+) 
[M+Na]+ calcd for C33H57IO4S2SiNa 759.2404, found 759.2383, Δ 2.8 ppm. 
 
Mosher Ester Analysis of (2S,5R,6R,E)-5-Hydroxy-8-iodo-2,6,7-trimethyl-1-(2-
(((2R,5R)-5-((R,E)-5-methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)oct-7-en-3-one 386 
 
 
 
 
 
 
 
 
To a solution of (R)-β-hydroxy ketone 386 (7 mg, 9 µmol) in CH2Cl2 (0.5 mL) at 
RT, were added (S)-α-methoxy-α-(trifluoromethyl)phenylacetic acid (7 mg, 0.03 
mmol, 3.0 equiv.), DCC (6 mg, 0.03 mmol, 3.0 equiv.) and DMAP (4 mg, 0.03 
mmol, 3.0 equiv.) sequentially. The resulting mixture was stirred at RT for 24 h, 
filtered through a cotton plug and concentrated. Crude material was purified by 
silica gel chromatography (hexane/EtOAc, 95:5) to afford (S)-Mosher ester 390 (5 
mg, 5 µmol, 50%) as a colourless oil. Rf = 0.47 (hexane/EtOAc, 90:10); [α]D21 −6.1 
(c = 0.23, CHCl3); νmax 2959, 2926, 1749, 1711, 1661, 1452, 1260, 1169, 1080, 
1017 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.54−7.45 (2H, m, CH−Ar MTPA), 
7.45−7.38 (3H, m, CH−Ar MTPA), 6.42 (1H, ddd, J = 15.2, 11.0, 1.4 Hz, CH−C26), 
5.94 (1H, br s, CH−C10), 5.81 (1H, dm, J = 11.0 Hz, CH−C27), 5.64 (1H, ddd, J = 
7.5, 5.9, 4.1 Hz, CH−C13), 5.51 (1H, dd, J = 15.2, 6.2 Hz, CH−C25), 4.21−4.14 
(2H, m, CH−C20, CH−C24), 3.98 (1H, app td, J = 7.3, 5.0 Hz, CH−C23), 3.50 (3H, 
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s, CH3−OMe MTPA), 3.08 (1H, dd, J = 18.7, 4.1 Hz, CH−C14), 3.06−2.93 (2H, m, 
CH−C17, CH−CA), 2.84 (1H, dd, J = 18.7, 7.5 Hz, CH−C14), 2.77−2.63 (3H, m, 
CH−C16, 2 × CH−CA), 2.63−2.57 (1H, m, CH−C12), 2.44−2.37 (1H, m, CH−CA), 
2.05 (1H, dd, J = 14.8, 7.4 Hz, CH−C19), 2.05−1.96 (3H, m, CH−C19, CH−C21, 
CH−CB), 1.94 (1H, dd, J = 14.4, 0.9 Hz, CH−C17), 1.90−1.74 (2H, m, CH−C22, 
CH−CB), 1.78 (3H, d, J = 0.7 Hz, CH3−C32), 1.77 (3H, br s, CH3−C35), 1.75 (3H, 
br s, CH3−C29), 1.73−1.65 (1H, m, CH−C22), 1.52−1.43 (1H, m, CH−C21), 1.00 
(3H, d, J = 7.1 Hz, CH3−C34), 0.99 (3H, d, J = 7.0 Hz, CH3−C33), 0.94 (9H, t, J = 
7.9 Hz, CH3−TES), 0.59 (6H, q, J = 7.9 Hz, CH2−TES); HRMS (ESI+) [M+Na]+ 
calcd for C43H64F3IO6S2SiNa 975.2803, found 975.2792, Δ 1.1 ppm. 
 
The same procedure was followed for the preparation of (R)-Mosher ester 391. Rf 
= 0.42 (hexane/EtOAc, 90:10); [α]D17 +19 (c = 0.40, CHCl3); νmax 2953, 2930, 
1751, 1715, 1663, 1452, 1377, 1260, 1169, 1082, 1017 cm−1; 1H NMR (500 MHz, 
CDCl3) δ 7.53−7.46 (2H, m, CH−Ar MTPA), 7.45−7.38 (3H, m, CH−Ar MTPA), 
6.42 (1H, ddd, J = 15.3, 11.0, 1.4 Hz, CH−C26), 6.02 (1H, br s, CH−C10), 5.81 
(1H, dm, J = 11.0 Hz, CH−C27), 5.65 (1H, app dt, J = 6.7, 5.2 Hz, CH−C13), 5.51 
(1H, dd, J = 15.3, 6.1 Hz, CH−C25), 4.21−4.14 (2H, m, CH−C20, CH−C24), 3.97 
(1H, app td, J = 7.3, 5.3 Hz, CH−C23), 3.48 (3H, s, CH3−OMe MTPA), 3.04 (1H, 
dd, J = 18.7, 5.2 Hz, CH−C14), 3.05−2.96 (2H, m, CH−C17, CH−CA), 2.85 (1H, 
dd, J = 18.7, 6.7 Hz, CH−C14), 2.74−2.61 (4H, m, CH−C12, CH−C16, 2 × 
CH−CA), 2.41−2.34 (1H, m, CH−CA), 2.04 (1H, dd, J = 15.1, 7.6 Hz, CH−C19), 
2.04−1.94 (3H, m, CH−C19, CH−C21, CH−CB), 1.91 (1H, dd, J = 14.4, 0.6 Hz, 
CH−C17), 1.87 (3H, d, J = 1.0 Hz, CH3−C32), 1.94−1.78 (2H, m, CH−C22, 
CH−CB), 1.77 (3H, br s, CH3−C35), 1.75 (3H, br s, CH3−C29), 1.74−1.67 (1H, m, 
CH−C22), 1.52−1.42 (1H, m, CH−C21), 1.05 (3H, d, J = 7.0 Hz, CH3−C34), 0.96 
(3H, d, J = 7.0 Hz, CH3−C33), 0.95 (9H, t, J = 8.0 Hz, CH3−TES), 0.59 (6H, q, J = 
8.0 Hz, CH2−TES); HRMS (ESI+) [M+Na]+ calcd for C43H64F3IO6S2SiNa 975.2803, 
found 975.2790, Δ 1.3 ppm. 
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Both products were analysed according to Hoye and co-workers:94 
 
Table S1. Mosher Ester Analysis for the Assignment of the C13 Stereocentre 
 
 
 
 
 
 
 
 
Assignment 386 (δ), 
ppm 
δ (S-ester), 
ppm 
δ (R-ester), 
ppm 
Δ (δ-(S−R)), 
ppm 
10 6.03 5.940 6.017 −0.077 
14 2.86 3.083 3.036 +0.047 
 2.49 2.844 2.854 −0.010 
17 1.95 1.945 1.912 +0.033 
19 2.05 2.047 2.038 +0.009 
23 3.98 3.977 3.970 +0.007 
32 1.75 1.778 1.873 −0.095 
33 1.13 0.990 1.048 −0.058 
34 1.06 0.998 0.956 +0.042 
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(2S,5S,6R,E)-5-((tert-Butyldimethylsilyl)oxy)-8-iodo-2,6,7-trimethyl-1-(2-
(((2R,5R)-5-((R,E)-5-methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)oct-7-en-3-one 360 
 
 
 
 
 
 
 
 
To a solution of β-hydroxy ketone 385 (20 mg, 27 µmol) in CH2Cl2 (1.6 mL) at −78 
°C, were added 2,6-lutidine (25 µL, 0.11 mmol, 8.0 equiv.) and TBSOTf (25 µL, 54 
µmol, 4.0 equiv.) sequentially. The resulting solution was stirred at −78 °C for 5 h, 
before the addition of water (2 mL) and the biphasic mixture was allowed to warm 
to RT. The layers were separated and the aqueous phase was extracted with Et2O 
(3 × 2 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated. Crude material was purified by silica gel chromatography 
(hexane/EtOAc, 95:5) to deliver TBS ether 360 (22 mg, 26 µmol, 95%) as a 
colourless oil. Rf = 0.34 (pet. ether/EtOAc, 95:5); [α]D28 +23.8 (c = 0.650, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.43 (1H, ddd, J = 15.2, 11.0, 1.4 Hz, CH−C26), 5.83 
(1H, br s, CH−C10), 5.82 (1H, dm, J = 11.0 Hz, CH−C27), 5.52 (1H, dd, J = 15.2, 
6.1 Hz, CH−C25), 4.22−4.15 (2H, m, CH−C20, CH−C24), 4.07 (1H, app dt, J = 
9.1, 3.3 Hz, CH−C13), 3.98 (1H, app td, J = 7.6, 5.3 Hz, CH−C23), 3.04−2.93 (2H, 
m, CH−C17, CH−CA), 2.86 (1H, dd, J = 18.9, 3.3 Hz, CH−C14), 2.78 (1H, dd, J = 
18.9, 9.1 Hz, CH−C14), 2.76−2.69 (3H, m, CH−C12, CH−C16, CH−CA), 2.66 (1H, 
dddd, J = 14.3, 5.7, 2.9, 0.9 Hz, CH−CA), 2.49−2.41 (1H, m, CH−CA), 2.06 (1H, dd, 
J = 15.0, 7.4 Hz, CH−C19), 2.07−1.95 (2H, m, CH−C21, CH−CB), 1.97 (1H, dd, J = 
15.0, 3.2 Hz, CH−C19), 1.88 (1H, dd, J = 14.6, 1.0 Hz, CH−C17), 1.90−1.78 (2H, 
m, CH−C22, CH−CB), 1.82 (3H, d, J = 1.1 Hz, CH3−C32), 1.77 (3H, br s, 
CH3−C35), 1.75 (3H, br s, CH3−C29), 1.70 (1H, app ddt, J = 12.6, 10.1, 7.6 Hz, 
CH−C22), 1.47 (1H, app ddt, J = 11.8, 10.1, 8.4 Hz, CH−C21), 1.07 (3H, d, J = 7.1 
Hz, CH3−C33), 1.02 (3H, d, J = 7.1 Hz, CH3−C34), 0.95 (9H, t, J = 7.9 Hz, 
CH3−TES), 0.88 (9H, s, CH3−t-Bu TBS), 0.59 (6H, q, J = 7.9 Hz, CH2−TES), 0.03 
(3H, s, CH3−TBS), 0.01 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 212.4 
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(C−C15), 150.1 (C−C11), 135.2 (C−C28), 130.0 (CH−C25), 127.8 (CH−C26), 
124.8 (CH−C27), 82.4 (CH−C23), 77.6 (CH−C10), 75.5 (CH−C24), 75.0 
(CH−C20), 70.2 (CH−C13), 51.9 (C−C18), 48.5 (CH2−C14), 47.4 (CH−C12), 45.6 
(CH2−C19), 43.2 (CH−C16), 40.4 (CH2−C17), 34.1 (CH2−C21), 27.1 (CH2−C22), 
27.0 (CH2−CA), 26.2 (CH3−C35), 26.1 (CH2−CA), 26.0 (CH3−t-Bu TBS), 25.1 
(CH2−CB), 22.4 (CH3−C32), 19.2 (CH3−C34), 18.5 (CH3−C29), 18.1 (C−t-Bu TBS), 
16.2 (CH3−C33), 7.1 (CH3−TES), 5.2 (CH2−TES), −4.4 (CH3−TBS), −4.8 
(CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C39H71IO4S2Si2Na 873.3269, found 
873.3227, Δ 4.8 ppm. 
 
(2S,5R,6R,E)-5-((tert-Butyldimethylsilyl)oxy)-8-iodo-2,6,7-trimethyl-1-(2-
(((2R,5R)-5-((R,E)-5-methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)methyl)-1,3-dithian-2-yl)oct-7-en-3-one 393 
 
 
 
 
 
 
 
 
To a solution of β-hydroxy ketone 386 (43 mg, 58 µmol) in CH2Cl2 (2.7 mL) at −78 
°C, were added 2,6-lutidine (40 µL, 0.35 mmol, 6.0 equiv.) and TBSOTf (40 µL, 
0.18 mmol, 3.0 equiv.) sequentially. The resulting solution was stirred at −78 °C for 
5 h, before the addition of water (3 mL) and the biphasic mixture was allowed to 
warm to RT. The layers were separated and the aqueous phase was extracted 
with Et2O (3 × 3 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (hexane/EtOAc, 95:5) to deliver TBS ether 393 (46 mg, 54 µmol, 
93%) as a colourless oil. Rf = 0.36 (hexane/EtOAc, 95:5); [α]D23 +27.6 (c = 0.600, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.42 (1H, ddd, J = 15.3, 11.0, 1.4 Hz, 
CH−C26), 5.93−5.89 (1H, m, CH−C10), 5.81 (1H, dm, J = 11.0 Hz, CH−C27), 5.52 
(1H, dd, J = 15.3, 6.1 Hz, CH−C25), 4.22 (1H, app dt, J = 6.3, 4.8 Hz, CH−C13), 
4.22−4.15 (2H, m, CH−C20, CH−C24), 3.98 (1H, app td, J = 7.6, 5.3 Hz, 
CH−C23), 3.08−2.98 (2H, m, CH−C17, CH−CA), 2.97 (1H, dd, J = 18.8, 6.3 Hz, 
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CH−C14), 2.76−2.64 (3H, m, CH−C16, 2 × CH−CA), 2.65 (1H, dd, J = 18.8, 4.8 
Hz, CH−C14), 2.49−2.36 (2H, m, CH−C12, CH−CA), 2.07 (1H, dd, J = 14.9, 7.3 
Hz, CH−C19), 2.04−1.97 (2H, m, CH−C21, CH−CB), 1.96 (1H, dd, J = 14.9, 3.2 
Hz, CH−C19), 1.90 (1H, dd, J = 14.3, 1.0 Hz, CH−C17), 1.90−1.78 (2H, m, 
CH−C22, CH−CB), 1.84 (3H, d, J = 1.1 Hz, CH3−C32), 1.77 (3H, br s, CH3−C35), 
1.75 (3H, br s, CH3−C29), 1.70 (1H, app ddt, J = 12.8, 10.2, 7.6 Hz, CH−C22), 
1.48 (1H, app ddt, J = 11.9, 10.2, 8.5 Hz, CH−C21), 1.06 (3H, d, J = 7.2 Hz, 
CH3−C34), 1.00 (3H, d, J = 7.0 Hz, CH3−C33), 0.95 (9H, t, J = 7.9 Hz, CH3−TES), 
0.85 (9H, s, CH3−t-Bu TBS), 0.59 (6H, q, J = 7.9 Hz, CH2−TES), 0.02 (3H, s, 
CH3−TBS), −0.03 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 212.1 
(C−C15), 150.3 (C−C11), 135.2 (C−C28), 130.0 (CH−C25), 127.8 (CH−C26), 
124.8 (CH−C27), 82.4 (CH−C23), 77.5 (CH−C10), 75.6 (CH−C24), 74.9 
(CH−C20), 68.5 (CH−C13), 51.9 (C−C18), 48.7 (CH2−C14), 47.6 (CH−C12), 45.6 
(CH2−C19), 43.3 (CH−C16), 40.4 (CH2−C17), 34.0 (CH2−C21), 27.0 (CH2−C22), 
27.0 (CH2−CA), 26.2 (CH3−C35), 26.1 (CH3−t-Bu TBS), 26.1 (CH2−CA), 25.1 
(CH2−CB), 24.0 (CH3−C32), 18.9 (CH3−C34), 18.4 (CH3−C29), 18.2 (C−t-Bu TBS), 
13.3 (CH3−C33), 7.1 (CH3−TES), 5.2 (CH2−TES), −4.3 (CH3−TBS), −4.6 
(CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C39H71IO4S2Si2Na 873.3269, found 
873.3230, Δ 4.5 ppm. 
 
2-((2S,3R,5R)-3-Methyl-5-((5S,6S)-2,2,3,3,8,8,9,9-octamethyl-6-(1-
(tributylstannyl)vinyl)-4,7-dioxa-3,8-disiladecan-5-yl)tetrahydrofuran-2-
yl)ethanol 394 
 
 
 
 
 
 
 
To a solution of pivalate 28073 (23 mg, 28 µmol) in Et2O (2.3 mL) at −78 °C, was 
added i-Bu2AlH (1.0 M in hexanes, 0.11 mL, 0.11 mmol, 4.0 equiv.) dropwise. The 
resulting solution was stirred at −78 °C for 30 min. The reaction was quenched by 
the dropwise addition of a sat. aq. potassium sodium tartrate solution (3 mL) and 
the biphasic mixture was stirred vigorously at RT for 30 min. The layers were 
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separated and the aqueous phase was extracted with Et2O (3 × 3 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated. 
Crude material was purified by silica gel chromatography (CH2Cl2/EtOAc, 99:1) to 
give alcohol 394 (20 mg, 27 µmol, 97%) as a colourless oil. Rf = 0.36 
(hexane/EtOAc, 90:10); [α]D21 −16.4 (c = 0.950, CHCl3); νmax 3393, 2955, 2928, 
2857, 1464, 1252, 1088, 1071, 1005 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.96 (1H, 
dd, J = 2.9, 1.9 Hz, 3JSnH = 132.3 Hz, CH−C31), 5.25 (1H, dd, J = 2.9, 1.9 Hz, 3JSnH 
= 64.0 Hz, CH−C31), 4.33 (1H, app q, J = 1.9 Hz, 3JSnH = 29.7 Hz, CH−C8), 4.16 
(1H, app q, J = 7.3 Hz, CH−C6), 3.96 (1H, ddd, J = 10.5, 5.3, 3.0 Hz, CH−C3), 
3.82−3.72 (2H, m, CH2−C1), 3.54 (1H, dd, J = 7.3, 1.9 Hz, CH−C7), 2.65 (1H, dd, 
J = 7.8, 3.3 Hz, OH−C1), 2.21−2.11 (1H, m, CH−C4), 1.82 (1H, ddd, J = 12.7, 8.1, 
7.3 Hz, CH−C5), 1.70 (1H, dddd, J = 13.7, 10.5, 8.3, 5.1 Hz, CH−C2), 1.58−1.40 
(8H, m, CH−C2, CH−C5, 3 × CH2−n-Bu3Sn), 1.32 (6H, h, J = 7.2 Hz, 3 × CH2−n-
Bu3Sn), 0.91 (9H, s, CH3−t-Bu TBS), 0.90 (9H, s, CH3−t-Bu TBS), 0.96−0.86 (18H, 
m, CH3−C30, 3 × CH2−n-Bu3Sn, 3 × CH3−n-Bu3Sn), 0.11 (3H, s, CH3−TBS), 0.09 
(3H, s, CH3−TBS), 0.08 (3H, s, CH3−TBS), 0.00 (3H, s, CH3−TBS); 13C NMR (126 
MHz, CDCl3) δ 153.9 (C−C9), 125.9 (CH2−C31), 82.7 (CH−C8), 80.8 (CH−C3), 
78.9 (CH−C6), 78.7 (CH−C7), 62.4 (CH2−C1), 37.2 (CH2−C5), 36.7 (CH−C4), 33.0 
(CH2−C2), 29.3 (1J119SnC = 19 Hz, 1J117SnC = 19 Hz, CH2−n-Bu3Sn), 27.6 (1J119SnC = 
61 Hz, 1J117SnC = 59 Hz, CH2−n-Bu3Sn), 26.4 (CH3−t-Bu TBS), 26.3 (CH3−t-Bu 
TBS), 18.6 (C−t-Bu TBS), 18.6 (C−t-Bu TBS), 14.2 (CH3−C30), 13.9 (CH3−n-
Bu3Sn), 10.3 (1J119SnC = 336 Hz, 1J117SnC = 321 Hz, CH2−n-Bu3Sn), −3.6 
(CH3−TBS), −3.9 (CH3−TBS), −4.1 (CH3−TBS), −4.3 (CH3−TBS); HRMS (ESI+) 
[M+Na]+ calcd for C35H74O4Si2SnNa 757.4040, found 757.4018, Δ 2.8 ppm. 
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2-((2S,3R,5R)-3-Methyl-5-((5S,6S)-2,2,3,3,8,8,9,9-octamethyl-6-(1-
(tributylstannyl)vinyl)-4,7-dioxa-3,8-disiladecan-5-yl)tetrahydrofuran-2-
yl)acetaldehyde 395 
 
 
 
 
 
 
 
To a solution of alcohol 394 (19 mg, 26 µmol) in CH2Cl2 (1.7 mL) at RT, was 
added DMP (22 mg, 52 µmol, 2.0 equiv.). The resulting solution was stirred at RT 
for 2 h. More DMP (22 mg, 52 µmol, 2.0 equiv.) was added and the reaction 
mixture was stirred for another 2 h. The reaction was quenched by the addition of 
a 1:1 mixture of a sat. aq. Na2S2O3 solution and a sat. aq. NaHCO3 solution (3 
mL). The biphasic mixture was stirred vigorously until layers became clear (20 
min). The layers were separated and the aqueous phase was extracted with 
CH2Cl2 (3 × 3 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated. Crude material was purified by silica gel 
chromatography (hexane/EtOAc, 95:5) to deliver aldehyde 395 (19 mg, 26 µmol, 
quant.) as a colourless oil. Rf = 0.45 (hexane/EtOAc, 95:5); 1H NMR (500 MHz, 
CDCl3) δ 9.74 (1H, dd, J = 2.5, 2.0 Hz, CH−C1), 5.88 (1H, dd, J = 2.8, 2.0 Hz, 
3JSnH = 131.7 Hz, CH−C31), 5.17 (1H, dd, J = 2.8, 2.0 Hz, 3JSnH = 63.7 Hz, 
CH−C31), 4.26 (1H, app q, J = 2.0 Hz, 3JSnH = 29.0 Hz, CH−C8), 4.18 (1H, app dt, 
J = 8.8, 4.9 Hz, CH−C3), 4.06 (1H, ddd, J = 9.1, 7.3, 6.6 Hz, CH−C6), 3.48 (1H, 
dd, J = 7.3, 2.0 Hz, CH−C7), 2.52 (1H, ddd, J = 16.1, 8.8, 2.5 Hz, CH−C2), 2.34 
(1H, ddd, J = 16.1, 4.9, 2.0 Hz, CH−C2), 2.24−2.16 (1H, m, CH−C4), 1.72 (1H, 
ddd, J = 12.9, 9.1, 6.9 Hz, CH−C5), 1.50 (1H, ddd, J = 12.9, 6.6, 2.4 Hz, CH−C5), 
1.46−1.35 (6H, m, 3 × CH2−n-Bu3Sn), 1.25 (6H, h, J = 7.3 Hz, 3 × CH2−n-Bu3Sn), 
0.89−0.77 (36H, m, CH3−C30, 2 × CH3−t-Bu TBS, 3 × CH2−n-Bu3Sn, 3 × CH3−n-
Bu3Sn), 0.01 (3H, s, CH3−TBS), 0.00 (3H, s, CH3−TBS), −0.01 (3H, s, CH3−TBS), 
−0.07 (3H, s, CH3−TBS). 
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2-((2S,3R,5R)-3-Methyl-5-((5S,6S)-2,2,3,3,8,8,9,9-octamethyl-6-(1-
(tributylstannyl)vinyl)-4,7-dioxa-3,8-disiladecan-5-yl)tetrahydrofuran-2-
yl)acetic acid 396 
 
 
 
 
 
 
 
To a vigorously stirred solution of aldehyde 395 (19 mg, 26 µmol) in a 2:1 mixture 
of t-BuOH and water (3.7 mL) at 0 °C, were added 2-methyl-2-butene (0.14 mL, 
1.3 mmol, 50 equiv.), NaH2PO4•2H2O (40 mg, 0.26 mmol, 10 equiv.) and NaClO2 
(12 mg, 0.13 mmol, 5.0 equiv.) sequentially. The resulting mixture was stirred at 0 
°C for 15 min and at RT for 1 h. The reaction mixture was diluted with CH2Cl2 (4 
mL) and water (4 mL) was added. The layers were separated and the aqueous 
phase was extracted with CH2Cl2 (3 × 4 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated. Crude material was purified by silica 
gel chromatography (hexane/EtOAc, 90:10) to give acid 396 (17 mg, 23 µmol, 
88%) as a colourless oil. Rf = 0.21 (hexane/EtOAc, 90:10); [α]D19 −18.4 (c = 0.800, 
CHCl3); νmax 2957, 2926, 2855, 1713, 1464, 1256, 1084, 1022 cm−1; 1H NMR (500 
MHz, CDCl3) δ 10.62 (1H, br s, OH−C1), 5.96 (1H, dd, J = 2.5, 1.5 Hz, 3JSnH = 
131.6 Hz, CH−C31), 5.26 (1H, dd, J = 2.5, 1.5 Hz, 3JSnH = 63.7 Hz, CH−C31), 
4.35−4.33 (1H, m, 3JSnH = 28.6 Hz, CH−C8), 4.24−4.14 (2H, m, CH−C3, CH−C6), 
3.55 (1H, dd, J = 7.1, 2.2 Hz, CH−C7), 2.52 (1H, dd, J = 15.9, 8.1 Hz, CH−C2), 
2.45 (1H, dd, J = 15.9, 5.4 Hz, CH−C2), 2.34−2.25 (1H, m, CH−C4), 1.87−1.80 
(1H, m, CH−C5), 1.57 (1H, ddd, J = 13.0, 6.8, 3.2 Hz, CH−C5), 1.53−1.42 (6H, m, 
3 × CH2−n-Bu3Sn), 1.32 (6H, h, J = 7.2 Hz, 3 × CH2−n-Bu3Sn), 0.96−0.87 (36H, m, 
2 × CH3−t-Bu TBS, CH3−C30, 3 × CH2−n-Bu3Sn, 3 × CH3−n-Bu3Sn), 0.08 (3H, s, 
CH3−TBS), 0.08 (3H, s, CH3−TBS), 0.07 (3H, s, CH3−TBS), 0.00 (3H, s, 
CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 174.7 (C−C1), 153.9 (C−C9), 126.0 
(CH2−C31), 82.6 (1J119SnC = 57 Hz, 1J117SnC = 56 Hz, CH−C8), 79.1 (CH−C6), 78.5 
(CH−C7), 76.6 (CH−C3), 37.3 (CH2−C5), 36.2 (CH−C4, CH2−C2), 29.3 (1J119SnC = 
19 Hz, 1J117SnC = 19 Hz, CH2−n-Bu3Sn), 27.6 (1J119SnC = 61 Hz, 1J117SnC = 59 Hz, 
CH2−n-Bu3Sn), 26.5 (CH3−t-Bu TBS), 26.3 (CH3−t-Bu TBS), 18.7 (C−t-Bu TBS), 
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18.6 (C−t-Bu TBS), 14.0 (CH3−C30), 13.8 (CH3−n-Bu3Sn), 10.3 (1J119SnC = 336 Hz, 
1J117SnC = 321 Hz, CH2−n-Bu3Sn), −3.7 (CH3−TBS), −3.9 (CH3−TBS), −4.2 
(CH3−TBS), −4.3 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C35H72O5Si2SnNa 
771.3832, found 771.3808, Δ 3.1 ppm. 
 
(4S,7R,8R,E)-7-((tert-Butyldimethylsilyl)oxy)-10-iodo-4,8,9-trimethyl-1-
((2R,5R)-5-((R,E)-5-methyl-1-((triethylsilyl)oxy)hexa-2,4-dien-1-
yl)tetrahydrofuran-2-yl)dec-9-ene-2,5-dione 399 
 
 
 
 
 
 
 
 
To a solution of dithiane 393 (6 mg, 7 µmol) in a 10:4:1 mixture of MeCN, THF and 
water (400 µL) at 0 °C, were added 2,6-di-tert-butyl-4-methylpyridine (8 mg, 0.04 
mmol, 6.0 equiv.) and PhI(OCOCF3)2 (8 mg, 0.02 mmol, 3.0 equiv.) sequentially. 
The resulting solution was stirred at 0 °C for 45 min, before the addition of a sat. 
aq. NaHCO3 solution (600 µL) and Et2O (600 µL). The layers were separated and 
the aqueous phase was extracted with Et2O (3 × 1 mL). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated. A 1:1.5 ratio of 1,4-
diketones 400 and 399 was observed by 1H NMR analysis of the crude mixture 
(integration of the signals corresponding to CH−C25 and CH−C26). Crude material 
was purified by silica gel chromatography (hexane/EtOAc, 90:10) to afford 1,4-
diketone 399 (2 mg, 3 µmol, 41%) as a colourless oil. Rf = 0.38 (hexane/EtOAc, 
90:10); [α]D24 +24 (c = 0.29, CHCl3); νmax 2959, 2926, 1713, 1661, 1460, 1377, 
1260, 1084, 1017 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.44 (1H, ddd, J = 15.2, 
11.0, 1.1 Hz, CH−C26), 5.97−5.92 (1H, m, CH−C10), 5.82 (1H, dm, J = 11.0 Hz, 
CH−C27), 5.52 (1H, dd, J = 15.2, 5.9 Hz, CH−C25), 4.28 (1H, app dq, J = 8.3, 6.4 
Hz, CH−C20), 4.22 (1H, ddd, J = 5.9, 5.5, 4.5 Hz, CH−C13), 4.16 (1H, app td, J = 
5.9, 1.1 Hz, CH−C24), 3.93 (1H, app td, J = 7.2, 5.9 Hz, CH−C23), 2.99−2.89 (2H, 
m, CH−C16, CH−C17), 2.74 (1H, dd, J = 17.9, 5.9 Hz, CH−C14), 2.68 (1H, dd, J = 
15.5, 6.4 Hz, CH−C19), 2.62 (1H, dd, J = 17.9, 5.5 Hz, CH−C14), 2.50 (1H, dd, J = 
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15.5, 6.4 Hz, CH−C19), 2.50−2.41 (2H, m, CH−C12, CH−C17), 2.09−1.98 (1H, m, 
CH−C21), 1.91−1.82 (1H, m, CH−C22), 1.83 (3H, d, J = 1.1 Hz, CH3−C32), 1.77 
(3H, br s, CH3−C35), 1.75 (3H, br s, CH3−C29), 1.79−1.68 (1H, m, CH−C22), 1.43 
(1H, app ddt, J = 12.2, 9.7, 8.3 Hz, CH−C21), 1.06 (3H, d, J = 6.9 Hz, CH3−C34), 
1.06 (3H, d, J = 7.1 Hz, CH3−C33), 0.94 (9H, t, J = 7.9 Hz, CH3−TES), 0.85 (9H, s, 
CH3−t-Bu TBS), 0.59 (6H, q, J = 7.9 Hz, CH2−TES), 0.02 (3H, s, CH3−TBS), −0.04 
(3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 211.2 (C−C15), 207.7 (C−C18), 
150.0 (C−C11), 135.4 (C−C28), 129.8 (CH−C25), 127.8 (CH−C26), 124.8 
(CH−C27), 82.4 (CH−C23), 77.8 (CH−C10), 75.5 (CH−C20 or CH−C24), 75.4 
(CH−C20 or CH−C24), 69.2 (CH−C13), 49.1 (CH2−C19), 48.4 (CH−C12), 47.5 
(CH2−C14), 46.0 (CH2−C17), 41.6 (CH−C16), 32.3 (CH2−C21), 27.3 (CH2−C22), 
26.2 (CH3−C35), 26.1 (CH3−t-Bu TBS), 23.9 (CH3−C32), 18.4 (CH3−C29), 18.2 
(C−t-Bu TBS), 16.4 (CH3−C34), 13.9 (CH3−C33), 7.0 (CH3−TES), 5.1 (CH2−TES), 
−4.3 (CH3−TBS), −4.5 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for 
C36H65IO5Si2Na 783.3307, found 783.3277, Δ 3.9 ppm. 
 
(4S,7R,8R,E)-7-((tert-Butyldimethylsilyl)oxy)-1-((2R,5R)-5-((R,E)-1-hydroxy-5-
methylhexa-2,4-dien-1-yl)tetrahydrofuran-2-yl)-10-iodo-4,8,9-trimethyldec-9-
ene-2,5-dione 400 
 
 
 
 
 
 
 
 
To a solution of dithiane 393 (6 mg, 7 µmol) in a 10:4:1 mixture of MeCN, THF and 
water (400 µL) at 0 °C, were added CaCO3 (7 mg, 0.07 mmol, 10 equiv.) and 
Hg(ClO4)4H2O (6 mg, 0.01 mmol, 2.0 equiv.) sequentially. The resulting mixture 
was stirred at 0 °C for 15 min (a white precipitate formed), before the addition of a 
sat. aq. NaHCO3 solution (600 µL) and Et2O (600 µL). The layers were separated 
and the aqueous phase was extracted with Et2O (3 × 1 mL). The combined 
organic extracts were dried over Na2SO4, filtered and concentrated. A 9:1 ratio of 
1,4-diketones 400 and 399 was observed by 1H NMR analysis of the crude mixture 
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(integration of the signals corresponding to CH−C25 and CH−C26). Crude material 
was purified by silica gel chromatography (hexane/EtOAc, 70:30) to afford 1,4-
diketone 400 (3 mg, 5 µmol, 77%) as a colourless oil. Rf = 0.36 (hexane/EtOAc, 
70:30); [α]D24 +15 (c = 0.38, CHCl3); νmax 3426, 2926, 2855, 1709, 1663, 1460, 
1377, 1258, 1082, 1026 cm−1; 1H NMR (500 MHz, CDCl3) δ 6.53 (1H, ddd, J = 
15.2, 10.9, 1.0 Hz, CH−C26), 5.95 (1H, m, CH−C10), 5.82 (1H, dm, J = 10.9 Hz, 
CH−C27), 5.45 (1H, dd, J = 15.2, 6.9 Hz, CH−C25), 4.28 (1H, app ddt, J = 8.5, 
7.1, 5.8 Hz, CH−C20), 4.21 (1H, ddd, J = 5.9, 5.4, 4.9 Hz, CH−C13), 3.95 (1H, 
ddd, J = 7.2, 6.9, 1.0 Hz, CH−C24), 3.87 (1H, app q, J = 7.2 Hz, CH−C23), 3.04 
(1H, dd, J = 17.8, 9.0 Hz, CH−C17), 3.00−2.92 (1H, m, CH−C16), 2.75 (1H, dd, J 
= 17.9, 5.9 Hz, CH−C14), 2.74 (1H, dd, J = 15.1, 7.1 Hz, CH−C19), 2.72−2.69 
(1H, m, OH−C24), 2.63 (1H, dd, J = 17.9, 5.4 Hz, CH−C14), 2.50 (1H, dd, J = 
15.1, 5.8 Hz, CH−C19), 2.46 (1H, qd, J = 7.1, 4.9 Hz, CH−C12), 2.39 (1H, dd, J = 
17.8, 4.2 Hz, CH−C17), 2.13 (1H, dddd, J = 12.0, 8.3, 5.8, 3.2 Hz, CH−C21), 1.95 
(1H, dddd, J = 12.5, 8.5, 7.2, 3.2 Hz, CH−C22), 1.83 (3H, d, J = 0.9 Hz, 
CH3−C32), 1.78 (3H, br s, CH3−C35), 1.76 (3H, br s, CH3−C29), 1.66 (1H, dddd, J 
= 12.5, 9.8, 8.3, 7.2 Hz, CH−C22), 1.53 (1H, app ddt, J = 12.0, 9.8, 8.5 Hz, 
CH−C21), 1.07 (3H, d, J = 7.0 Hz, CH3−C34), 1.06 (3H, d, J = 7.1 Hz, CH3−C33), 
0.85 (9H, s, CH3−t-Bu TBS), 0.03 (3H, s, CH3−TBS), −0.04 (3H, s, CH3−TBS); 13C 
NMR (126 MHz, CDCl3) δ 211.1 (C−C15), 207.7 (C−C18), 150.0 (C−C11), 136.7 
(C−C28), 129.5 (CH−C26), 128.1 (CH−C25), 124.6 (CH−C27), 82.4 (CH−C23), 
77.8 (CH−C10), 75.7 (CH−C24), 75.4 (CH−C20), 69.3 (CH−C13), 48.6 
(CH2−C19), 48.4 (CH−C12), 47.6 (CH2−C14), 46.5 (CH2−C17), 41.6 (CH−C16), 
32.5 (CH2−C21), 28.1 (CH2−C22), 26.2 (CH3−C35), 26.1 (CH3−t-Bu TBS), 23.8 
(CH3−C32), 18.5 (CH3−C29), 18.2 (C−t-Bu TBS), 16.4 (CH3−C34), 14.0 
(CH3−C33), −4.3 (CH3−TBS), −4.5 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for 
C30H51IO5SiNa 669.2443, found 669.2412, Δ 4.5 ppm. 
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(R,E)-1-((2R,5R)-5-((4S,7R,8R,E)-7-((tert-Butyldimethylsilyl)oxy)-10-iodo-4,8,9-
trimethyl-2,5-dioxodec-9-en-1-yl)tetrahydrofuran-2-yl)-5-methylhexa-2,4-dien-
1-yl 2-((2S,3R,5R)-3-methyl-5-((5S,6S)-2,2,3,3,8,8,9,9-octamethyl-6-(1-
(tributylstannyl)vinyl)-4,7-dioxa-3,8-disiladecan-5-yl)tetrahydrofuran-2-
yl)acetate 402 
 
 
 
 
 
 
 
 
 
 
To a solution of acid 396 (dried by azeotropic distillation with benzene (2 ×), 9.4 
mg, 13 µmol, 1.1 equiv.) in toluene (220 µL) at RT, were added Et3N (15 µL, 0.11 
mmol, 9.6 equiv.) in toluene (100 µL) and 2,4,6-trichlorobenzoyl chloride (4 µL, 
0.03 mmol, 2.3 equiv.) in toluene (100 µL) sequentially. The resulting mixture was 
stirred at RT for 1 h. To a separate vial containing alcohol 400 (dried by azeotropic 
distillation with benzene (2 ×), 7.5 mg, 12 µmol) was added DMAP (5 mg, 0.04 
mmol, 3.7 equiv.) in toluene (100 µL). The resulting solution was added to the vial 
containing the Yamaguchi anhydride and the vial was rinsed with toluene (3 ×100 
µL). The cloudy mixture was stirred at RT for 3 h and diluted with toluene (1.6 mL). 
The reaction was quenched by the addition of a sat. aq. NaHCO3 solution (1 mL) 
and the layers were separated. The aqueous phase was diluted with water (3 mL) 
and extracted with toluene (3 × 3 mL). The combined organic extracts were 
washed with brine (10 mL), dried over Na2SO4, filtered and concentrated. Crude 
material was purified by silica gel chromatography (hexane/EtOAc, 90:10) to afford 
ester 402 (11 mg, 8.0 µmol, 69%) as a colourless oil. Rf = 0.33 (hexane/EtOAc, 
90:10); [α]D22 −2.9 (c = 0.55, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.49 (1H, ddd, J 
= 15.1, 10.9, 1.0 Hz, CH−C26), 5.95−5.94 (1H, m, CH−C10), 5.93 (1H, dd, J = 2.7, 
1.9 Hz, 3JSnH = 132.0 Hz, CH−C31), 5.78 (1H, dm, J = 10.9 Hz, CH−C27), 5.42 
(1H, dd, J = 15.1, 7.8 Hz, CH−C25), 5.28 (1H, ddd, J = 7.8, 6.2, 1.0 Hz, CH−C24), 
5.23 (1H, dd, J = 2.7, 1.8 Hz, 3JSnH = 63.7 Hz, CH−C31), 4.35−4.27 (2H, m, 
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CH−C8, CH−C20), 4.24−4.16 (2H, m, CH−C3, CH−C13), 4.10−4.03 (2H, m, 
CH−C6, CH−C23), 3.51 (1H, dd, J = 7.4, 2.5 Hz, CH−C7), 2.97−2.89 (2H, m, 
CH−C16, CH−C17), 2.74 (1H, dd, J = 17.8, 6.0 Hz, CH−C14), 2.70 (1H, dd, J = 
15.5, 6.2 Hz, CH−C19), 2.62 (1H, dd, J = 17.8, 5.4 Hz, CH−C14), 2.59 (1H, dd, J = 
15.8, 6.6 Hz, CH−C2), 2.51 (1H, dd, J = 15.5, 6.8 Hz, CH−C19), 2.48−2.39 (3H, m, 
CH−C2, CH−C12, CH−C17), 2.30−2.22 (1H, m, CH−C4), 2.12 (1H, dddd, J = 12.0, 
8.0, 5.7, 3.6 Hz, CH−C21), 1.94 (1H, dddd, J = 12.4, 8.3, 7.0, 3.6 Hz, CH−C22), 
1.83 (3H, d, J = 1.1 Hz, CH3−C32), 1.77 (3H, br s, CH3−C35), 1.74 (3H, br s, 
CH3−C29), 1.78−1.65 (2H, m, CH−C5, CH−C22), 1.54−1.41 (8H, m, CH−C5, 
CH−C21, 3 × CH2−n-Bu3Sn), 1.32 (6H, h, J = 7.3 Hz, 3 × CH2−n-Bu3Sn), 1.06 (3H, 
d, J = 6.7 Hz, CH3−C34), 1.06 (3H, d, J = 7.0 Hz, CH3−C33), 0.91 (9H, s, CH3−t-
Bu TBS), 0.88 (9H, s, CH3−t-Bu TBS), 0.85 (9H, s, CH3−t-Bu TBS), 0.96−0.83 
(18H, m, CH3−C30, 3 × CH2−n-Bu3Sn, 3 × CH3−n-Bu3Sn), 0.08 (3H, s, CH3−TBS), 
0.07 (3H, s, CH3−TBS), 0.06 (3H, s, CH3−TBS), 0.03 (3H, s, CH3−TBS), −0.01 
(3H, s, CH3−TBS), −0.04 (3H, s, CH3−TBS); 13C NMR (126 MHz, CDCl3) δ 211.1 
(C−C15), 207.4 (C−C18), 170.7 (C−C1), 154.2 (C−C9), 150.0 (C−C11), 137.6 
(C−C28), 131.4 (CH−C26), 125.8 (CH2−C31), 124.5 (CH−C25), 124.4 (CH−C27), 
82.7 (CH−C8), 79.7 (CH−C23), 79.3 (CH−C7), 78.8 (CH−C6), 77.7 (CH−C10), 
76.5 (CH−C3), 76.5 (CH−C24), 75.4 (CH−C20), 69.3 (CH−C13), 48.9 (CH2−C19), 
48.4 (CH−C12), 47.5 (CH2−C14), 45.8 (CH2−C17), 41.6 (CH−C16), 37.6 
(CH2−C5), 36.7 (CH2−C2), 36.0 (CH−C4), 32.1 (CH2−C21), 29.3 (CH2−n-Bu3Sn), 
28.0 (CH2−C22), 27.6 (CH2−n-Bu3Sn), 26.6 (CH3−t-Bu TBS), 26.3 (CH3−t-Bu 
TBS), 26.2 (CH3−C35), 26.1 (CH3−t-Bu TBS), 23.9 (CH3−C32), 18.8 (C−t-Bu 
TBS), 18.7 (C−t-Bu TBS), 18.6 (CH3−C29), 18.2 (C−t-Bu TBS), 16.4 (CH3−C34), 
14.2 (CH3−C30), 13.9 (CH3−C33), 13.9 (CH3−n-Bu3Sn), 10.3 (CH2−n-Bu3Sn), −3.6 
(CH3−TBS), −3.9 (CH3−TBS), −4.2 (CH3−TBS), −4.3 (CH3−TBS), −4.3 (CH3−TBS), 
−4.5 (CH3−TBS); HRMS (ESI+) [M+Na]+ calcd for C65H121IO9Si3SnNa 1399.6277, 
found 1399.6253, Δ 1.7 ppm. 
References | 176 
4. References 
 
1. Lovering, F.; Bikker, J.; Humblet, C. J. Med. Chem. 2009, 52, 6752. 
2. Marris, E. Nature 2006, 443, 904. 
3. Montaser, R.; Luesch, H. Future Med. Chem. 2011, 3, 1475. 
4. Ledford, H. Nature 2010, 468, 608. 
5. Aicher, T. D.; Buszek, K. R.; Fang, F. G.; Forsyth, C. J.; Jung, S. H.; Kishi, Y.; 
Matellich, M. C.; Scola, P. M.; Spero, D. M.; Yoon, S. K. J. Am. Chem. Soc. 
1992, 114, 3162. 
6. Kobayashi, J.; Kubota, T. J. Nat. Prod. 2007, 70, 451. 
7. Kobayashi, J. J. Antibiot. 2008, 61, 271. 
8. Kobayashi, J.; Tsuda, M. Nat. Prod. Rep. 2004, 21, 77.  
9. Fürstner, A. Isr. J. Chem. 2011, 51, 329. 
10. (a) Clark, J. S.; Vignard, D.; Parkin, A. Org. Lett. 2011, 13, 3980. (b) Clark, J. 
S.; Delion, L.; Farrugia, L. J. Org. Lett. 2014, 16, 4300. (c) Clark, J. S.; Delion, 
L.; Farrugia, L. J. Chem. Eur. J. 2015, 21, 4772. (d) Clark, J. S.; Romiti, F. 
Angew. Chem. Int. Ed. 2013, 52, 10072. 
11. Kobayashi, J.; Ishibashi, M.; Wälchli, M. R.; Nakamura, H.; Hirata, Y.; Sasaki, 
T.; Ohizumi, Y. J. Am. Chem. Soc. 1988, 110, 490. 
12. Kobayashi, J.; Ishibashi, M. Chem. Rev. 1993, 93, 1753.  
13. Ishiyama, H.; Ishibashi, M.; Kobayashi, J. Chem. Pharm. Bull. 1996, 44, 1819.  
14. (a) Kubota, T.; Tsuda, M.; Kobayashi, J. Org. Lett. 2001, 3, 1363. (b) Kubota, 
T.; Tsuda, M.; Kobayashi, J. Tetrahedron 2003, 59, 1613. 
15. Kobayashi, J.; Tsuda, M.; Ishibashi, M.; Shigemori, H.; Yamasu, T.; Hirota, H.; 
Sasaki, T. J. Antibiot. 1991, 44, 1259. 
16. Kubota, T.; Sakuma, Y.; Tsuda, M.; Kobayashi, J. Mar. Drugs 2004, 2, 83. 
17. Kubota, T.; Suzuki, A.; Yamada, M.; Baba, S.; Kobayashi, J. Heterocycles 
2010, 82, 333.  
18. Mahapatra, S.; Carter, R. G. Angew. Chem. Int. Ed. 2012, 51, 7948.  
19. (a) Shotwell, J. B.; Roush, W. R. Org. Lett. 2004, 6, 3865. (b) Bates, R. H.; 
Shotwell, J. B.; Roush, W. R. Org. Lett. 2008, 10, 4343. 
20. Armstrong, A.; Pyrkotis, C. Tedrahedron Lett. 2009, 50, 3325.  
21. (a) Paudyal, M. P.; Rath, N. P.; Spilling, C. D. Org. Lett. 2010, 12, 2954. (b) 
Roy, S.; Spilling, C. D. Org. Lett. 2010, 12, 5326. 
References | 177 
 
22. Mohapatra, D. K.; Rahaman, H.; Chorghade, M. S.; Gurjar, M. K. Synlett 2007, 
567. 
23. (a) Morra, N. A.; Pagenkopf, B. L. Org. Lett. 2011, 13, 572. (b) Morra, N. A.; 
Pagenkopf, B. L. Tetrahedron 2013, 69, 8632. 
24. Ferrié, L.; Figadère, B. Org. Lett. 2010, 12, 4976.  
25. Wu, D.; Forsyth, C. J. Org. Lett. 2013, 15, 1178.  
26. (a) Clark, J. S.; Yang, G.; Osnowski, A. P. Org. Lett. 2013, 15, 1460. (b) Clark, 
J. S.; Yang, G.; Osnowski, A. P. Org. Lett. 2013, 15, 1464.  
27. Mahapatra, S.; Carter, R. G. J. Am. Chem. Soc. 2013, 135, 10792. 
28. (a) Valot, G.; Regens, C. S.; O' Malley, D. P.; Godineau, E.; Takikawa, H.; 
Fürstner, A. Angew. Chem. Int. Ed. 2013, 52, 9534. (b) Valot, G.; Mailhol, D.; 
Regens, C. S.; O' Malley, D. P.; Godineau, E.; Takikawa, H.; Philipps, P.; 
Fürstner, A. Chem. Eur. J. 2015, 21, 2398. 
29. Micalizio, G. C.; Roush, W. R. Org. Lett. 2000, 2, 461. 
30. (a) Brown, H. C.; Jadhav, P. K. J. Am. Chem. Soc. 1983, 105, 2092. (b) 
Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919. (c) Racherla, U. 
S.; Brown, H. C. J. Org. Chem. 1991, 56, 401.  
31. Keck, G. E.; Savin, K. A.; Cressman, E. N. K.; Abbott, D. E. J. Org. Chem. 
1994, 59, 7889.  
32. (a) Paton, R. S.; Goodman, J. M. Org. Lett. 2006, 8, 4299. (b) Paton, R. S.; 
Goodman, J. M. J. Org. Chem. 2008, 73, 1253. (c) Arikan, F.; Li, J.; Menche, 
D. Org. Lett. 2008, 10, 3521. (d) Paterson, I.; Steadman (née Doughty), V. A.; 
McLeod, M. D.; Trieselmann, T. Tetrahedron 2011, 67, 10119. (e) Dieckmann, 
M.; Rudolph, S.; Lang, C.; Ahlbrecht, W.; Menche, D. Synthesis 2013, 45, 
2305. 
33. Davies, H.; Hansen, T.; Rutberg, J.; Bruzinski, P. Tetrahedron Lett. 1997, 38, 
1741.  
34. Kimura, M.; Ezoe, A.; Mori, M.; Iwata, K.; Tamaru, Y. J. Am. Chem. Soc. 2006, 
128, 8559.  
35. Prestat, G.; Baylon, C.; Heck, M.-P.; Mioskowski, C. Tetrahedron Lett. 2000, 
41, 3829.  
36. (a) Jin, H.; Uenishi, J.; Chirst, W. J.; Kishi, Y. J. Am. Chem. Soc. 1986, 108, 
5644. (b) Fürstner, A. Chem. Rev. 1999, 99, 991. 
37. Jalce, G.; Frank, X.; Figadère, B. Eur. J. Org. Chem. 2009, 378.  
References | 178 
 
38. De Luca, L.; Giacomelli, G.; Porcheddu, A. Org. Lett. 2001, 3, 3041.  
39. Kazmaier, U.; Pohlman, M.; Schaub, D. Eur. J. Org. Chem. 2000, 2761.   
40. Albers, M. O.; Coville, N. J.; Ashworth, T. V.; Singleton, E.; Swanepoel, H. E. 
J. Organomet. Chem. 1980, 199, 55.  
41. Palmer, C.; Morra, N. A.; Stevens, A. C.; Bajtos, B.; Machin, B. P.; Pagenkopf, 
B. L. Org. Lett. 2009, 11, 5614.  
42. Pérez, B. M.; Schuch, D.; Hartung, J. Org. Biomol. Chem. 2008, 6, 3532.  
43. (a) Corey, E. J.; Bakshi, R. K.; Shibata, S. J. Am. Chem. Soc. 1987, 109, 5551. 
(b) Mathre, D. J.; Thompson, A. S.; Douglas, A. W.; Hoogsteen, K.; Carroll, J. 
D.; Corley, E. G.; Grabowski, E. J. J. J. Org. Chem. 1993, 58, 2880. 
44. Jones, D. K.; Liotta, D. C. J. Org. Chem. 1993, 58, 799.  
45. Schuch, D.; Fries, P.; Dönges, M.; Pérez, B. M.; Hartung, J. J. Am. Chem. 
Soc. 2009, 131, 12918. 
46. Raghavan, S.; Krishnaiah, V.; Rathore, K. Tetrahedron Lett. 2008, 49, 4999.  
47. Mahapatra, S.; Carter, R. G. Org. Biomol. Chem. 2009, 7, 4582.  
48. Vedejs, E.; Marth, C. F.; Ruggeri, R. J. Am. Chem. Soc. 1988, 110, 3940. 
49. Trost, B. M.; Weiss, A. H.; Wangelin, A. K.-V. J. Am. Chem. Soc. 2006, 128, 8.   
50. (a) Marshall, J. A.; Adams, N. D. J. Org. Chem. 1999, 64, 5201. (b) Marshall, 
J. A. J. Org. Chem. 2007, 72, 8153. 
51. Oppolzer, W.; Radinov, R. N. Tetrahedron Lett. 1991, 32, 5777.  
52. (a) Notz, W.; List, B. J. Am. Chem. Soc. 2000, 122, 7386. (b) Mukherjee, S.; 
Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471.   
53. Fürstner, A.; Funel, J.-A.; Tremblay, M.; Bouchez, L. C.; Nevado, C.; Waser, 
M.; Ackerstaff, J.; Stimson, C. C. Chem. Commun. 2008, 2873.  
54. (a) Nugent, W. A. Chem. Commun. 1999, 1369. (b) Kim, J. G.; Walsh, P. J. 
Angew. Chem. Int. Ed. 2006, 45, 4175. 
55. (a) Clark, J. S. Tetrahedron Lett. 1992, 33, 6193. (b) Clark, J. S.; Fretwell, M.; 
Whitlock, G. A.; Burns, C. J.; Fox, N. A. Tetrahedron Lett. 1998, 39, 97. (c) 
Clark, J. S.; Hansen, K. E. Chem. Eur. J. 2014, 20, 5454. 
56. Wipf, P.; Lim, S. Angew. Chem., Int. Ed. Engl. 1993, 32, 1068.  
57. (a) Crabtree, R. Acc. Chem. Res. 1979, 12, 331. (b) Crabtree, R.; Davis, M. W. 
J. Org. Chem. 1986, 51, 2655.   
58. Smith, A. B., III; Adams, C. M. Acc. Chem. Res. 2004, 37, 365.   
References | 179 
 
59. Nicolaou, K. C.; Prasad, C. V. C.; Somers, P. K.; Hwang, C.-K. J. Am. Chem. 
Soc. 1989, 111, 5330. 
60. Braddock, D. C.; Bhuva, R.; Pérez-Fuertes, Y.; Pouwer, R.; Roberts, C. A.; 
Ruggiero, A.; Stokes, E. S. E.; White, A. J. P. Chem. Commun. 2008, 1419.  
61. (a) Frick, J. A.; Klassen, J. B.; Bathe, A.; Abramson, J. M.; Rapoport, H. 
Synthesis 1992, 621. (b) Zurwerra, D.; Gertsch, J.; Altmann, K.-H. Org. Lett. 
2010, 12, 2302. 
62. (a) Nakayama, Y.; Kumar, G. B.; Kobayashi, Y. J. Org. Chem. 2000, 65, 707. 
(b) Trost, B. M.; Rey, J. Org. Lett. 2012, 14, 5632. 
63. Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, 
K. B. J. Am. Chem. Soc. 1987, 109, 5765.  
64. (a) Corey, E. J. J. Org. Chem. 1990, 55, 1693. (b) Finn, M. G.; Sharpless, K. B. 
J. Am. Chem. Soc. 1991, 113, 113. 
65. (a) Ohira, S. Synth. Commun. 1989, 19, 561. (b) Müller, S.; Liepold, B.; Roth, 
G. J.; Bestmann, H.-J. Synlett 1996, 521. 
66. Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734.  
67. Alami, M.; Ferri, F.; Linstrumelle, G. Tetrahedron Lett. 1993, 34, 6403.    
68. Tougerti, A.; Negri, S.; Jutand, A. Chem. Eur. J. 2007, 13, 666.  
69. (a) Canham, S. M.; France, D. J.; Overman, L. E. J. Am. Chem. Soc. 2010, 
132, 7876. (b) Hog, D. T.; Huber, F. M. E.; Mayer, P.; Trauner, D. Angew. 
Chem. Int. Ed. 2014, 53, 8513. 
70. Yang, G.; Osnowski, A. P., unpublished results.  
71. Connelly, N. G.; Einig, T.; Garcia Herbosa, G.; Hopkins, P. M.; Mealli, C.; 
Orpen, A. G.; Rosair, G. M.; Viguri, F. J. Chem. Soc., Dalton Trans. 1994, 
2025. 
72. (a) Reece, C. A.; Rodin, J. O.; Brownlee, R. G.; Duncan, W. G.; Silverstein, R. 
M. Tetrahedron 1968, 24, 4249. (b) Nishide, K.; Yokota, K.; Nakamura, D.; 
Sumiya, T.; Node, M.; Ueda, M.; Fuji, K. Tetrahedron Lett. 1993, 34, 3425.  
73. Romiti, F. PhD Thesis, University of Glasgow, 2015. 
74. (a) Ahmed, M.; Barrett, A. G. M.; Beall, J. C.; Braddock, D. C.; Flack, K.; 
Gibson, V. C.; Procopiou, P. A.; Salter, M. M. Tetrahedron 1999, 55, 3219. (b) 
Barrett, A. G. M.; Beall, J. C.; Braddock, D. C.; Flack, K.; Gibson, V. C.; Salter, 
M. M. J. Org. Chem. 2000, 65, 6508. (c) Denmark, S. E.; Yang, S.-M. 
Tetrahedron 2004, 60, 9695. (d) Gaich, T.; Mulzer, J. Org. Lett. 2005, 7, 1311. 
References | 180 
 
75. (a) Semmelhack, M. F.; Bodurow, C. J. Am. Chem. Soc. 1984, 106, 1496. (b) 
Semmelhack, M. F.; Zhang, N. J. Org. Chem. 1989, 54, 4483. (c) Nicolaou, K. 
C.; Peng, X.-S.; Sun, Y.-P.; Polet, D.; Zou, B.; Lim, C. S.; Chen, D. Y.-K. J. 
Am. Chem. Soc. 2009, 131, 10587. 
76. (a) Trost, B. M.; Ball, Z. T. J. Am. Chem. Soc. 2001, 123, 12726. (b) Trost, B. 
M.; Ball, Z. T.; Jöge, T. J. Am. Chem. Soc. 2002, 124, 7922. (c) Trost, B. M.; 
Ball, Z. T. J. Am. Chem. Soc. 2005, 127, 17644. 
77. (a) Sundararaju, B.; Fürstner, A. Angew. Chem. Int. Ed. 2013, 52, 14050. (b) 
Rummelt, S.; Fürstner, A. Angew. Chem. Int. Ed. 2014, 53, 3626. 
78. Romiti, F., unpublished results. 
79. (a) Moure, A. L.; Arrayás, R. G.; Cárdenas, D. J.; Alonso, I.; Carretero, J. C. J. 
Am. Chem. Soc. 2012, 134, 7219. (b) Hesse, M. J.; Butts, C. P.; Willis, C. L.; 
Aggarwal, V. K. Angew. Chem. Int. Ed. 2012, 51, 12444. (c) Meng, F.; 
Haeffner, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 11304. (d) Glaus, 
F.; Altmann, K.-H. Angew. Chem. Int. Ed. 2015, 54, 1937. 
80. Clark, J. S.; Xu, C. Angew. Chem. Int. Ed. 2016, 55, 4332.  
81. Luche, J.-L. J. Am. Chem. Soc. 1978, 100, 2226. 
82. Montevecchi, P. C.; Navacchia, M. L.; Spagnolo, P. Tetrahedron 1998, 54, 
8207.  
83. Kleinbeck, F.; Fettes, G. J.; Fader, L. D.; Carreira, E. M. Chem. Eur. J. 2012, 
18, 3598.  
84. (a) Kraus, G. A.; Taschner, M. J. Tetrahedron Lett. 1977, 4575. (b) Züger, M.; 
Weller, T.; Seebach, D. Helv. Chim. Acta 1980, 63, 2005. (c) Seebach, D.; 
Aebi, J.; Wasmuth, D. Org. Synth. 1985, 63, 109.  
85. Ferrié, L.; Reymond, S.; Capdevielle, P.; Cossy, J. Org. Lett. 2006, 8, 3441.  
86. Kim, C. H.; An, H. J.; Shin, W. K.; Yu, W.; Woo, S. K.; Jung, S. K.; Lee, E. 
Angew. Chem. Int. Ed. 2006, 45, 8019.  
87. Corey, E. J.; Fuchs, P. L. Tetrahedron Lett. 1972, 13, 3769.  
88. Rink, C.; Navickas, V.; Maier, M. E. Org. Lett. 2011, 13, 2334.  
89. (a) Negishi, E.; Yoshida, T. J. Am. Chem. Soc. 1981, 103, 4985. (b) Negishi, 
E.; Van Horn, D. E.; Yoshida, T. J. Am. Chem. Soc. 1985, 107, 6639. (c) 
Negishi, E.; Kondakov, D. Y.; Choueiry, D.; Kasai, K.; Takahashi, T. J. Am. 
Chem. Soc. 1996, 118, 9577. (d) Negishi, E.; Kondakov, D. Y. Chem. Soc. 
Rev. 1996, 25, 417. 
References | 181 
 
90. (a) Brinkmann, Y.; Oger, C.; Guy, A.; Durand, T.; Galano, J.-M. J. Org. Chem. 
2010, 75, 2411. (b) Porta, A.; Chiesa, F.; Quaroni, M.; Persico, M.; Moratti, R.; 
Zanoni, G.; Vidari, G. Eur. J. Org. Chem. 2014, 2111. 
91. Arlt, A.; Benson, S.; Schulthoff, S.; Gabor, B.; Fürstner, A. Chem. Eur. J. 2013, 
19, 3596.  
92. Nakahata, T.; Satoh, Y.; Kuwahara, S. Tetrahedron Lett. 2008, 49, 2438.  
93 . Vulpetti, A.; Bernardi, A.; Gennari, C.; Goodman, J. M.; Paterson, I. 
Tetrahedron 1993, 49, 685.  
94. Hoye, T. R.; Jeffrey, C. S.; Shao, F. Nat. Protoc. 2007, 2, 2451. 
95. Tsunoda, T.; Yamamiya, Y.; Kawamura, Y.; Itô, S. Tetrahedron Lett. 1995, 36, 
2529. 
96. (a) Farina, V.; Krishnan, B. J. Am. Chem. Soc. 1991, 113, 9585. (b) Amatore, 
C.; Bahsoun, A. A.; Jutand, A.; Meyer, G.; Ntepe, A. N.; Ricard, L. J. Am. 
Chem. Soc. 2003, 125, 4212. (c) Espinet, P.; Echavarren, A. M. Angew. 
Chem. Int. Ed. 2004, 43, 4704. 
97. (a) Srogl, J.; Allred, G. D.; Liebeskind, L. S. J. Am. Chem. Soc. 1997, 119, 
12376. (b) Nielsen, T. E.; Le Quement, S.; Juhl, M.; Tanner, D. Tetrahedron 
2005, 61, 8013. 
98. Smith, A. B., III; Condon, S. M.; McCauley, J. A.; Leazer, J. L., Jr; Leahy, J. 
W.; Maleczka, R. E., Jr. J. Am. Chem. Soc. 1997, 119, 962. 
99. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. 
Jpn. 1979, 52, 1989.  
100. Cid, M. B.; Pattenden, G. Tetrahedron Lett. 2000, 41, 7373.  
101. Paterson, I.; Florence, G. J.; Gerlach, K.; Scott, J. P.; Sereinig, N. J. Am. 
Chem. Soc. 2001, 123, 9535. 
102. Smith, A. B., III; Ott, G. R. J. Am. Chem. Soc. 1996, 118, 13095.    
103. McGowan, M. A.; Stevenson, C. P.; Schiffler, M. A.; Jacobsen, E. N. Angew. 
Chem. Int. Ed. 2010, 49, 6147.  
104. Qayed, W. S.; Luzzio, F. A. Lett. Org. Chem. 2015, 12, 622. 
105. Arikan, F.; Li, J.; Menche, D. Org. Lett. 2008, 10, 3521. 
106. Wipf, P.; Xiao, J. Org. Lett. 2005, 7, 103. 
Appendices | 182 
Appendices 
 
1H and 13C NMR Spectra of Selected Compounds 
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